1 |
96-48-0 |
AAAS |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of AAAS mRNA |
affects^cotreatment|increases^expression |
19167446 |
2 |
96-48-0 |
AAAS |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of AAAS mRNA |
affects^cotreatment|increases^expression |
19167446 |
3 |
96-48-0 |
ABCC5 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ABCC5 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
4 |
96-48-0 |
ABCC5 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ABCC5 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
5 |
96-48-0 |
ABCF1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ABCF1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
6 |
96-48-0 |
ABCF1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ABCF1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
7 |
96-48-0 |
ABCG1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ABCG1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
8 |
96-48-0 |
ABCG1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ABCG1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
9 |
96-48-0 |
ABHD11 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ABHD11 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
10 |
96-48-0 |
ABHD11 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ABHD11 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
11 |
96-48-0 |
ABHD12 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ABHD12 mRNA |
affects^cotreatment|increases^expression |
19167446 |
12 |
96-48-0 |
ABHD12 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ABHD12 mRNA |
affects^cotreatment|increases^expression |
19167446 |
13 |
96-48-0 |
ABHD2 |
Homo sapiens |
2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of ABHD2 mRNA |
decreases^expression |
19167446 |
14 |
96-48-0 |
ABHD2 |
Homo sapiens |
2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of ABHD2 mRNA |
decreases^expression |
19167446 |
15 |
96-48-0 |
ACAA2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ACAA2 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
16 |
96-48-0 |
ACAA2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ACAA2 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
17 |
96-48-0 |
ACAT2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ACAT2 mRNA |
affects^cotreatment|increases^expression |
19167446 |
18 |
96-48-0 |
ACAT2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ACAT2 mRNA |
affects^cotreatment|increases^expression |
19167446 |
19 |
96-48-0 |
ACBD3 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ACBD3 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
20 |
96-48-0 |
ACBD3 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ACBD3 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
21 |
96-48-0 |
ACKR3 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ACKR3 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
22 |
96-48-0 |
ACKR3 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ACKR3 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
23 |
96-48-0 |
ACLY |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ACLY mRNA |
affects^cotreatment|increases^expression |
19167446 |
24 |
96-48-0 |
ACLY |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ACLY mRNA |
affects^cotreatment|increases^expression |
19167446 |
25 |
96-48-0 |
ACOT4 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ACOT4 mRNA |
affects^cotreatment|increases^expression |
19167446 |
26 |
96-48-0 |
ACOT4 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ACOT4 mRNA |
affects^cotreatment|increases^expression |
19167446 |
27 |
96-48-0 |
ACOT7 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ACOT7 mRNA |
affects^cotreatment|increases^expression |
19167446 |
28 |
96-48-0 |
ACOT7 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ACOT7 mRNA |
affects^cotreatment|increases^expression |
19167446 |
29 |
96-48-0 |
ACYP1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ACYP1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
30 |
96-48-0 |
ACYP1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ACYP1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
31 |
96-48-0 |
ADAT1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ADAT1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
32 |
96-48-0 |
ADAT1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ADAT1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
33 |
96-48-0 |
ADD3 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ADD3 mRNA |
affects^cotreatment|increases^expression |
19167446 |
34 |
96-48-0 |
ADD3 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ADD3 mRNA |
affects^cotreatment|increases^expression |
19167446 |
35 |
96-48-0 |
AFAP1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of AFAP1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
36 |
96-48-0 |
AFAP1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of AFAP1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
37 |
96-48-0 |
AFF4 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of AFF4 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
38 |
96-48-0 |
AFF4 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of AFF4 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
39 |
96-48-0 |
AGR2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of AGR2 mRNA |
affects^cotreatment|increases^expression |
19167446 |
40 |
96-48-0 |
AGR2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of AGR2 mRNA |
affects^cotreatment|increases^expression |
19167446 |
41 |
96-48-0 |
AGR3 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of AGR3 mRNA |
affects^cotreatment|increases^expression |
19167446 |
42 |
96-48-0 |
AGR3 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of AGR3 mRNA |
affects^cotreatment|increases^expression |
19167446 |
43 |
96-48-0 |
AJUBA |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of AJUBA mRNA |
affects^cotreatment|decreases^expression |
19167446 |
44 |
96-48-0 |
AJUBA |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of AJUBA mRNA |
affects^cotreatment|decreases^expression |
19167446 |
45 |
96-48-0 |
AKAP13 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of AKAP13 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
46 |
96-48-0 |
AKAP13 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of AKAP13 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
47 |
96-48-0 |
ALG6 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ALG6 mRNA |
affects^cotreatment|increases^expression |
19167446 |
48 |
96-48-0 |
ALG6 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ALG6 mRNA |
affects^cotreatment|increases^expression |
19167446 |
49 |
96-48-0 |
ALG8 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ALG8 mRNA |
affects^cotreatment|increases^expression |
19167446 |
50 |
96-48-0 |
ALG8 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ALG8 mRNA |
affects^cotreatment|increases^expression |
19167446 |
51 |
96-48-0 |
AMD1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of AMD1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
52 |
96-48-0 |
AMD1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of AMD1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
53 |
96-48-0 |
AMMECR1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of AMMECR1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
54 |
96-48-0 |
AMMECR1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of AMMECR1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
55 |
96-48-0 |
AMOTL2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of AMOTL2 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
56 |
96-48-0 |
AMOTL2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of AMOTL2 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
57 |
96-48-0 |
ANLN |
Homo sapiens |
2,3-bis(3'-hydroxybenzyl)butyrolactone results in increased expression of ANLN mRNA |
increases^expression |
19167446 |
58 |
96-48-0 |
ANLN |
Homo sapiens |
2,3-bis(3'-hydroxybenzyl)butyrolactone results in increased expression of ANLN mRNA |
increases^expression |
19167446 |
59 |
96-48-0 |
ANLN |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ANLN mRNA |
affects^cotreatment|increases^expression |
19167446 |
60 |
96-48-0 |
ANLN |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ANLN mRNA |
affects^cotreatment|increases^expression |
19167446 |
61 |
96-48-0 |
ANO6 |
Homo sapiens |
2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of ANO6 mRNA |
decreases^expression |
19167446 |
62 |
96-48-0 |
ANO6 |
Homo sapiens |
2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of ANO6 mRNA |
decreases^expression |
19167446 |
63 |
96-48-0 |
ANO6 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ANO6 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
64 |
96-48-0 |
ANO6 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ANO6 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
65 |
96-48-0 |
ANP32E |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ANP32E mRNA |
affects^cotreatment|increases^expression |
19167446 |
66 |
96-48-0 |
ANP32E |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ANP32E mRNA |
affects^cotreatment|increases^expression |
19167446 |
67 |
96-48-0 |
ANXA2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ANXA2 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
68 |
96-48-0 |
ANXA2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ANXA2 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
69 |
96-48-0 |
ANXA2P2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ANXA2P2 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
70 |
96-48-0 |
ANXA2P2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ANXA2P2 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
71 |
96-48-0 |
ANXA3 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ANXA3 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
72 |
96-48-0 |
ANXA3 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ANXA3 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
73 |
96-48-0 |
ANXA9 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ANXA9 mRNA |
affects^cotreatment|increases^expression |
19167446 |
74 |
96-48-0 |
ANXA9 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ANXA9 mRNA |
affects^cotreatment|increases^expression |
19167446 |
75 |
96-48-0 |
AP1B1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of AP1B1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
76 |
96-48-0 |
AP1B1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of AP1B1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
77 |
96-48-0 |
AP1M1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of AP1M1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
78 |
96-48-0 |
AP1M1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of AP1M1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
79 |
96-48-0 |
APBB2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of APBB2 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
80 |
96-48-0 |
APBB2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of APBB2 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
81 |
96-48-0 |
APOBEC3B |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of APOBEC3B mRNA |
affects^cotreatment|increases^expression |
19167446 |
82 |
96-48-0 |
APOBEC3B |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of APOBEC3B mRNA |
affects^cotreatment|increases^expression |
19167446 |
83 |
96-48-0 |
AQP3 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of AQP3 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
84 |
96-48-0 |
AQP3 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of AQP3 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
85 |
96-48-0 |
ARFGEF3 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ARFGEF3 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
86 |
96-48-0 |
ARFGEF3 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ARFGEF3 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
87 |
96-48-0 |
ARHGDIA |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ARHGDIA mRNA |
affects^cotreatment|increases^expression |
19167446 |
88 |
96-48-0 |
ARHGDIA |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ARHGDIA mRNA |
affects^cotreatment|increases^expression |
19167446 |
89 |
96-48-0 |
ARHGEF26 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ARHGEF26 mRNA |
affects^cotreatment|increases^expression |
19167446 |
90 |
96-48-0 |
ARHGEF26 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ARHGEF26 mRNA |
affects^cotreatment|increases^expression |
19167446 |
91 |
96-48-0 |
ARHGEF37 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ARHGEF37 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
92 |
96-48-0 |
ARHGEF37 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ARHGEF37 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
93 |
96-48-0 |
ARL3 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ARL3 mRNA |
affects^cotreatment|increases^expression |
19167446 |
94 |
96-48-0 |
ARL3 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ARL3 mRNA |
affects^cotreatment|increases^expression |
19167446 |
95 |
96-48-0 |
ARS2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ARS2 mRNA |
affects^cotreatment|increases^expression |
19167446 |
96 |
96-48-0 |
ARS2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ARS2 mRNA |
affects^cotreatment|increases^expression |
19167446 |
97 |
96-48-0 |
ARX |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ARX mRNA |
affects^cotreatment|decreases^expression |
19167446 |
98 |
96-48-0 |
ARX |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ARX mRNA |
affects^cotreatment|decreases^expression |
19167446 |
99 |
96-48-0 |
ASF1B |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ASF1B mRNA |
affects^cotreatment|increases^expression |
19167446 |
100 |
96-48-0 |
ASF1B |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ASF1B mRNA |
affects^cotreatment|increases^expression |
19167446 |
101 |
96-48-0 |
ASPM |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ASPM mRNA |
affects^cotreatment|increases^expression |
19167446 |
102 |
96-48-0 |
ASPM |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ASPM mRNA |
affects^cotreatment|increases^expression |
19167446 |
103 |
96-48-0 |
ATAD2 |
Homo sapiens |
2,3-bis(3'-hydroxybenzyl)butyrolactone results in increased expression of ATAD2 mRNA |
increases^expression |
19167446 |
104 |
96-48-0 |
ATAD2 |
Homo sapiens |
2,3-bis(3'-hydroxybenzyl)butyrolactone results in increased expression of ATAD2 mRNA |
increases^expression |
19167446 |
105 |
96-48-0 |
ATAD2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ATAD2 mRNA |
affects^cotreatment|increases^expression |
19167446 |
106 |
96-48-0 |
ATAD2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ATAD2 mRNA |
affects^cotreatment|increases^expression |
19167446 |
107 |
96-48-0 |
ATF3 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ATF3 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
108 |
96-48-0 |
ATF3 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ATF3 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
109 |
96-48-0 |
ATF5 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ATF5 mRNA |
affects^cotreatment|increases^expression |
19167446 |
110 |
96-48-0 |
ATF5 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ATF5 mRNA |
affects^cotreatment|increases^expression |
19167446 |
111 |
96-48-0 |
ATP1B1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ATP1B1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
112 |
96-48-0 |
ATP1B1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ATP1B1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
113 |
96-48-0 |
ATP23 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ATP23 mRNA |
affects^cotreatment|increases^expression |
19167446 |
114 |
96-48-0 |
ATP23 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ATP23 mRNA |
affects^cotreatment|increases^expression |
19167446 |
115 |
96-48-0 |
ATP2B1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ATP2B1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
116 |
96-48-0 |
ATP2B1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ATP2B1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
117 |
96-48-0 |
ATP2C1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ATP2C1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
118 |
96-48-0 |
ATP2C1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ATP2C1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
119 |
96-48-0 |
ATP5G1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ATP5G1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
120 |
96-48-0 |
ATP5G1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ATP5G1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
121 |
96-48-0 |
ATP6V0E1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ATP6V0E1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
122 |
96-48-0 |
ATP6V0E1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ATP6V0E1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
123 |
96-48-0 |
ATP9A |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ATP9A mRNA |
affects^cotreatment|decreases^expression |
19167446 |
124 |
96-48-0 |
ATP9A |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ATP9A mRNA |
affects^cotreatment|decreases^expression |
19167446 |
125 |
96-48-0 |
ATRX |
Homo sapiens |
2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of ATRX mRNA |
decreases^expression |
19167446 |
126 |
96-48-0 |
ATRX |
Homo sapiens |
2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of ATRX mRNA |
decreases^expression |
19167446 |
127 |
96-48-0 |
ATXN1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ATXN1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
128 |
96-48-0 |
ATXN1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ATXN1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
129 |
96-48-0 |
AURKA |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of AURKA mRNA |
affects^cotreatment|increases^expression |
19167446 |
130 |
96-48-0 |
AURKA |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of AURKA mRNA |
affects^cotreatment|increases^expression |
19167446 |
131 |
96-48-0 |
AURKB |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of AURKB mRNA |
affects^cotreatment|increases^expression |
19167446 |
132 |
96-48-0 |
AURKB |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of AURKB mRNA |
affects^cotreatment|increases^expression |
19167446 |
133 |
96-48-0 |
AXUD1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of AXUD1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
134 |
96-48-0 |
AXUD1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of AXUD1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
135 |
96-48-0 |
B3GALNT1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of B3GALNT1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
136 |
96-48-0 |
B3GALNT1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of B3GALNT1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
137 |
96-48-0 |
B3GNT5 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of B3GNT5 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
138 |
96-48-0 |
B3GNT5 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of B3GNT5 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
139 |
96-48-0 |
BACE1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of BACE1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
140 |
96-48-0 |
BACE1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of BACE1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
141 |
96-48-0 |
BACE2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of BACE2 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
142 |
96-48-0 |
BACE2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of BACE2 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
143 |
96-48-0 |
BAG3 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of BAG3 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
144 |
96-48-0 |
BAG3 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of BAG3 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
145 |
96-48-0 |
BARD1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of BARD1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
146 |
96-48-0 |
BARD1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of BARD1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
147 |
96-48-0 |
BCAR3 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of BCAR3 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
148 |
96-48-0 |
BCAR3 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of BCAR3 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
149 |
96-48-0 |
BCL2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of BCL2 mRNA |
affects^cotreatment|increases^expression |
19167446 |
150 |
96-48-0 |
BCL2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of BCL2 mRNA |
affects^cotreatment|increases^expression |
19167446 |
151 |
96-48-0 |
BCL2L12 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of BCL2L12 mRNA |
affects^cotreatment|increases^expression |
19167446 |
152 |
96-48-0 |
BCL2L12 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of BCL2L12 mRNA |
affects^cotreatment|increases^expression |
19167446 |
153 |
96-48-0 |
BCL3 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of BCL3 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
154 |
96-48-0 |
BCL3 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of BCL3 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
155 |
96-48-0 |
BCL9 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of BCL9 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
156 |
96-48-0 |
BCL9 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of BCL9 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
157 |
96-48-0 |
BEX2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of BEX2 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
158 |
96-48-0 |
BEX2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of BEX2 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
159 |
96-48-0 |
BHLHE40 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of BHLHE40 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
160 |
96-48-0 |
BHLHE40 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of BHLHE40 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
161 |
96-48-0 |
BIRC5 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of BIRC5 mRNA |
affects^cotreatment|increases^expression |
19167446 |
162 |
96-48-0 |
BIRC5 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of BIRC5 mRNA |
affects^cotreatment|increases^expression |
19167446 |
163 |
96-48-0 |
BLM |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of BLM mRNA |
affects^cotreatment|increases^expression |
19167446 |
164 |
96-48-0 |
BLM |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of BLM mRNA |
affects^cotreatment|increases^expression |
19167446 |
165 |
96-48-0 |
BLNK |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of BLNK mRNA |
affects^cotreatment|decreases^expression |
19167446 |
166 |
96-48-0 |
BLNK |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of BLNK mRNA |
affects^cotreatment|decreases^expression |
19167446 |
167 |
96-48-0 |
BMF |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of BMF mRNA |
affects^cotreatment|decreases^expression |
19167446 |
168 |
96-48-0 |
BMF |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of BMF mRNA |
affects^cotreatment|decreases^expression |
19167446 |
169 |
96-48-0 |
BMP7 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of BMP7 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
170 |
96-48-0 |
BMP7 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of BMP7 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
171 |
96-48-0 |
BMPR2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of BMPR2 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
172 |
96-48-0 |
BMPR2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of BMPR2 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
173 |
96-48-0 |
BRAT1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of BRAT1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
174 |
96-48-0 |
BRAT1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of BRAT1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
175 |
96-48-0 |
BRCA1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of BRCA1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
176 |
96-48-0 |
BRCA1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of BRCA1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
177 |
96-48-0 |
BRCA2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of BRCA2 mRNA |
affects^cotreatment|increases^expression |
19167446 |
178 |
96-48-0 |
BRCA2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of BRCA2 mRNA |
affects^cotreatment|increases^expression |
19167446 |
179 |
96-48-0 |
BRI3BP |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of BRI3BP mRNA |
affects^cotreatment|increases^expression |
19167446 |
180 |
96-48-0 |
BRI3BP |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of BRI3BP mRNA |
affects^cotreatment|increases^expression |
19167446 |
181 |
96-48-0 |
BRWD1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of BRWD1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
182 |
96-48-0 |
BRWD1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of BRWD1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
183 |
96-48-0 |
BSDC1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of BSDC1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
184 |
96-48-0 |
BSDC1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of BSDC1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
185 |
96-48-0 |
BSG |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of BSG mRNA |
affects^cotreatment|increases^expression |
19167446 |
186 |
96-48-0 |
BSG |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of BSG mRNA |
affects^cotreatment|increases^expression |
19167446 |
187 |
96-48-0 |
BTG1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of BTG1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
188 |
96-48-0 |
BTG1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of BTG1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
189 |
96-48-0 |
BUB1B |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of BUB1B mRNA |
affects^cotreatment|increases^expression |
19167446 |
190 |
96-48-0 |
BUB1B |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of BUB1B mRNA |
affects^cotreatment|increases^expression |
19167446 |
191 |
96-48-0 |
C16ORF45 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of C16ORF45 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
192 |
96-48-0 |
C16ORF45 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of C16ORF45 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
193 |
96-48-0 |
C1ORF112 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of C1ORF112 mRNA |
affects^cotreatment|increases^expression |
19167446 |
194 |
96-48-0 |
C1ORF112 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of C1ORF112 mRNA |
affects^cotreatment|increases^expression |
19167446 |
195 |
96-48-0 |
C5 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of C5 mRNA |
affects^cotreatment|increases^expression |
19167446 |
196 |
96-48-0 |
C5 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of C5 mRNA |
affects^cotreatment|increases^expression |
19167446 |
197 |
96-48-0 |
C5ORF34 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of C5ORF34 mRNA |
affects^cotreatment|increases^expression |
19167446 |
198 |
96-48-0 |
C5ORF34 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of C5ORF34 mRNA |
affects^cotreatment|increases^expression |
19167446 |
199 |
96-48-0 |
C9ORF152 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of C9ORF152 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
200 |
96-48-0 |
C9ORF152 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of C9ORF152 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
201 |
96-48-0 |
C9ORF40 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of C9ORF40 mRNA |
affects^cotreatment|increases^expression |
19167446 |
202 |
96-48-0 |
C9ORF40 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of C9ORF40 mRNA |
affects^cotreatment|increases^expression |
19167446 |
203 |
96-48-0 |
CA12 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CA12 mRNA |
affects^cotreatment|increases^expression |
19167446 |
204 |
96-48-0 |
CA12 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CA12 mRNA |
affects^cotreatment|increases^expression |
19167446 |
205 |
96-48-0 |
CADM1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CADM1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
206 |
96-48-0 |
CADM1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CADM1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
207 |
96-48-0 |
CALM3 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CALM3 mRNA |
affects^cotreatment|increases^expression |
19167446 |
208 |
96-48-0 |
CALM3 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CALM3 mRNA |
affects^cotreatment|increases^expression |
19167446 |
209 |
96-48-0 |
CALU |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CALU mRNA |
affects^cotreatment|increases^expression |
19167446 |
210 |
96-48-0 |
CALU |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CALU mRNA |
affects^cotreatment|increases^expression |
19167446 |
211 |
96-48-0 |
CAMK2D |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CAMK2D mRNA |
affects^cotreatment|decreases^expression |
19167446 |
212 |
96-48-0 |
CAMK2D |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CAMK2D mRNA |
affects^cotreatment|decreases^expression |
19167446 |
213 |
96-48-0 |
CAMK2N1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CAMK2N1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
214 |
96-48-0 |
CAMK2N1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CAMK2N1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
215 |
96-48-0 |
CARHSP1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CARHSP1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
216 |
96-48-0 |
CARHSP1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CARHSP1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
217 |
96-48-0 |
CAST |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CAST mRNA |
affects^cotreatment|decreases^expression |
19167446 |
218 |
96-48-0 |
CAST |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CAST mRNA |
affects^cotreatment|decreases^expression |
19167446 |
219 |
96-48-0 |
CBFB |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CBFB mRNA |
affects^cotreatment|increases^expression |
19167446 |
220 |
96-48-0 |
CBFB |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CBFB mRNA |
affects^cotreatment|increases^expression |
19167446 |
221 |
96-48-0 |
CBLB |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CBLB mRNA |
affects^cotreatment|decreases^expression |
19167446 |
222 |
96-48-0 |
CBLB |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CBLB mRNA |
affects^cotreatment|decreases^expression |
19167446 |
223 |
96-48-0 |
CCDC14 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CCDC14 mRNA |
affects^cotreatment|increases^expression |
19167446 |
224 |
96-48-0 |
CCDC14 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CCDC14 mRNA |
affects^cotreatment|increases^expression |
19167446 |
225 |
96-48-0 |
CCDC34 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CCDC34 mRNA |
affects^cotreatment|increases^expression |
19167446 |
226 |
96-48-0 |
CCDC34 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CCDC34 mRNA |
affects^cotreatment|increases^expression |
19167446 |
227 |
96-48-0 |
CCNB1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CCNB1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
228 |
96-48-0 |
CCNB1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CCNB1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
229 |
96-48-0 |
CCNB2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CCNB2 mRNA |
affects^cotreatment|increases^expression |
19167446 |
230 |
96-48-0 |
CCNB2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CCNB2 mRNA |
affects^cotreatment|increases^expression |
19167446 |
231 |
96-48-0 |
CCNE2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CCNE2 mRNA |
affects^cotreatment|increases^expression |
19167446 |
232 |
96-48-0 |
CCNE2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CCNE2 mRNA |
affects^cotreatment|increases^expression |
19167446 |
233 |
96-48-0 |
CCNF |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CCNF mRNA |
affects^cotreatment|increases^expression |
19167446 |
234 |
96-48-0 |
CCNF |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CCNF mRNA |
affects^cotreatment|increases^expression |
19167446 |
235 |
96-48-0 |
CCPG1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CCPG1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
236 |
96-48-0 |
CCPG1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CCPG1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
237 |
96-48-0 |
CD55 |
Homo sapiens |
2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of CD55 mRNA |
decreases^expression |
19167446 |
238 |
96-48-0 |
CD55 |
Homo sapiens |
2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of CD55 mRNA |
decreases^expression |
19167446 |
239 |
96-48-0 |
CD55 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CD55 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
240 |
96-48-0 |
CD55 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CD55 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
241 |
96-48-0 |
CD59 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CD59 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
242 |
96-48-0 |
CD59 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CD59 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
243 |
96-48-0 |
CDC25A |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDC25A mRNA |
affects^cotreatment|increases^expression |
19167446 |
244 |
96-48-0 |
CDC25A |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDC25A mRNA |
affects^cotreatment|increases^expression |
19167446 |
245 |
96-48-0 |
CDC25C |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDC25C mRNA |
affects^cotreatment|increases^expression |
19167446 |
246 |
96-48-0 |
CDC25C |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDC25C mRNA |
affects^cotreatment|increases^expression |
19167446 |
247 |
96-48-0 |
CDC27 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDC27 mRNA |
affects^cotreatment|increases^expression |
19167446 |
248 |
96-48-0 |
CDC27 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDC27 mRNA |
affects^cotreatment|increases^expression |
19167446 |
249 |
96-48-0 |
CDC45L |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDC45L mRNA |
affects^cotreatment|increases^expression |
19167446 |
250 |
96-48-0 |
CDC45L |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDC45L mRNA |
affects^cotreatment|increases^expression |
19167446 |
251 |
96-48-0 |
CDC6 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDC6 mRNA |
affects^cotreatment|increases^expression |
19167446 |
252 |
96-48-0 |
CDC6 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDC6 mRNA |
affects^cotreatment|increases^expression |
19167446 |
253 |
96-48-0 |
CDC7 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDC7 mRNA |
affects^cotreatment|increases^expression |
19167446 |
254 |
96-48-0 |
CDC7 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDC7 mRNA |
affects^cotreatment|increases^expression |
19167446 |
255 |
96-48-0 |
CDCA2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDCA2 mRNA |
affects^cotreatment|increases^expression |
19167446 |
256 |
96-48-0 |
CDCA2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDCA2 mRNA |
affects^cotreatment|increases^expression |
19167446 |
257 |
96-48-0 |
CDCA3 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDCA3 mRNA |
affects^cotreatment|increases^expression |
19167446 |
258 |
96-48-0 |
CDCA3 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDCA3 mRNA |
affects^cotreatment|increases^expression |
19167446 |
259 |
96-48-0 |
CDCA4 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDCA4 mRNA |
affects^cotreatment|increases^expression |
19167446 |
260 |
96-48-0 |
CDCA4 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDCA4 mRNA |
affects^cotreatment|increases^expression |
19167446 |
261 |
96-48-0 |
CDCA5 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDCA5 mRNA |
affects^cotreatment|increases^expression |
19167446 |
262 |
96-48-0 |
CDCA5 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDCA5 mRNA |
affects^cotreatment|increases^expression |
19167446 |
263 |
96-48-0 |
CDCA7L |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDCA7L mRNA |
affects^cotreatment|increases^expression |
19167446 |
264 |
96-48-0 |
CDCA7L |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDCA7L mRNA |
affects^cotreatment|increases^expression |
19167446 |
265 |
96-48-0 |
CDCA8 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDCA8 mRNA |
affects^cotreatment|increases^expression |
19167446 |
266 |
96-48-0 |
CDCA8 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDCA8 mRNA |
affects^cotreatment|increases^expression |
19167446 |
267 |
96-48-0 |
CDH12 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDH12 mRNA |
affects^cotreatment|increases^expression |
19167446 |
268 |
96-48-0 |
CDH12 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDH12 mRNA |
affects^cotreatment|increases^expression |
19167446 |
269 |
96-48-0 |
CDK1 |
Homo sapiens |
2,3-bis(3'-hydroxybenzyl)butyrolactone results in increased expression of CDK1 mRNA |
increases^expression |
19167446 |
270 |
96-48-0 |
CDK1 |
Homo sapiens |
2,3-bis(3'-hydroxybenzyl)butyrolactone results in increased expression of CDK1 mRNA |
increases^expression |
19167446 |
271 |
96-48-0 |
CDK1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDK1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
272 |
96-48-0 |
CDK1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDK1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
273 |
96-48-0 |
CDK2AP2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDK2AP2 mRNA |
affects^cotreatment|increases^expression |
19167446 |
274 |
96-48-0 |
CDK2AP2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDK2AP2 mRNA |
affects^cotreatment|increases^expression |
19167446 |
275 |
96-48-0 |
CDK5RAP2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDK5RAP2 mRNA |
affects^cotreatment|increases^expression |
19167446 |
276 |
96-48-0 |
CDK5RAP2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDK5RAP2 mRNA |
affects^cotreatment|increases^expression |
19167446 |
277 |
96-48-0 |
CDKN1A |
Homo sapiens |
2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of CDKN1A mRNA |
decreases^expression |
19167446 |
278 |
96-48-0 |
CDKN1A |
Homo sapiens |
2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of CDKN1A mRNA |
decreases^expression |
19167446 |
279 |
96-48-0 |
CDKN1A |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CDKN1A mRNA |
affects^cotreatment|decreases^expression |
19167446 |
280 |
96-48-0 |
CDKN1A |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CDKN1A mRNA |
affects^cotreatment|decreases^expression |
19167446 |
281 |
96-48-0 |
CDKN2B |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CDKN2B mRNA |
affects^cotreatment|decreases^expression |
19167446 |
282 |
96-48-0 |
CDKN2B |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CDKN2B mRNA |
affects^cotreatment|decreases^expression |
19167446 |
283 |
96-48-0 |
CDKN2C |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDKN2C mRNA |
affects^cotreatment|increases^expression |
19167446 |
284 |
96-48-0 |
CDKN2C |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDKN2C mRNA |
affects^cotreatment|increases^expression |
19167446 |
285 |
96-48-0 |
CDKN3 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDKN3 mRNA |
affects^cotreatment|increases^expression |
19167446 |
286 |
96-48-0 |
CDKN3 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDKN3 mRNA |
affects^cotreatment|increases^expression |
19167446 |
287 |
96-48-0 |
CDS1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CDS1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
288 |
96-48-0 |
CDS1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CDS1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
289 |
96-48-0 |
CDT1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDT1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
290 |
96-48-0 |
CDT1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDT1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
291 |
96-48-0 |
CEBPD |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CEBPD mRNA |
affects^cotreatment|decreases^expression |
19167446 |
292 |
96-48-0 |
CEBPD |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CEBPD mRNA |
affects^cotreatment|decreases^expression |
19167446 |
293 |
96-48-0 |
CELSR2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CELSR2 mRNA |
affects^cotreatment|increases^expression |
19167446 |
294 |
96-48-0 |
CELSR2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CELSR2 mRNA |
affects^cotreatment|increases^expression |
19167446 |
295 |
96-48-0 |
CENPA |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CENPA mRNA |
affects^cotreatment|increases^expression |
19167446 |
296 |
96-48-0 |
CENPA |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CENPA mRNA |
affects^cotreatment|increases^expression |
19167446 |
297 |
96-48-0 |
CENPF |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CENPF mRNA |
affects^cotreatment|increases^expression |
19167446 |
298 |
96-48-0 |
CENPF |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CENPF mRNA |
affects^cotreatment|increases^expression |
19167446 |
299 |
96-48-0 |
CENPH |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CENPH mRNA |
affects^cotreatment|increases^expression |
19167446 |
300 |
96-48-0 |
CENPH |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CENPH mRNA |
affects^cotreatment|increases^expression |
19167446 |
301 |
96-48-0 |
CENPI |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CENPI mRNA |
affects^cotreatment|increases^expression |
19167446 |
302 |
96-48-0 |
CENPI |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CENPI mRNA |
affects^cotreatment|increases^expression |
19167446 |
303 |
96-48-0 |
CENPL |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CENPL mRNA |
affects^cotreatment|increases^expression |
19167446 |
304 |
96-48-0 |
CENPL |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CENPL mRNA |
affects^cotreatment|increases^expression |
19167446 |
305 |
96-48-0 |
CENPN |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CENPN mRNA |
affects^cotreatment|increases^expression |
19167446 |
306 |
96-48-0 |
CENPN |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CENPN mRNA |
affects^cotreatment|increases^expression |
19167446 |
307 |
96-48-0 |
CENPO |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CENPO mRNA |
affects^cotreatment|increases^expression |
19167446 |
308 |
96-48-0 |
CENPO |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CENPO mRNA |
affects^cotreatment|increases^expression |
19167446 |
309 |
96-48-0 |
CENPQ |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CENPQ mRNA |
affects^cotreatment|increases^expression |
19167446 |
310 |
96-48-0 |
CENPQ |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CENPQ mRNA |
affects^cotreatment|increases^expression |
19167446 |
311 |
96-48-0 |
CENPS |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CENPS mRNA |
affects^cotreatment|increases^expression |
19167446 |
312 |
96-48-0 |
CENPS |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CENPS mRNA |
affects^cotreatment|increases^expression |
19167446 |
313 |
96-48-0 |
CENPU |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CENPU mRNA |
affects^cotreatment|increases^expression |
19167446 |
314 |
96-48-0 |
CENPU |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CENPU mRNA |
affects^cotreatment|increases^expression |
19167446 |
315 |
96-48-0 |
CENPW |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CENPW mRNA |
affects^cotreatment|increases^expression |
19167446 |
316 |
96-48-0 |
CENPW |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CENPW mRNA |
affects^cotreatment|increases^expression |
19167446 |
317 |
96-48-0 |
CEP55 |
Homo sapiens |
2,3-bis(3'-hydroxybenzyl)butyrolactone results in increased expression of CEP55 mRNA |
increases^expression |
19167446 |
318 |
96-48-0 |
CEP55 |
Homo sapiens |
2,3-bis(3'-hydroxybenzyl)butyrolactone results in increased expression of CEP55 mRNA |
increases^expression |
19167446 |
319 |
96-48-0 |
CEP55 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CEP55 mRNA |
affects^cotreatment|increases^expression |
19167446 |
320 |
96-48-0 |
CEP55 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CEP55 mRNA |
affects^cotreatment|increases^expression |
19167446 |
321 |
96-48-0 |
CEP57 |
Homo sapiens |
2,3-bis(3'-hydroxybenzyl)butyrolactone results in increased expression of CEP57 mRNA |
increases^expression |
19167446 |
322 |
96-48-0 |
CEP57 |
Homo sapiens |
2,3-bis(3'-hydroxybenzyl)butyrolactone results in increased expression of CEP57 mRNA |
increases^expression |
19167446 |
323 |
96-48-0 |
CEP78 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CEP78 mRNA |
affects^cotreatment|increases^expression |
19167446 |
324 |
96-48-0 |
CEP78 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CEP78 mRNA |
affects^cotreatment|increases^expression |
19167446 |
325 |
96-48-0 |
CEP85 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CEP85 mRNA |
affects^cotreatment|increases^expression |
19167446 |
326 |
96-48-0 |
CEP85 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CEP85 mRNA |
affects^cotreatment|increases^expression |
19167446 |
327 |
96-48-0 |
CHAC2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CHAC2 mRNA |
affects^cotreatment|increases^expression |
19167446 |
328 |
96-48-0 |
CHAC2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CHAC2 mRNA |
affects^cotreatment|increases^expression |
19167446 |
329 |
96-48-0 |
CHAF1A |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CHAF1A mRNA |
affects^cotreatment|increases^expression |
19167446 |
330 |
96-48-0 |
CHAF1A |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CHAF1A mRNA |
affects^cotreatment|increases^expression |
19167446 |
331 |
96-48-0 |
CHAF1B |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CHAF1B mRNA |
affects^cotreatment|increases^expression |
19167446 |
332 |
96-48-0 |
CHAF1B |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CHAF1B mRNA |
affects^cotreatment|increases^expression |
19167446 |
333 |
96-48-0 |
CHD2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CHD2 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
334 |
96-48-0 |
CHD2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CHD2 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
335 |
96-48-0 |
CHEK1 |
Homo sapiens |
2,3-bis(3'-hydroxybenzyl)butyrolactone results in increased expression of CHEK1 mRNA |
increases^expression |
19167446 |
336 |
96-48-0 |
CHEK1 |
Homo sapiens |
2,3-bis(3'-hydroxybenzyl)butyrolactone results in increased expression of CHEK1 mRNA |
increases^expression |
19167446 |
337 |
96-48-0 |
CHEK1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CHEK1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
338 |
96-48-0 |
CHEK1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CHEK1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
339 |
96-48-0 |
CHEK2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CHEK2 mRNA |
affects^cotreatment|increases^expression |
19167446 |
340 |
96-48-0 |
CHEK2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CHEK2 mRNA |
affects^cotreatment|increases^expression |
19167446 |
341 |
96-48-0 |
CHES1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CHES1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
342 |
96-48-0 |
CHES1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CHES1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
343 |
96-48-0 |
CHPT1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CHPT1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
344 |
96-48-0 |
CHPT1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CHPT1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
345 |
96-48-0 |
CITED2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CITED2 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
346 |
96-48-0 |
CITED2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CITED2 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
347 |
96-48-0 |
CKAP5 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CKAP5 mRNA |
affects^cotreatment|increases^expression |
19167446 |
348 |
96-48-0 |
CKAP5 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CKAP5 mRNA |
affects^cotreatment|increases^expression |
19167446 |
349 |
96-48-0 |
CKLF |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CKLF mRNA |
affects^cotreatment|increases^expression |
19167446 |
350 |
96-48-0 |
CKLF |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CKLF mRNA |
affects^cotreatment|increases^expression |
19167446 |
351 |
96-48-0 |
CKS1B |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CKS1B mRNA |
affects^cotreatment|increases^expression |
19167446 |
352 |
96-48-0 |
CKS1B |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CKS1B mRNA |
affects^cotreatment|increases^expression |
19167446 |
353 |
96-48-0 |
CKS2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CKS2 mRNA |
affects^cotreatment|increases^expression |
19167446 |
354 |
96-48-0 |
CKS2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CKS2 mRNA |
affects^cotreatment|increases^expression |
19167446 |
355 |
96-48-0 |
CLDN1 |
Homo sapiens |
2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of CLDN1 mRNA |
decreases^expression |
19167446 |
356 |
96-48-0 |
CLDN1 |
Homo sapiens |
2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of CLDN1 mRNA |
decreases^expression |
19167446 |
357 |
96-48-0 |
CLDN1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CLDN1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
358 |
96-48-0 |
CLDN1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CLDN1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
359 |
96-48-0 |
CLDN4 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CLDN4 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
360 |
96-48-0 |
CLDN4 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CLDN4 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
361 |
96-48-0 |
CLIP1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CLIP1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
362 |
96-48-0 |
CLIP1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CLIP1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
363 |
96-48-0 |
CLN6 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CLN6 mRNA |
affects^cotreatment|increases^expression |
19167446 |
364 |
96-48-0 |
CLN6 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CLN6 mRNA |
affects^cotreatment|increases^expression |
19167446 |
365 |
96-48-0 |
CLU |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CLU mRNA |
affects^cotreatment|decreases^expression |
19167446 |
366 |
96-48-0 |
CLU |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CLU mRNA |
affects^cotreatment|decreases^expression |
19167446 |
367 |
96-48-0 |
CMC2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CMC2 mRNA |
affects^cotreatment|increases^expression |
19167446 |
368 |
96-48-0 |
CMC2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CMC2 mRNA |
affects^cotreatment|increases^expression |
19167446 |
369 |
96-48-0 |
COL21A1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of COL21A1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
370 |
96-48-0 |
COL21A1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of COL21A1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
371 |
96-48-0 |
COL5A1 |
Homo sapiens |
2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of COL5A1 mRNA |
decreases^expression |
19167446 |
372 |
96-48-0 |
COL5A1 |
Homo sapiens |
2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of COL5A1 mRNA |
decreases^expression |
19167446 |
373 |
96-48-0 |
CRY1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CRY1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
374 |
96-48-0 |
CRY1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CRY1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
375 |
96-48-0 |
CSE1L |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CSE1L mRNA |
affects^cotreatment|increases^expression |
19167446 |
376 |
96-48-0 |
CSE1L |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CSE1L mRNA |
affects^cotreatment|increases^expression |
19167446 |
377 |
96-48-0 |
CSPG5 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CSPG5 mRNA |
affects^cotreatment|increases^expression |
19167446 |
378 |
96-48-0 |
CSPG5 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CSPG5 mRNA |
affects^cotreatment|increases^expression |
19167446 |
379 |
96-48-0 |
CSRNP2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CSRNP2 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
380 |
96-48-0 |
CSRNP2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CSRNP2 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
381 |
96-48-0 |
CTDSPL2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CTDSPL2 mRNA |
affects^cotreatment|increases^expression |
19167446 |
382 |
96-48-0 |
CTDSPL2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CTDSPL2 mRNA |
affects^cotreatment|increases^expression |
19167446 |
383 |
96-48-0 |
CTNNAL1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CTNNAL1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
384 |
96-48-0 |
CTNNAL1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CTNNAL1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
385 |
96-48-0 |
CTR9 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CTR9 mRNA |
affects^cotreatment|increases^expression |
19167446 |
386 |
96-48-0 |
CTR9 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CTR9 mRNA |
affects^cotreatment|increases^expression |
19167446 |
387 |
96-48-0 |
CTTN |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CTTN mRNA |
affects^cotreatment|decreases^expression |
19167446 |
388 |
96-48-0 |
CTTN |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CTTN mRNA |
affects^cotreatment|decreases^expression |
19167446 |
389 |
96-48-0 |
CTTNBP2NL |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CTTNBP2NL mRNA |
affects^cotreatment|decreases^expression |
19167446 |
390 |
96-48-0 |
CTTNBP2NL |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CTTNBP2NL mRNA |
affects^cotreatment|decreases^expression |
19167446 |
391 |
96-48-0 |
CXXC5 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CXXC5 mRNA |
affects^cotreatment|increases^expression |
19167446 |
392 |
96-48-0 |
CXXC5 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CXXC5 mRNA |
affects^cotreatment|increases^expression |
19167446 |
393 |
96-48-0 |
CYB5R1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CYB5R1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
394 |
96-48-0 |
CYB5R1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CYB5R1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
395 |
96-48-0 |
CYP19A1 |
Homo sapiens |
2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased activity of CYP19A1 protein |
decreases^activity |
15876411 |
396 |
96-48-0 |
CYP19A1 |
Homo sapiens |
2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased activity of CYP19A1 protein |
decreases^activity |
15876411 |
397 |
96-48-0 |
CYP2R1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CYP2R1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
398 |
96-48-0 |
CYP2R1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CYP2R1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
399 |
96-48-0 |
CYR61 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CYR61 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
400 |
96-48-0 |
CYR61 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CYR61 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
401 |
96-48-0 |
DANCR |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of DANCR mRNA |
affects^cotreatment|decreases^expression |
19167446 |
402 |
96-48-0 |
DANCR |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of DANCR mRNA |
affects^cotreatment|decreases^expression |
19167446 |
403 |
96-48-0 |
DARS2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DARS2 mRNA |
affects^cotreatment|increases^expression |
19167446 |
404 |
96-48-0 |
DARS2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DARS2 mRNA |
affects^cotreatment|increases^expression |
19167446 |
405 |
96-48-0 |
DBF4 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DBF4 mRNA |
affects^cotreatment|increases^expression |
19167446 |
406 |
96-48-0 |
DBF4 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DBF4 mRNA |
affects^cotreatment|increases^expression |
19167446 |
407 |
96-48-0 |
DBN1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of DBN1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
408 |
96-48-0 |
DBN1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of DBN1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
409 |
96-48-0 |
DCAF15 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DCAF15 mRNA |
affects^cotreatment|increases^expression |
19167446 |
410 |
96-48-0 |
DCAF15 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DCAF15 mRNA |
affects^cotreatment|increases^expression |
19167446 |
411 |
96-48-0 |
DCAF4 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of DCAF4 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
412 |
96-48-0 |
DCAF4 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of DCAF4 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
413 |
96-48-0 |
DCAF5 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of DCAF5 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
414 |
96-48-0 |
DCAF5 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of DCAF5 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
415 |
96-48-0 |
DCLK1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of DCLK1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
416 |
96-48-0 |
DCLK1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of DCLK1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
417 |
96-48-0 |
DCLRE1A |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DCLRE1A mRNA |
affects^cotreatment|increases^expression |
19167446 |
418 |
96-48-0 |
DCLRE1A |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DCLRE1A mRNA |
affects^cotreatment|increases^expression |
19167446 |
419 |
96-48-0 |
DCLRE1B |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DCLRE1B mRNA |
affects^cotreatment|increases^expression |
19167446 |
420 |
96-48-0 |
DCLRE1B |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DCLRE1B mRNA |
affects^cotreatment|increases^expression |
19167446 |
421 |
96-48-0 |
DDAH2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of DDAH2 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
422 |
96-48-0 |
DDAH2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of DDAH2 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
423 |
96-48-0 |
DDB2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DDB2 mRNA |
affects^cotreatment|increases^expression |
19167446 |
424 |
96-48-0 |
DDB2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DDB2 mRNA |
affects^cotreatment|increases^expression |
19167446 |
425 |
96-48-0 |
DDEF1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of DDEF1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
426 |
96-48-0 |
DDEF1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of DDEF1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
427 |
96-48-0 |
DDIAS |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DDIAS mRNA |
affects^cotreatment|increases^expression |
19167446 |
428 |
96-48-0 |
DDIAS |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DDIAS mRNA |
affects^cotreatment|increases^expression |
19167446 |
429 |
96-48-0 |
DDX39B |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DDX39B mRNA |
affects^cotreatment|increases^expression |
19167446 |
430 |
96-48-0 |
DDX39B |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DDX39B mRNA |
affects^cotreatment|increases^expression |
19167446 |
431 |
96-48-0 |
DEPDC1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DEPDC1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
432 |
96-48-0 |
DEPDC1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DEPDC1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
433 |
96-48-0 |
DEPDC6 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DEPDC6 mRNA |
affects^cotreatment|increases^expression |
19167446 |
434 |
96-48-0 |
DEPDC6 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DEPDC6 mRNA |
affects^cotreatment|increases^expression |
19167446 |
435 |
96-48-0 |
DERA |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DERA mRNA |
affects^cotreatment|increases^expression |
19167446 |
436 |
96-48-0 |
DERA |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DERA mRNA |
affects^cotreatment|increases^expression |
19167446 |
437 |
96-48-0 |
DHFR |
Homo sapiens |
2,3-bis(3'-hydroxybenzyl)butyrolactone results in increased expression of DHFR mRNA |
increases^expression |
19167446 |
438 |
96-48-0 |
DHFR |
Homo sapiens |
2,3-bis(3'-hydroxybenzyl)butyrolactone results in increased expression of DHFR mRNA |
increases^expression |
19167446 |
439 |
96-48-0 |
DHFR |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DHFR mRNA |
affects^cotreatment|increases^expression |
19167446 |
440 |
96-48-0 |
DHFR |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DHFR mRNA |
affects^cotreatment|increases^expression |
19167446 |
441 |
96-48-0 |
DHRS2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DHRS2 mRNA |
affects^cotreatment|increases^expression |
19167446 |
442 |
96-48-0 |
DHRS2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DHRS2 mRNA |
affects^cotreatment|increases^expression |
19167446 |
443 |
96-48-0 |
DHTKD1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DHTKD1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
444 |
96-48-0 |
DHTKD1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DHTKD1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
445 |
96-48-0 |
DIAPH3 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DIAPH3 mRNA |
affects^cotreatment|increases^expression |
19167446 |
446 |
96-48-0 |
DIAPH3 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DIAPH3 mRNA |
affects^cotreatment|increases^expression |
19167446 |
447 |
96-48-0 |
DIP2C |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of DIP2C mRNA |
affects^cotreatment|decreases^expression |
19167446 |
448 |
96-48-0 |
DIP2C |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of DIP2C mRNA |
affects^cotreatment|decreases^expression |
19167446 |
449 |
96-48-0 |
DKC1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DKC1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
450 |
96-48-0 |
DKC1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DKC1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
451 |
96-48-0 |
DLGAP5 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DLGAP5 mRNA |
affects^cotreatment|increases^expression |
19167446 |
452 |
96-48-0 |
DLGAP5 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DLGAP5 mRNA |
affects^cotreatment|increases^expression |
19167446 |
453 |
96-48-0 |
DLX2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of DLX2 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
454 |
96-48-0 |
DLX2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of DLX2 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
455 |
96-48-0 |
DMXL1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of DMXL1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
456 |
96-48-0 |
DMXL1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of DMXL1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
457 |
96-48-0 |
DNAJA2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of DNAJA2 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
458 |
96-48-0 |
DNAJA2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of DNAJA2 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
459 |
96-48-0 |
DNAJB9 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of DNAJB9 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
460 |
96-48-0 |
DNAJB9 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of DNAJB9 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
461 |
96-48-0 |
DNAJC9 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DNAJC9 mRNA |
affects^cotreatment|increases^expression |
19167446 |
462 |
96-48-0 |
DNAJC9 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DNAJC9 mRNA |
affects^cotreatment|increases^expression |
19167446 |
463 |
96-48-0 |
DNASE2 |
Homo sapiens |
2,3-bis(3'-hydroxybenzyl)butyrolactone results in increased expression of DNASE2 mRNA |
increases^expression |
19167446 |
464 |
96-48-0 |
DNASE2 |
Homo sapiens |
2,3-bis(3'-hydroxybenzyl)butyrolactone results in increased expression of DNASE2 mRNA |
increases^expression |
19167446 |
465 |
96-48-0 |
DNASE2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DNASE2 mRNA |
affects^cotreatment|increases^expression |
19167446 |
466 |
96-48-0 |
DNASE2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DNASE2 mRNA |
affects^cotreatment|increases^expression |
19167446 |
467 |
96-48-0 |
DNM1L |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of DNM1L mRNA |
affects^cotreatment|decreases^expression |
19167446 |
468 |
96-48-0 |
DNM1L |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of DNM1L mRNA |
affects^cotreatment|decreases^expression |
19167446 |
469 |
96-48-0 |
DNMT1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DNMT1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
470 |
96-48-0 |
DNMT1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DNMT1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
471 |
96-48-0 |
DONSON |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DONSON mRNA |
affects^cotreatment|increases^expression |
19167446 |
472 |
96-48-0 |
DONSON |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DONSON mRNA |
affects^cotreatment|increases^expression |
19167446 |
473 |
96-48-0 |
DSCC1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DSCC1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
474 |
96-48-0 |
DSCC1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DSCC1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
475 |
96-48-0 |
DSCR1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of DSCR1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
476 |
96-48-0 |
DSCR1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of DSCR1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
477 |
96-48-0 |
DSN1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DSN1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
478 |
96-48-0 |
DSN1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DSN1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
479 |
96-48-0 |
DTNA |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of DTNA mRNA |
affects^cotreatment|decreases^expression |
19167446 |
480 |
96-48-0 |
DTNA |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of DTNA mRNA |
affects^cotreatment|decreases^expression |
19167446 |
481 |
96-48-0 |
DUSP1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of DUSP1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
482 |
96-48-0 |
DUSP1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of DUSP1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
483 |
96-48-0 |
DUT |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DUT mRNA |
affects^cotreatment|increases^expression |
19167446 |
484 |
96-48-0 |
DUT |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DUT mRNA |
affects^cotreatment|increases^expression |
19167446 |
485 |
96-48-0 |
DYNC1LI1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of DYNC1LI1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
486 |
96-48-0 |
DYNC1LI1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of DYNC1LI1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
487 |
96-48-0 |
E2F2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of E2F2 mRNA |
affects^cotreatment|increases^expression |
19167446 |
488 |
96-48-0 |
E2F2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of E2F2 mRNA |
affects^cotreatment|increases^expression |
19167446 |
489 |
96-48-0 |
E2F5 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of E2F5 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
490 |
96-48-0 |
E2F5 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of E2F5 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
491 |
96-48-0 |
E2F7 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of E2F7 mRNA |
affects^cotreatment|increases^expression |
19167446 |
492 |
96-48-0 |
E2F7 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of E2F7 mRNA |
affects^cotreatment|increases^expression |
19167446 |
493 |
96-48-0 |
E2F8 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of E2F8 mRNA |
affects^cotreatment|increases^expression |
19167446 |
494 |
96-48-0 |
E2F8 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of E2F8 mRNA |
affects^cotreatment|increases^expression |
19167446 |
495 |
96-48-0 |
EBP |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of EBP mRNA |
affects^cotreatment|increases^expression |
19167446 |
496 |
96-48-0 |
EBP |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of EBP mRNA |
affects^cotreatment|increases^expression |
19167446 |
497 |
96-48-0 |
ECT2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ECT2 mRNA |
affects^cotreatment|increases^expression |
19167446 |
498 |
96-48-0 |
ECT2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ECT2 mRNA |
affects^cotreatment|increases^expression |
19167446 |
499 |
96-48-0 |
EDIL3 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of EDIL3 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
500 |
96-48-0 |
EDIL3 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of EDIL3 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
501 |
96-48-0 |
EED |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of EED mRNA |
affects^cotreatment|increases^expression |
19167446 |
502 |
96-48-0 |
EED |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of EED mRNA |
affects^cotreatment|increases^expression |
19167446 |
503 |
96-48-0 |
EEF1A1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of EEF1A1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
504 |
96-48-0 |
EEF1A1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of EEF1A1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
505 |
96-48-0 |
EFEMP1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of EFEMP1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
506 |
96-48-0 |
EFEMP1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of EFEMP1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
507 |
96-48-0 |
EFHD1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of EFHD1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
508 |
96-48-0 |
EFHD1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of EFHD1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
509 |
96-48-0 |
EFNA1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of EFNA1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
510 |
96-48-0 |
EFNA1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of EFNA1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
511 |
96-48-0 |
EFNB2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of EFNB2 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
512 |
96-48-0 |
EFNB2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of EFNB2 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
513 |
96-48-0 |
EGR1 |
Homo sapiens |
2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of EGR1 mRNA |
decreases^expression |
19167446 |
514 |
96-48-0 |
EGR1 |
Homo sapiens |
2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of EGR1 mRNA |
decreases^expression |
19167446 |
515 |
96-48-0 |
EGR1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of EGR1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
516 |
96-48-0 |
EGR1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of EGR1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
517 |
96-48-0 |
EGR3 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of EGR3 mRNA |
affects^cotreatment|increases^expression |
19167446 |
518 |
96-48-0 |
EGR3 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of EGR3 mRNA |
affects^cotreatment|increases^expression |
19167446 |
519 |
96-48-0 |
ELF5 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ELF5 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
520 |
96-48-0 |
ELF5 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ELF5 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
521 |
96-48-0 |
ELK1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ELK1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
522 |
96-48-0 |
ELK1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ELK1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
523 |
96-48-0 |
ELOVL2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ELOVL2 mRNA |
affects^cotreatment|increases^expression |
19167446 |
524 |
96-48-0 |
ELOVL2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ELOVL2 mRNA |
affects^cotreatment|increases^expression |
19167446 |
525 |
96-48-0 |
ELOVL6 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ELOVL6 mRNA |
affects^cotreatment|increases^expression |
19167446 |
526 |
96-48-0 |
ELOVL6 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ELOVL6 mRNA |
affects^cotreatment|increases^expression |
19167446 |
527 |
96-48-0 |
ELOVL7 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ELOVL7 mRNA |
affects^cotreatment|increases^expression |
19167446 |
528 |
96-48-0 |
ELOVL7 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ELOVL7 mRNA |
affects^cotreatment|increases^expression |
19167446 |
529 |
96-48-0 |
ELP6 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ELP6 mRNA |
affects^cotreatment|increases^expression |
19167446 |
530 |
96-48-0 |
ELP6 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ELP6 mRNA |
affects^cotreatment|increases^expression |
19167446 |
531 |
96-48-0 |
EMC9 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of EMC9 mRNA |
affects^cotreatment|increases^expression |
19167446 |
532 |
96-48-0 |
EMC9 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of EMC9 mRNA |
affects^cotreatment|increases^expression |
19167446 |
533 |
96-48-0 |
EME1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of EME1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
534 |
96-48-0 |
EME1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of EME1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
535 |
96-48-0 |
ENC1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ENC1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
536 |
96-48-0 |
ENC1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ENC1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
537 |
96-48-0 |
ENDOD1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ENDOD1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
538 |
96-48-0 |
ENDOD1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ENDOD1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
539 |
96-48-0 |
ENOSF1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ENOSF1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
540 |
96-48-0 |
ENOSF1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ENOSF1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
541 |
96-48-0 |
EPB41L5 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of EPB41L5 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
542 |
96-48-0 |
EPB41L5 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of EPB41L5 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
543 |
96-48-0 |
EPHA4 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of EPHA4 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
544 |
96-48-0 |
EPHA4 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of EPHA4 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
545 |
96-48-0 |
EPS15L1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of EPS15L1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
546 |
96-48-0 |
EPS15L1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of EPS15L1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
547 |
96-48-0 |
ERCC6L |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ERCC6L mRNA |
affects^cotreatment|increases^expression |
19167446 |
548 |
96-48-0 |
ERCC6L |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ERCC6L mRNA |
affects^cotreatment|increases^expression |
19167446 |
549 |
96-48-0 |
ERI2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ERI2 mRNA |
affects^cotreatment|increases^expression |
19167446 |
550 |
96-48-0 |
ERI2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ERI2 mRNA |
affects^cotreatment|increases^expression |
19167446 |
551 |
96-48-0 |
ERRFI1 |
Homo sapiens |
2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of ERRFI1 mRNA |
decreases^expression |
19167446 |
552 |
96-48-0 |
ERRFI1 |
Homo sapiens |
2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of ERRFI1 mRNA |
decreases^expression |
19167446 |
553 |
96-48-0 |
ERRFI1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ERRFI1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
554 |
96-48-0 |
ERRFI1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ERRFI1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
555 |
96-48-0 |
ESPL1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ESPL1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
556 |
96-48-0 |
ESPL1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ESPL1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
557 |
96-48-0 |
EXO1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of EXO1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
558 |
96-48-0 |
EXO1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of EXO1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
559 |
96-48-0 |
EXOC2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of EXOC2 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
560 |
96-48-0 |
EXOC2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of EXOC2 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
561 |
96-48-0 |
EXT1 |
Homo sapiens |
2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of EXT1 mRNA |
decreases^expression |
19167446 |
562 |
96-48-0 |
EXT1 |
Homo sapiens |
2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of EXT1 mRNA |
decreases^expression |
19167446 |
563 |
96-48-0 |
EXT1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of EXT1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
564 |
96-48-0 |
EXT1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of EXT1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
565 |
96-48-0 |
EZH2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of EZH2 mRNA |
affects^cotreatment|increases^expression |
19167446 |
566 |
96-48-0 |
EZH2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of EZH2 mRNA |
affects^cotreatment|increases^expression |
19167446 |
567 |
96-48-0 |
EZR |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of EZR mRNA |
affects^cotreatment|decreases^expression |
19167446 |
568 |
96-48-0 |
EZR |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of EZR mRNA |
affects^cotreatment|decreases^expression |
19167446 |
569 |
96-48-0 |
F2RL1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of F2RL1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
570 |
96-48-0 |
F2RL1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of F2RL1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
571 |
96-48-0 |
FAM107B |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FAM107B mRNA |
affects^cotreatment|decreases^expression |
19167446 |
572 |
96-48-0 |
FAM107B |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FAM107B mRNA |
affects^cotreatment|decreases^expression |
19167446 |
573 |
96-48-0 |
FAM110B |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FAM110B mRNA |
affects^cotreatment|decreases^expression |
19167446 |
574 |
96-48-0 |
FAM110B |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FAM110B mRNA |
affects^cotreatment|decreases^expression |
19167446 |
575 |
96-48-0 |
FAM111A |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of FAM111A mRNA |
affects^cotreatment|increases^expression |
19167446 |
576 |
96-48-0 |
FAM111A |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of FAM111A mRNA |
affects^cotreatment|increases^expression |
19167446 |
577 |
96-48-0 |
FAM149B1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FAM149B1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
578 |
96-48-0 |
FAM149B1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FAM149B1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
579 |
96-48-0 |
FAM189A2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FAM189A2 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
580 |
96-48-0 |
FAM189A2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FAM189A2 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
581 |
96-48-0 |
FAM214A |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FAM214A mRNA |
affects^cotreatment|decreases^expression |
19167446 |
582 |
96-48-0 |
FAM214A |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FAM214A mRNA |
affects^cotreatment|decreases^expression |
19167446 |
583 |
96-48-0 |
FAM43A |
Homo sapiens |
2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of FAM43A mRNA |
decreases^expression |
19167446 |
584 |
96-48-0 |
FAM43A |
Homo sapiens |
2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of FAM43A mRNA |
decreases^expression |
19167446 |
585 |
96-48-0 |
FAM43A |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FAM43A mRNA |
affects^cotreatment|decreases^expression |
19167446 |
586 |
96-48-0 |
FAM43A |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FAM43A mRNA |
affects^cotreatment|decreases^expression |
19167446 |
587 |
96-48-0 |
FAM49B |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FAM49B mRNA |
affects^cotreatment|decreases^expression |
19167446 |
588 |
96-48-0 |
FAM49B |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FAM49B mRNA |
affects^cotreatment|decreases^expression |
19167446 |
589 |
96-48-0 |
FANCD2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of FANCD2 mRNA |
affects^cotreatment|increases^expression |
19167446 |
590 |
96-48-0 |
FANCD2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of FANCD2 mRNA |
affects^cotreatment|increases^expression |
19167446 |
591 |
96-48-0 |
FANCG |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of FANCG mRNA |
affects^cotreatment|increases^expression |
19167446 |
592 |
96-48-0 |
FANCG |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of FANCG mRNA |
affects^cotreatment|increases^expression |
19167446 |
593 |
96-48-0 |
FANCI |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of FANCI mRNA |
affects^cotreatment|increases^expression |
19167446 |
594 |
96-48-0 |
FANCI |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of FANCI mRNA |
affects^cotreatment|increases^expression |
19167446 |
595 |
96-48-0 |
FANCL |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of FANCL mRNA |
affects^cotreatment|increases^expression |
19167446 |
596 |
96-48-0 |
FANCL |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of FANCL mRNA |
affects^cotreatment|increases^expression |
19167446 |
597 |
96-48-0 |
FBXO38 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FBXO38 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
598 |
96-48-0 |
FBXO38 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FBXO38 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
599 |
96-48-0 |
FBXO5 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of FBXO5 mRNA |
affects^cotreatment|increases^expression |
19167446 |
600 |
96-48-0 |
FBXO5 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of FBXO5 mRNA |
affects^cotreatment|increases^expression |
19167446 |
601 |
96-48-0 |
FCMR |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of FCMR mRNA |
affects^cotreatment|increases^expression |
19167446 |
602 |
96-48-0 |
FCMR |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of FCMR mRNA |
affects^cotreatment|increases^expression |
19167446 |
603 |
96-48-0 |
FDFT1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of FDFT1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
604 |
96-48-0 |
FDFT1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of FDFT1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
605 |
96-48-0 |
FEN1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of FEN1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
606 |
96-48-0 |
FEN1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of FEN1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
607 |
96-48-0 |
FERMT2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FERMT2 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
608 |
96-48-0 |
FERMT2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FERMT2 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
609 |
96-48-0 |
FIBP |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of FIBP mRNA |
affects^cotreatment|increases^expression |
19167446 |
610 |
96-48-0 |
FIBP |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of FIBP mRNA |
affects^cotreatment|increases^expression |
19167446 |
611 |
96-48-0 |
FIGNL1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of FIGNL1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
612 |
96-48-0 |
FIGNL1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of FIGNL1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
613 |
96-48-0 |
FILIP1L |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FILIP1L mRNA |
affects^cotreatment|decreases^expression |
19167446 |
614 |
96-48-0 |
FILIP1L |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FILIP1L mRNA |
affects^cotreatment|decreases^expression |
19167446 |
615 |
96-48-0 |
FKBP11 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of FKBP11 mRNA |
affects^cotreatment|increases^expression |
19167446 |
616 |
96-48-0 |
FKBP11 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of FKBP11 mRNA |
affects^cotreatment|increases^expression |
19167446 |
617 |
96-48-0 |
FKBP4 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of FKBP4 mRNA |
affects^cotreatment|increases^expression |
19167446 |
618 |
96-48-0 |
FKBP4 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of FKBP4 mRNA |
affects^cotreatment|increases^expression |
19167446 |
619 |
96-48-0 |
FLCN |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FLCN mRNA |
affects^cotreatment|decreases^expression |
19167446 |
620 |
96-48-0 |
FLCN |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FLCN mRNA |
affects^cotreatment|decreases^expression |
19167446 |
621 |
96-48-0 |
FNBP1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FNBP1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
622 |
96-48-0 |
FNBP1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FNBP1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
623 |
96-48-0 |
FNBP1L |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FNBP1L mRNA |
affects^cotreatment|decreases^expression |
19167446 |
624 |
96-48-0 |
FNBP1L |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FNBP1L mRNA |
affects^cotreatment|decreases^expression |
19167446 |
625 |
96-48-0 |
FOS |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FOS mRNA |
affects^cotreatment|decreases^expression |
19167446 |
626 |
96-48-0 |
FOS |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FOS mRNA |
affects^cotreatment|decreases^expression |
19167446 |
627 |
96-48-0 |
FOXM1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of FOXM1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
628 |
96-48-0 |
FOXM1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of FOXM1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
629 |
96-48-0 |
FOXO3 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FOXO3 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
630 |
96-48-0 |
FOXO3 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FOXO3 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
631 |
96-48-0 |
FOXP2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FOXP2 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
632 |
96-48-0 |
FOXP2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FOXP2 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
633 |
96-48-0 |
FRMD6 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FRMD6 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
634 |
96-48-0 |
FRMD6 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FRMD6 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
635 |
96-48-0 |
FSCN1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FSCN1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
636 |
96-48-0 |
FSCN1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FSCN1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
637 |
96-48-0 |
FYCO1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FYCO1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
638 |
96-48-0 |
FYCO1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of FYCO1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
639 |
96-48-0 |
G2E3 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of G2E3 mRNA |
affects^cotreatment|increases^expression |
19167446 |
640 |
96-48-0 |
G2E3 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of G2E3 mRNA |
affects^cotreatment|increases^expression |
19167446 |
641 |
96-48-0 |
G3BP2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of G3BP2 mRNA |
affects^cotreatment|increases^expression |
19167446 |
642 |
96-48-0 |
G3BP2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of G3BP2 mRNA |
affects^cotreatment|increases^expression |
19167446 |
643 |
96-48-0 |
GABPB2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GABPB2 mRNA |
affects^cotreatment|increases^expression |
19167446 |
644 |
96-48-0 |
GABPB2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GABPB2 mRNA |
affects^cotreatment|increases^expression |
19167446 |
645 |
96-48-0 |
GADD45A |
Homo sapiens |
2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of GADD45A mRNA |
decreases^expression |
19167446 |
646 |
96-48-0 |
GADD45A |
Homo sapiens |
2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of GADD45A mRNA |
decreases^expression |
19167446 |
647 |
96-48-0 |
GADD45A |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of GADD45A mRNA |
affects^cotreatment|decreases^expression |
19167446 |
648 |
96-48-0 |
GADD45A |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of GADD45A mRNA |
affects^cotreatment|decreases^expression |
19167446 |
649 |
96-48-0 |
GALNS |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of GALNS mRNA |
affects^cotreatment|decreases^expression |
19167446 |
650 |
96-48-0 |
GALNS |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of GALNS mRNA |
affects^cotreatment|decreases^expression |
19167446 |
651 |
96-48-0 |
GALNT1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of GALNT1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
652 |
96-48-0 |
GALNT1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of GALNT1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
653 |
96-48-0 |
GALNT10 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of GALNT10 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
654 |
96-48-0 |
GALNT10 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of GALNT10 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
655 |
96-48-0 |
GALNT7 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of GALNT7 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
656 |
96-48-0 |
GALNT7 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of GALNT7 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
657 |
96-48-0 |
GANAB |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GANAB mRNA |
affects^cotreatment|increases^expression |
19167446 |
658 |
96-48-0 |
GANAB |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GANAB mRNA |
affects^cotreatment|increases^expression |
19167446 |
659 |
96-48-0 |
GAS2L3 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GAS2L3 mRNA |
affects^cotreatment|increases^expression |
19167446 |
660 |
96-48-0 |
GAS2L3 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GAS2L3 mRNA |
affects^cotreatment|increases^expression |
19167446 |
661 |
96-48-0 |
GATA2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of GATA2 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
662 |
96-48-0 |
GATA2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of GATA2 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
663 |
96-48-0 |
GBP2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of GBP2 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
664 |
96-48-0 |
GBP2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of GBP2 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
665 |
96-48-0 |
GCHFR |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GCHFR mRNA |
affects^cotreatment|increases^expression |
19167446 |
666 |
96-48-0 |
GCHFR |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GCHFR mRNA |
affects^cotreatment|increases^expression |
19167446 |
667 |
96-48-0 |
GDF15 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of GDF15 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
668 |
96-48-0 |
GDF15 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of GDF15 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
669 |
96-48-0 |
GDPD3 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of GDPD3 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
670 |
96-48-0 |
GDPD3 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of GDPD3 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
671 |
96-48-0 |
GEMIN2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GEMIN2 mRNA |
affects^cotreatment|increases^expression |
19167446 |
672 |
96-48-0 |
GEMIN2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GEMIN2 mRNA |
affects^cotreatment|increases^expression |
19167446 |
673 |
96-48-0 |
GFRA1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GFRA1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
674 |
96-48-0 |
GFRA1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GFRA1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
675 |
96-48-0 |
GGCT |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GGCT mRNA |
affects^cotreatment|increases^expression |
19167446 |
676 |
96-48-0 |
GGCT |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GGCT mRNA |
affects^cotreatment|increases^expression |
19167446 |
677 |
96-48-0 |
GGH |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GGH mRNA |
affects^cotreatment|increases^expression |
19167446 |
678 |
96-48-0 |
GGH |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GGH mRNA |
affects^cotreatment|increases^expression |
19167446 |
679 |
96-48-0 |
GINS1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GINS1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
680 |
96-48-0 |
GINS1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GINS1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
681 |
96-48-0 |
GINS2 |
Homo sapiens |
2,3-bis(3'-hydroxybenzyl)butyrolactone results in increased expression of GINS2 mRNA |
increases^expression |
19167446 |
682 |
96-48-0 |
GINS2 |
Homo sapiens |
2,3-bis(3'-hydroxybenzyl)butyrolactone results in increased expression of GINS2 mRNA |
increases^expression |
19167446 |
683 |
96-48-0 |
GINS2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GINS2 mRNA |
affects^cotreatment|increases^expression |
19167446 |
684 |
96-48-0 |
GINS2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GINS2 mRNA |
affects^cotreatment|increases^expression |
19167446 |
685 |
96-48-0 |
GINS3 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GINS3 mRNA |
affects^cotreatment|increases^expression |
19167446 |
686 |
96-48-0 |
GINS3 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GINS3 mRNA |
affects^cotreatment|increases^expression |
19167446 |
687 |
96-48-0 |
GINS4 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GINS4 mRNA |
affects^cotreatment|increases^expression |
19167446 |
688 |
96-48-0 |
GINS4 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GINS4 mRNA |
affects^cotreatment|increases^expression |
19167446 |
689 |
96-48-0 |
GLE1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GLE1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
690 |
96-48-0 |
GLE1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GLE1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
691 |
96-48-0 |
GMNN |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GMNN mRNA |
affects^cotreatment|increases^expression |
19167446 |
692 |
96-48-0 |
GMNN |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GMNN mRNA |
affects^cotreatment|increases^expression |
19167446 |
693 |
96-48-0 |
GMPS |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GMPS mRNA |
affects^cotreatment|increases^expression |
19167446 |
694 |
96-48-0 |
GMPS |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GMPS mRNA |
affects^cotreatment|increases^expression |
19167446 |
695 |
96-48-0 |
GNAS |
Homo sapiens |
2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of GNAS mRNA |
decreases^expression |
19167446 |
696 |
96-48-0 |
GNAS |
Homo sapiens |
2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of GNAS mRNA |
decreases^expression |
19167446 |
697 |
96-48-0 |
GOLGA2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of GOLGA2 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
698 |
96-48-0 |
GOLGA2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of GOLGA2 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
699 |
96-48-0 |
GOT1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GOT1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
700 |
96-48-0 |
GOT1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GOT1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
701 |
96-48-0 |
GPAA1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GPAA1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
702 |
96-48-0 |
GPAA1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GPAA1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
703 |
96-48-0 |
GPAT4 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GPAT4 mRNA |
affects^cotreatment|increases^expression |
19167446 |
704 |
96-48-0 |
GPAT4 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GPAT4 mRNA |
affects^cotreatment|increases^expression |
19167446 |
705 |
96-48-0 |
GPRC5A |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of GPRC5A mRNA |
affects^cotreatment|decreases^expression |
19167446 |
706 |
96-48-0 |
GPRC5A |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of GPRC5A mRNA |
affects^cotreatment|decreases^expression |
19167446 |
707 |
96-48-0 |
GPRC5C |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of GPRC5C mRNA |
affects^cotreatment|decreases^expression |
19167446 |
708 |
96-48-0 |
GPRC5C |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of GPRC5C mRNA |
affects^cotreatment|decreases^expression |
19167446 |
709 |
96-48-0 |
GPSM2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GPSM2 mRNA |
affects^cotreatment|increases^expression |
19167446 |
710 |
96-48-0 |
GPSM2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GPSM2 mRNA |
affects^cotreatment|increases^expression |
19167446 |
711 |
96-48-0 |
GPSN2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GPSN2 mRNA |
affects^cotreatment|increases^expression |
19167446 |
712 |
96-48-0 |
GPSN2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GPSN2 mRNA |
affects^cotreatment|increases^expression |
19167446 |
713 |
96-48-0 |
GRAMD1A |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of GRAMD1A mRNA |
affects^cotreatment|decreases^expression |
19167446 |
714 |
96-48-0 |
GRAMD1A |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of GRAMD1A mRNA |
affects^cotreatment|decreases^expression |
19167446 |
715 |
96-48-0 |
GREB1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GREB1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
716 |
96-48-0 |
GREB1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GREB1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
717 |
96-48-0 |
GRHL3 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of GRHL3 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
718 |
96-48-0 |
GRHL3 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of GRHL3 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
719 |
96-48-0 |
GTF2IRD1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of GTF2IRD1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
720 |
96-48-0 |
GTF2IRD1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of GTF2IRD1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
721 |
96-48-0 |
GTSE1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GTSE1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
722 |
96-48-0 |
GTSE1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GTSE1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
723 |
96-48-0 |
GULP1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of GULP1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
724 |
96-48-0 |
GULP1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of GULP1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
725 |
96-48-0 |
H2AFV |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of H2AFV mRNA |
affects^cotreatment|increases^expression |
19167446 |
726 |
96-48-0 |
H2AFV |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of H2AFV mRNA |
affects^cotreatment|increases^expression |
19167446 |
727 |
96-48-0 |
H2AFX |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of H2AFX mRNA |
affects^cotreatment|increases^expression |
19167446 |
728 |
96-48-0 |
H2AFX |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of H2AFX mRNA |
affects^cotreatment|increases^expression |
19167446 |
729 |
96-48-0 |
H2AFZ |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of H2AFZ mRNA |
affects^cotreatment|increases^expression |
19167446 |
730 |
96-48-0 |
H2AFZ |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of H2AFZ mRNA |
affects^cotreatment|increases^expression |
19167446 |
731 |
96-48-0 |
H3F3B |
Homo sapiens |
2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of H3F3B mRNA |
decreases^expression |
19167446 |
732 |
96-48-0 |
H3F3B |
Homo sapiens |
2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of H3F3B mRNA |
decreases^expression |
19167446 |
733 |
96-48-0 |
H3F3B |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of H3F3B mRNA |
affects^cotreatment|decreases^expression |
19167446 |
734 |
96-48-0 |
H3F3B |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of H3F3B mRNA |
affects^cotreatment|decreases^expression |
19167446 |
735 |
96-48-0 |
HADH |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of HADH mRNA |
affects^cotreatment|increases^expression |
19167446 |
736 |
96-48-0 |
HADH |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of HADH mRNA |
affects^cotreatment|increases^expression |
19167446 |
737 |
96-48-0 |
HAUS1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of HAUS1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
738 |
96-48-0 |
HAUS1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of HAUS1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
739 |
96-48-0 |
HAUS4 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of HAUS4 mRNA |
affects^cotreatment|increases^expression |
19167446 |
740 |
96-48-0 |
HAUS4 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of HAUS4 mRNA |
affects^cotreatment|increases^expression |
19167446 |
741 |
96-48-0 |
HEBP1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of HEBP1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
742 |
96-48-0 |
HEBP1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of HEBP1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
743 |
96-48-0 |
HELLS |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of HELLS mRNA |
affects^cotreatment|increases^expression |
19167446 |
744 |
96-48-0 |
HELLS |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of HELLS mRNA |
affects^cotreatment|increases^expression |
19167446 |
745 |
96-48-0 |
HELZ2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of HELZ2 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
746 |
96-48-0 |
HELZ2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of HELZ2 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
747 |
96-48-0 |
HERC1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of HERC1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
748 |
96-48-0 |
HERC1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of HERC1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
749 |
96-48-0 |
HES1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of HES1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
750 |
96-48-0 |
HES1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of HES1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
751 |
96-48-0 |
HIRIP3 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of HIRIP3 mRNA |
affects^cotreatment|increases^expression |
19167446 |
752 |
96-48-0 |
HIRIP3 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of HIRIP3 mRNA |
affects^cotreatment|increases^expression |
19167446 |
753 |
96-48-0 |
HIST1H1C |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of HIST1H1C mRNA |
affects^cotreatment|decreases^expression |
19167446 |
754 |
96-48-0 |
HIST1H1C |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of HIST1H1C mRNA |
affects^cotreatment|decreases^expression |
19167446 |
755 |
96-48-0 |
HIST1H2AC |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of HIST1H2AC mRNA |
affects^cotreatment|decreases^expression |
19167446 |
756 |
96-48-0 |
HIST1H2AC |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of HIST1H2AC mRNA |
affects^cotreatment|decreases^expression |
19167446 |
757 |
96-48-0 |
HIST1H2AE |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of HIST1H2AE mRNA |
affects^cotreatment|decreases^expression |
19167446 |
758 |
96-48-0 |
HIST1H2AE |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of HIST1H2AE mRNA |
affects^cotreatment|decreases^expression |
19167446 |
759 |
96-48-0 |
HIST1H2BC |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of HIST1H2BC mRNA |
affects^cotreatment|decreases^expression |
19167446 |
760 |
96-48-0 |
HIST1H2BC |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of HIST1H2BC mRNA |
affects^cotreatment|decreases^expression |
19167446 |
761 |
96-48-0 |
HIST1H2BD |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of HIST1H2BD mRNA |
affects^cotreatment|decreases^expression |
19167446 |
762 |
96-48-0 |
HIST1H2BD |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of HIST1H2BD mRNA |
affects^cotreatment|decreases^expression |
19167446 |
763 |
96-48-0 |
HIST1H2BG |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of HIST1H2BG mRNA |
affects^cotreatment|decreases^expression |
19167446 |
764 |
96-48-0 |
HIST1H2BG |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of HIST1H2BG mRNA |
affects^cotreatment|decreases^expression |
19167446 |
765 |
96-48-0 |
HIST1H2BH |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of HIST1H2BH mRNA |
affects^cotreatment|decreases^expression |
19167446 |
766 |
96-48-0 |
HIST1H2BH |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of HIST1H2BH mRNA |
affects^cotreatment|decreases^expression |
19167446 |
767 |
96-48-0 |
HIST1H3D |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of HIST1H3D mRNA |
affects^cotreatment|decreases^expression |
19167446 |
768 |
96-48-0 |
HIST1H3D |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of HIST1H3D mRNA |
affects^cotreatment|decreases^expression |
19167446 |
769 |
96-48-0 |
HIST1H3H |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of HIST1H3H mRNA |
affects^cotreatment|decreases^expression |
19167446 |
770 |
96-48-0 |
HIST1H3H |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of HIST1H3H mRNA |
affects^cotreatment|decreases^expression |
19167446 |
771 |
96-48-0 |
HIST1H4H |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of HIST1H4H mRNA |
affects^cotreatment|decreases^expression |
19167446 |
772 |
96-48-0 |
HIST1H4H |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of HIST1H4H mRNA |
affects^cotreatment|decreases^expression |
19167446 |
773 |
96-48-0 |
HIST2H2BE |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of HIST2H2BE mRNA |
affects^cotreatment|decreases^expression |
19167446 |
774 |
96-48-0 |
HIST2H2BE |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of HIST2H2BE mRNA |
affects^cotreatment|decreases^expression |
19167446 |
775 |
96-48-0 |
HIST3H2A |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of HIST3H2A mRNA |
affects^cotreatment|decreases^expression |
19167446 |
776 |
96-48-0 |
HIST3H2A |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of HIST3H2A mRNA |
affects^cotreatment|decreases^expression |
19167446 |
777 |
96-48-0 |
HJURP |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of HJURP mRNA |
affects^cotreatment|increases^expression |
19167446 |
778 |
96-48-0 |
HJURP |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of HJURP mRNA |
affects^cotreatment|increases^expression |
19167446 |
779 |
96-48-0 |
HMGA1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of HMGA1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
780 |
96-48-0 |
HMGA1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of HMGA1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
781 |
96-48-0 |
HMGB1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of HMGB1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
782 |
96-48-0 |
HMGB1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of HMGB1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
783 |
96-48-0 |
HMGB2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of HMGB2 mRNA |
affects^cotreatment|increases^expression |
19167446 |
784 |
96-48-0 |
HMGB2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of HMGB2 mRNA |
affects^cotreatment|increases^expression |
19167446 |
785 |
96-48-0 |
HMGN3 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of HMGN3 mRNA |
affects^cotreatment|increases^expression |
19167446 |
786 |
96-48-0 |
HMGN3 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of HMGN3 mRNA |
affects^cotreatment|increases^expression |
19167446 |
787 |
96-48-0 |
HMMR |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of HMMR mRNA |
affects^cotreatment|increases^expression |
19167446 |
788 |
96-48-0 |
HMMR |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of HMMR mRNA |
affects^cotreatment|increases^expression |
19167446 |
789 |
96-48-0 |
HNRNPH1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of HNRNPH1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
790 |
96-48-0 |
HNRNPH1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of HNRNPH1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
791 |
96-48-0 |
HOXC6 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of HOXC6 mRNA |
affects^cotreatment|increases^expression |
19167446 |
792 |
96-48-0 |
HOXC6 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of HOXC6 mRNA |
affects^cotreatment|increases^expression |
19167446 |
793 |
96-48-0 |
HPRT1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of HPRT1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
794 |
96-48-0 |
HPRT1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of HPRT1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
795 |
96-48-0 |
HS6ST2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of HS6ST2 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
796 |
96-48-0 |
HS6ST2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of HS6ST2 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
797 |
96-48-0 |
HSD17B1 |
Homo sapiens |
2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased activity of HSD17B1 protein |
decreases^activity |
15876411 |
798 |
96-48-0 |
HSD17B1 |
Homo sapiens |
2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased activity of HSD17B1 protein |
decreases^activity |
15876411 |
799 |
96-48-0 |
HSD17B6 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of HSD17B6 mRNA |
affects^cotreatment|increases^expression |
19167446 |
800 |
96-48-0 |
HSD17B6 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of HSD17B6 mRNA |
affects^cotreatment|increases^expression |
19167446 |
801 |
96-48-0 |
HSPA4L |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of HSPA4L mRNA |
affects^cotreatment|increases^expression |
19167446 |
802 |
96-48-0 |
HSPA4L |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of HSPA4L mRNA |
affects^cotreatment|increases^expression |
19167446 |
803 |
96-48-0 |
HYLS1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of HYLS1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
804 |
96-48-0 |
HYLS1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of HYLS1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
805 |
96-48-0 |
ICA1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ICA1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
806 |
96-48-0 |
ICA1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ICA1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
807 |
96-48-0 |
ICE1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ICE1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
808 |
96-48-0 |
ICE1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ICE1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
809 |
96-48-0 |
ICMT |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ICMT mRNA |
affects^cotreatment|increases^expression |
19167446 |
810 |
96-48-0 |
ICMT |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ICMT mRNA |
affects^cotreatment|increases^expression |
19167446 |
811 |
96-48-0 |
ID3 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ID3 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
812 |
96-48-0 |
ID3 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ID3 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
813 |
96-48-0 |
IDS |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of IDS mRNA |
affects^cotreatment|decreases^expression |
19167446 |
814 |
96-48-0 |
IDS |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of IDS mRNA |
affects^cotreatment|decreases^expression |
19167446 |
815 |
96-48-0 |
IER2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of IER2 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
816 |
96-48-0 |
IER2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of IER2 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
817 |
96-48-0 |
IER5 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of IER5 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
818 |
96-48-0 |
IER5 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of IER5 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
819 |
96-48-0 |
IFI44L |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of IFI44L mRNA |
affects^cotreatment|decreases^expression |
19167446 |
820 |
96-48-0 |
IFI44L |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of IFI44L mRNA |
affects^cotreatment|decreases^expression |
19167446 |
821 |
96-48-0 |
IFIT2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of IFIT2 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
822 |
96-48-0 |
IFIT2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of IFIT2 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
823 |
96-48-0 |
IFRD2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of IFRD2 mRNA |
affects^cotreatment|increases^expression |
19167446 |
824 |
96-48-0 |
IFRD2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of IFRD2 mRNA |
affects^cotreatment|increases^expression |
19167446 |
825 |
96-48-0 |
IFT122 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of IFT122 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
826 |
96-48-0 |
IFT122 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of IFT122 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
827 |
96-48-0 |
IFT20 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of IFT20 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
828 |
96-48-0 |
IFT20 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of IFT20 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
829 |
96-48-0 |
IFT43 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of IFT43 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
830 |
96-48-0 |
IFT43 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of IFT43 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
831 |
96-48-0 |
IGFBP2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of IGFBP2 mRNA |
affects^cotreatment|increases^expression |
19167446 |
832 |
96-48-0 |
IGFBP2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of IGFBP2 mRNA |
affects^cotreatment|increases^expression |
19167446 |
833 |
96-48-0 |
IGFBP4 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of IGFBP4 mRNA |
affects^cotreatment|increases^expression |
19167446 |
834 |
96-48-0 |
IGFBP4 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of IGFBP4 mRNA |
affects^cotreatment|increases^expression |
19167446 |
835 |
96-48-0 |
IGFBP5 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of IGFBP5 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
836 |
96-48-0 |
IGFBP5 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of IGFBP5 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
837 |
96-48-0 |
IGFLR1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of IGFLR1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
838 |
96-48-0 |
IGFLR1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of IGFLR1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
839 |
96-48-0 |
IL1R1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of IL1R1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
840 |
96-48-0 |
IL1R1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of IL1R1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
841 |
96-48-0 |
IL20 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of IL20 mRNA |
affects^cotreatment|increases^expression |
19167446 |
842 |
96-48-0 |
IL20 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of IL20 mRNA |
affects^cotreatment|increases^expression |
19167446 |
843 |
96-48-0 |
ILF2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ILF2 mRNA |
affects^cotreatment|increases^expression |
19167446 |
844 |
96-48-0 |
ILF2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ILF2 mRNA |
affects^cotreatment|increases^expression |
19167446 |
845 |
96-48-0 |
ILVBL |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ILVBL mRNA |
affects^cotreatment|increases^expression |
19167446 |
846 |
96-48-0 |
ILVBL |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ILVBL mRNA |
affects^cotreatment|increases^expression |
19167446 |
847 |
96-48-0 |
INCENP |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of INCENP mRNA |
affects^cotreatment|increases^expression |
19167446 |
848 |
96-48-0 |
INCENP |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of INCENP mRNA |
affects^cotreatment|increases^expression |
19167446 |
849 |
96-48-0 |
INHBB |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of INHBB mRNA |
affects^cotreatment|decreases^expression |
19167446 |
850 |
96-48-0 |
INHBB |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of INHBB mRNA |
affects^cotreatment|decreases^expression |
19167446 |
851 |
96-48-0 |
INO80E |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of INO80E mRNA |
affects^cotreatment|increases^expression |
19167446 |
852 |
96-48-0 |
INO80E |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of INO80E mRNA |
affects^cotreatment|increases^expression |
19167446 |
853 |
96-48-0 |
INSIG1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of INSIG1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
854 |
96-48-0 |
INSIG1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of INSIG1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
855 |
96-48-0 |
IP6K2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of IP6K2 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
856 |
96-48-0 |
IP6K2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of IP6K2 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
857 |
96-48-0 |
IQCK |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of IQCK mRNA |
affects^cotreatment|decreases^expression |
19167446 |
858 |
96-48-0 |
IQCK |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of IQCK mRNA |
affects^cotreatment|decreases^expression |
19167446 |
859 |
96-48-0 |
IQGAP3 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of IQGAP3 mRNA |
affects^cotreatment|increases^expression |
19167446 |
860 |
96-48-0 |
IQGAP3 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of IQGAP3 mRNA |
affects^cotreatment|increases^expression |
19167446 |
861 |
96-48-0 |
IRF6 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of IRF6 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
862 |
96-48-0 |
IRF6 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of IRF6 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
863 |
96-48-0 |
IRF9 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of IRF9 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
864 |
96-48-0 |
IRF9 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of IRF9 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
865 |
96-48-0 |
IRS2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of IRS2 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
866 |
96-48-0 |
IRS2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of IRS2 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
867 |
96-48-0 |
ISYNA1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ISYNA1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
868 |
96-48-0 |
ISYNA1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ISYNA1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
869 |
96-48-0 |
ITGA2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ITGA2 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
870 |
96-48-0 |
ITGA2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ITGA2 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
871 |
96-48-0 |
ITGAE |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ITGAE mRNA |
affects^cotreatment|increases^expression |
19167446 |
872 |
96-48-0 |
ITGAE |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ITGAE mRNA |
affects^cotreatment|increases^expression |
19167446 |
873 |
96-48-0 |
ITGB3BP |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ITGB3BP mRNA |
affects^cotreatment|increases^expression |
19167446 |
874 |
96-48-0 |
ITGB3BP |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ITGB3BP mRNA |
affects^cotreatment|increases^expression |
19167446 |
875 |
96-48-0 |
ITPR1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ITPR1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
876 |
96-48-0 |
ITPR1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ITPR1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
877 |
96-48-0 |
JAG1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of JAG1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
878 |
96-48-0 |
JAG1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of JAG1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
879 |
96-48-0 |
JMY |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of JMY mRNA |
affects^cotreatment|decreases^expression |
19167446 |
880 |
96-48-0 |
JMY |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of JMY mRNA |
affects^cotreatment|decreases^expression |
19167446 |
881 |
96-48-0 |
JUN |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of JUN mRNA |
affects^cotreatment|decreases^expression |
19167446 |
882 |
96-48-0 |
JUN |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of JUN mRNA |
affects^cotreatment|decreases^expression |
19167446 |
883 |
96-48-0 |
JUNB |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of JUNB mRNA |
affects^cotreatment|decreases^expression |
19167446 |
884 |
96-48-0 |
JUNB |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of JUNB mRNA |
affects^cotreatment|decreases^expression |
19167446 |
885 |
96-48-0 |
KDM4B |
Homo sapiens |
2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of KDM4B mRNA |
decreases^expression |
19167446 |
886 |
96-48-0 |
KDM4B |
Homo sapiens |
2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of KDM4B mRNA |
decreases^expression |
19167446 |
887 |
96-48-0 |
KDM5A |
Homo sapiens |
2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of KDM5A mRNA |
decreases^expression |
19167446 |
888 |
96-48-0 |
KDM5A |
Homo sapiens |
2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of KDM5A mRNA |
decreases^expression |
19167446 |
889 |
96-48-0 |
KDM5B |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of KDM5B mRNA |
affects^cotreatment|decreases^expression |
19167446 |
890 |
96-48-0 |
KDM5B |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of KDM5B mRNA |
affects^cotreatment|decreases^expression |
19167446 |
891 |
96-48-0 |
KDR |
Mus musculus |
2,3-bis(3'-hydroxybenzyl)butyrolactone inhibits the reaction [Estradiol results in increased expression of KDR protein] |
decreases^reaction|increases^expression |
17289903 |
892 |
96-48-0 |
KDR |
Mus musculus |
2,3-bis(3'-hydroxybenzyl)butyrolactone inhibits the reaction [Estradiol results in increased expression of KDR protein] |
decreases^reaction|increases^expression |
17289903 |
893 |
96-48-0 |
KIAA0100 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of KIAA0100 mRNA |
affects^cotreatment|increases^expression |
19167446 |
894 |
96-48-0 |
KIAA0100 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of KIAA0100 mRNA |
affects^cotreatment|increases^expression |
19167446 |
895 |
96-48-0 |
KIAA0513 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of KIAA0513 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
896 |
96-48-0 |
KIAA0513 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of KIAA0513 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
897 |
96-48-0 |
KIAA1147 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of KIAA1147 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
898 |
96-48-0 |
KIAA1147 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of KIAA1147 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
899 |
96-48-0 |
KIAA1211 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of KIAA1211 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
900 |
96-48-0 |
KIAA1211 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of KIAA1211 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
901 |
96-48-0 |
KIDINS220 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of KIDINS220 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
902 |
96-48-0 |
KIDINS220 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of KIDINS220 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
903 |
96-48-0 |
KIF11 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of KIF11 mRNA |
affects^cotreatment|increases^expression |
19167446 |
904 |
96-48-0 |
KIF11 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of KIF11 mRNA |
affects^cotreatment|increases^expression |
19167446 |
905 |
96-48-0 |
KIF14 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of KIF14 mRNA |
affects^cotreatment|increases^expression |
19167446 |
906 |
96-48-0 |
KIF14 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of KIF14 mRNA |
affects^cotreatment|increases^expression |
19167446 |
907 |
96-48-0 |
KIF18A |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of KIF18A mRNA |
affects^cotreatment|increases^expression |
19167446 |
908 |
96-48-0 |
KIF18A |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of KIF18A mRNA |
affects^cotreatment|increases^expression |
19167446 |
909 |
96-48-0 |
KIF20A |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of KIF20A mRNA |
affects^cotreatment|increases^expression |
19167446 |
910 |
96-48-0 |
KIF20A |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of KIF20A mRNA |
affects^cotreatment|increases^expression |
19167446 |
911 |
96-48-0 |
KIF2C |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of KIF2C mRNA |
affects^cotreatment|increases^expression |
19167446 |
912 |
96-48-0 |
KIF2C |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of KIF2C mRNA |
affects^cotreatment|increases^expression |
19167446 |
913 |
96-48-0 |
KIF5C |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of KIF5C mRNA |
affects^cotreatment|decreases^expression |
19167446 |
914 |
96-48-0 |
KIF5C |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of KIF5C mRNA |
affects^cotreatment|decreases^expression |
19167446 |
915 |
96-48-0 |
KIFC1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of KIFC1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
916 |
96-48-0 |
KIFC1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of KIFC1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
917 |
96-48-0 |
KLF12 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of KLF12 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
918 |
96-48-0 |
KLF12 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of KLF12 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
919 |
96-48-0 |
KLF6 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of KLF6 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
920 |
96-48-0 |
KLF6 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of KLF6 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
921 |
96-48-0 |
KLF9 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of KLF9 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
922 |
96-48-0 |
KLF9 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of KLF9 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
923 |
96-48-0 |
KLHDC3 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of KLHDC3 mRNA |
affects^cotreatment|increases^expression |
19167446 |
924 |
96-48-0 |
KLHDC3 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of KLHDC3 mRNA |
affects^cotreatment|increases^expression |
19167446 |
925 |
96-48-0 |
KLHL24 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of KLHL24 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
926 |
96-48-0 |
KLHL24 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of KLHL24 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
927 |
96-48-0 |
KLHL5 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of KLHL5 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
928 |
96-48-0 |
KLHL5 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of KLHL5 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
929 |
96-48-0 |
KMT2E |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of KMT2E mRNA |
affects^cotreatment|decreases^expression |
19167446 |
930 |
96-48-0 |
KMT2E |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of KMT2E mRNA |
affects^cotreatment|decreases^expression |
19167446 |
931 |
96-48-0 |
KNSTRN |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of KNSTRN mRNA |
affects^cotreatment|increases^expression |
19167446 |
932 |
96-48-0 |
KNSTRN |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of KNSTRN mRNA |
affects^cotreatment|increases^expression |
19167446 |
933 |
96-48-0 |
KNTC2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of KNTC2 mRNA |
affects^cotreatment|increases^expression |
19167446 |
934 |
96-48-0 |
KNTC2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of KNTC2 mRNA |
affects^cotreatment|increases^expression |
19167446 |
935 |
96-48-0 |
KPNA4 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of KPNA4 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
936 |
96-48-0 |
KPNA4 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of KPNA4 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
937 |
96-48-0 |
KRT80 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of KRT80 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
938 |
96-48-0 |
KRT80 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of KRT80 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
939 |
96-48-0 |
L1CAM |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of L1CAM mRNA |
affects^cotreatment|decreases^expression |
19167446 |
940 |
96-48-0 |
L1CAM |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of L1CAM mRNA |
affects^cotreatment|decreases^expression |
19167446 |
941 |
96-48-0 |
L2HGDH |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of L2HGDH mRNA |
affects^cotreatment|increases^expression |
19167446 |
942 |
96-48-0 |
L2HGDH |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of L2HGDH mRNA |
affects^cotreatment|increases^expression |
19167446 |
943 |
96-48-0 |
LAGE3 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of LAGE3 mRNA |
affects^cotreatment|increases^expression |
19167446 |
944 |
96-48-0 |
LAGE3 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of LAGE3 mRNA |
affects^cotreatment|increases^expression |
19167446 |
945 |
96-48-0 |
LARP6 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of LARP6 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
946 |
96-48-0 |
LARP6 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of LARP6 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
947 |
96-48-0 |
LCMT2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of LCMT2 mRNA |
affects^cotreatment|increases^expression |
19167446 |
948 |
96-48-0 |
LCMT2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of LCMT2 mRNA |
affects^cotreatment|increases^expression |
19167446 |
949 |
96-48-0 |
LDLR |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of LDLR mRNA |
affects^cotreatment|increases^expression |
19167446 |
950 |
96-48-0 |
LDLR |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of LDLR mRNA |
affects^cotreatment|increases^expression |
19167446 |
951 |
96-48-0 |
LEPR |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of LEPR mRNA |
affects^cotreatment|decreases^expression |
19167446 |
952 |
96-48-0 |
LEPR |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of LEPR mRNA |
affects^cotreatment|decreases^expression |
19167446 |
953 |
96-48-0 |
LGALS1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of LGALS1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
954 |
96-48-0 |
LGALS1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of LGALS1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
955 |
96-48-0 |
LIG1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of LIG1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
956 |
96-48-0 |
LIG1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of LIG1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
957 |
96-48-0 |
LINC00052 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of LINC00052 mRNA |
affects^cotreatment|increases^expression |
19167446 |
958 |
96-48-0 |
LINC00052 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of LINC00052 mRNA |
affects^cotreatment|increases^expression |
19167446 |
959 |
96-48-0 |
LMNB1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of LMNB1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
960 |
96-48-0 |
LMNB1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of LMNB1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
961 |
96-48-0 |
LMNB2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of LMNB2 mRNA |
affects^cotreatment|increases^expression |
19167446 |
962 |
96-48-0 |
LMNB2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of LMNB2 mRNA |
affects^cotreatment|increases^expression |
19167446 |
963 |
96-48-0 |
LRIG1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of LRIG1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
964 |
96-48-0 |
LRIG1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of LRIG1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
965 |
96-48-0 |
LRR1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of LRR1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
966 |
96-48-0 |
LRR1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of LRR1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
967 |
96-48-0 |
LSM2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of LSM2 mRNA |
affects^cotreatment|increases^expression |
19167446 |
968 |
96-48-0 |
LSM2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of LSM2 mRNA |
affects^cotreatment|increases^expression |
19167446 |
969 |
96-48-0 |
MAD2L1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MAD2L1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
970 |
96-48-0 |
MAD2L1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MAD2L1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
971 |
96-48-0 |
MAFF |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MAFF mRNA |
affects^cotreatment|decreases^expression |
19167446 |
972 |
96-48-0 |
MAFF |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MAFF mRNA |
affects^cotreatment|decreases^expression |
19167446 |
973 |
96-48-0 |
MAGI1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MAGI1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
974 |
96-48-0 |
MAGI1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MAGI1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
975 |
96-48-0 |
MALAT1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MALAT1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
976 |
96-48-0 |
MALAT1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MALAT1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
977 |
96-48-0 |
MAP1B |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MAP1B mRNA |
affects^cotreatment|decreases^expression |
19167446 |
978 |
96-48-0 |
MAP1B |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MAP1B mRNA |
affects^cotreatment|decreases^expression |
19167446 |
979 |
96-48-0 |
MAP4K4 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MAP4K4 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
980 |
96-48-0 |
MAP4K4 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MAP4K4 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
981 |
96-48-0 |
MAST4 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MAST4 mRNA |
affects^cotreatment|increases^expression |
19167446 |
982 |
96-48-0 |
MAST4 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MAST4 mRNA |
affects^cotreatment|increases^expression |
19167446 |
983 |
96-48-0 |
MASTL |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MASTL mRNA |
affects^cotreatment|increases^expression |
19167446 |
984 |
96-48-0 |
MASTL |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MASTL mRNA |
affects^cotreatment|increases^expression |
19167446 |
985 |
96-48-0 |
MATN3 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MATN3 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
986 |
96-48-0 |
MATN3 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MATN3 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
987 |
96-48-0 |
MAZ |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MAZ mRNA |
affects^cotreatment|increases^expression |
19167446 |
988 |
96-48-0 |
MAZ |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MAZ mRNA |
affects^cotreatment|increases^expression |
19167446 |
989 |
96-48-0 |
MB21D2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MB21D2 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
990 |
96-48-0 |
MB21D2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MB21D2 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
991 |
96-48-0 |
MCAM |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MCAM mRNA |
affects^cotreatment|increases^expression |
19167446 |
992 |
96-48-0 |
MCAM |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MCAM mRNA |
affects^cotreatment|increases^expression |
19167446 |
993 |
96-48-0 |
MCM10 |
Homo sapiens |
2,3-bis(3'-hydroxybenzyl)butyrolactone results in increased expression of MCM10 mRNA |
increases^expression |
19167446 |
994 |
96-48-0 |
MCM10 |
Homo sapiens |
2,3-bis(3'-hydroxybenzyl)butyrolactone results in increased expression of MCM10 mRNA |
increases^expression |
19167446 |
995 |
96-48-0 |
MCM10 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MCM10 mRNA |
affects^cotreatment|increases^expression |
19167446 |
996 |
96-48-0 |
MCM10 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MCM10 mRNA |
affects^cotreatment|increases^expression |
19167446 |
997 |
96-48-0 |
MCM2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MCM2 mRNA |
affects^cotreatment|increases^expression |
19167446 |
998 |
96-48-0 |
MCM2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MCM2 mRNA |
affects^cotreatment|increases^expression |
19167446 |
999 |
96-48-0 |
MCM3 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MCM3 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1000 |
96-48-0 |
MCM3 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MCM3 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1001 |
96-48-0 |
MCM4 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MCM4 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1002 |
96-48-0 |
MCM4 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MCM4 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1003 |
96-48-0 |
MCM5 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MCM5 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1004 |
96-48-0 |
MCM5 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MCM5 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1005 |
96-48-0 |
MCM6 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MCM6 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1006 |
96-48-0 |
MCM6 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MCM6 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1007 |
96-48-0 |
MCM7 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MCM7 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1008 |
96-48-0 |
MCM7 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MCM7 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1009 |
96-48-0 |
MCM8 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MCM8 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1010 |
96-48-0 |
MCM8 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MCM8 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1011 |
96-48-0 |
MCUB |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MCUB mRNA |
affects^cotreatment|increases^expression |
19167446 |
1012 |
96-48-0 |
MCUB |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MCUB mRNA |
affects^cotreatment|increases^expression |
19167446 |
1013 |
96-48-0 |
MDC1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MDC1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1014 |
96-48-0 |
MDC1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MDC1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1015 |
96-48-0 |
MEA1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MEA1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1016 |
96-48-0 |
MEA1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MEA1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1017 |
96-48-0 |
MEAF6 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MEAF6 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1018 |
96-48-0 |
MEAF6 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MEAF6 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1019 |
96-48-0 |
MEF2A |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MEF2A mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1020 |
96-48-0 |
MEF2A |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MEF2A mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1021 |
96-48-0 |
MELK |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MELK mRNA |
affects^cotreatment|increases^expression |
19167446 |
1022 |
96-48-0 |
MELK |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MELK mRNA |
affects^cotreatment|increases^expression |
19167446 |
1023 |
96-48-0 |
MEPCE |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MEPCE mRNA |
affects^cotreatment|increases^expression |
19167446 |
1024 |
96-48-0 |
MEPCE |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MEPCE mRNA |
affects^cotreatment|increases^expression |
19167446 |
1025 |
96-48-0 |
METAP2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of METAP2 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1026 |
96-48-0 |
METAP2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of METAP2 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1027 |
96-48-0 |
METTL7A |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of METTL7A mRNA |
affects^cotreatment|increases^expression |
19167446 |
1028 |
96-48-0 |
METTL7A |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of METTL7A mRNA |
affects^cotreatment|increases^expression |
19167446 |
1029 |
96-48-0 |
MGAT4B |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MGAT4B mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1030 |
96-48-0 |
MGAT4B |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MGAT4B mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1031 |
96-48-0 |
MGLL |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MGLL mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1032 |
96-48-0 |
MGLL |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MGLL mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1033 |
96-48-0 |
MGP |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MGP mRNA |
affects^cotreatment|increases^expression |
19167446 |
1034 |
96-48-0 |
MGP |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MGP mRNA |
affects^cotreatment|increases^expression |
19167446 |
1035 |
96-48-0 |
MIR21 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MIR21 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1036 |
96-48-0 |
MIR21 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MIR21 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1037 |
96-48-0 |
MIS18BP1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MIS18BP1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1038 |
96-48-0 |
MIS18BP1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MIS18BP1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1039 |
96-48-0 |
MKI67 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MKI67 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1040 |
96-48-0 |
MKI67 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MKI67 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1041 |
96-48-0 |
MKNK2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MKNK2 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1042 |
96-48-0 |
MKNK2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MKNK2 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1043 |
96-48-0 |
MLH1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MLH1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1044 |
96-48-0 |
MLH1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MLH1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1045 |
96-48-0 |
MOAP1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MOAP1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1046 |
96-48-0 |
MOAP1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MOAP1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1047 |
96-48-0 |
MPHOSPH9 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MPHOSPH9 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1048 |
96-48-0 |
MPHOSPH9 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MPHOSPH9 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1049 |
96-48-0 |
MRE11 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MRE11 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1050 |
96-48-0 |
MRE11 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MRE11 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1051 |
96-48-0 |
MRM2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MRM2 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1052 |
96-48-0 |
MRM2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MRM2 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1053 |
96-48-0 |
MRPL37 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MRPL37 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1054 |
96-48-0 |
MRPL37 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MRPL37 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1055 |
96-48-0 |
MRPS26 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MRPS26 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1056 |
96-48-0 |
MRPS26 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MRPS26 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1057 |
96-48-0 |
MRPS27 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MRPS27 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1058 |
96-48-0 |
MRPS27 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MRPS27 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1059 |
96-48-0 |
MSH6 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MSH6 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1060 |
96-48-0 |
MSH6 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MSH6 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1061 |
96-48-0 |
MTCP1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MTCP1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1062 |
96-48-0 |
MTCP1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MTCP1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1063 |
96-48-0 |
MTFP1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MTFP1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1064 |
96-48-0 |
MTFP1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MTFP1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1065 |
96-48-0 |
MTHFD1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MTHFD1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1066 |
96-48-0 |
MTHFD1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MTHFD1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1067 |
96-48-0 |
MTMR4 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MTMR4 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1068 |
96-48-0 |
MTMR4 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MTMR4 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1069 |
96-48-0 |
MTUS1 |
Homo sapiens |
2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of MTUS1 mRNA |
decreases^expression |
19167446 |
1070 |
96-48-0 |
MTUS1 |
Homo sapiens |
2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of MTUS1 mRNA |
decreases^expression |
19167446 |
1071 |
96-48-0 |
MTUS1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MTUS1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1072 |
96-48-0 |
MTUS1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MTUS1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1073 |
96-48-0 |
MVP |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MVP mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1074 |
96-48-0 |
MVP |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MVP mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1075 |
96-48-0 |
MXD4 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MXD4 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1076 |
96-48-0 |
MXD4 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MXD4 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1077 |
96-48-0 |
MYB |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MYB mRNA |
affects^cotreatment|increases^expression |
19167446 |
1078 |
96-48-0 |
MYB |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MYB mRNA |
affects^cotreatment|increases^expression |
19167446 |
1079 |
96-48-0 |
MYBL2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MYBL2 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1080 |
96-48-0 |
MYBL2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MYBL2 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1081 |
96-48-0 |
MYCBP |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MYCBP mRNA |
affects^cotreatment|increases^expression |
19167446 |
1082 |
96-48-0 |
MYCBP |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MYCBP mRNA |
affects^cotreatment|increases^expression |
19167446 |
1083 |
96-48-0 |
MYLIP |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MYLIP mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1084 |
96-48-0 |
MYLIP |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MYLIP mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1085 |
96-48-0 |
MYO1B |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MYO1B mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1086 |
96-48-0 |
MYO1B |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MYO1B mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1087 |
96-48-0 |
MYO5A |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MYO5A mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1088 |
96-48-0 |
MYO5A |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MYO5A mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1089 |
96-48-0 |
MYO5B |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MYO5B mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1090 |
96-48-0 |
MYO5B |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MYO5B mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1091 |
96-48-0 |
MYO6 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MYO6 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1092 |
96-48-0 |
MYO6 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MYO6 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1093 |
96-48-0 |
MZT1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MZT1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1094 |
96-48-0 |
MZT1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MZT1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1095 |
96-48-0 |
N4BP1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of N4BP1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1096 |
96-48-0 |
N4BP1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of N4BP1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1097 |
96-48-0 |
NAA50 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NAA50 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1098 |
96-48-0 |
NAA50 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NAA50 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1099 |
96-48-0 |
NANOS1 |
Homo sapiens |
2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of NANOS1 mRNA |
decreases^expression |
19167446 |
1100 |
96-48-0 |
NANOS1 |
Homo sapiens |
2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of NANOS1 mRNA |
decreases^expression |
19167446 |
1101 |
96-48-0 |
NANOS1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of NANOS1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1102 |
96-48-0 |
NANOS1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of NANOS1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1103 |
96-48-0 |
NASP |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NASP mRNA |
affects^cotreatment|increases^expression |
19167446 |
1104 |
96-48-0 |
NASP |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NASP mRNA |
affects^cotreatment|increases^expression |
19167446 |
1105 |
96-48-0 |
NBEA |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of NBEA mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1106 |
96-48-0 |
NBEA |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of NBEA mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1107 |
96-48-0 |
NBEAL1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of NBEAL1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1108 |
96-48-0 |
NBEAL1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of NBEAL1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1109 |
96-48-0 |
NBPF1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NBPF1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1110 |
96-48-0 |
NBPF1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NBPF1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1111 |
96-48-0 |
NCAPG |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NCAPG mRNA |
affects^cotreatment|increases^expression |
19167446 |
1112 |
96-48-0 |
NCAPG |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NCAPG mRNA |
affects^cotreatment|increases^expression |
19167446 |
1113 |
96-48-0 |
NCAPG2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NCAPG2 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1114 |
96-48-0 |
NCAPG2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NCAPG2 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1115 |
96-48-0 |
NCOA1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of NCOA1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1116 |
96-48-0 |
NCOA1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of NCOA1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1117 |
96-48-0 |
NCOA7 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of NCOA7 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1118 |
96-48-0 |
NCOA7 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of NCOA7 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1119 |
96-48-0 |
NDC1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NDC1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1120 |
96-48-0 |
NDC1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NDC1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1121 |
96-48-0 |
NDE1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NDE1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1122 |
96-48-0 |
NDE1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NDE1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1123 |
96-48-0 |
NDFIP1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of NDFIP1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1124 |
96-48-0 |
NDFIP1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of NDFIP1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1125 |
96-48-0 |
NEAT1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of NEAT1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1126 |
96-48-0 |
NEAT1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of NEAT1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1127 |
96-48-0 |
NEBL |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of NEBL mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1128 |
96-48-0 |
NEBL |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of NEBL mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1129 |
96-48-0 |
NEDD4L |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of NEDD4L mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1130 |
96-48-0 |
NEDD4L |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of NEDD4L mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1131 |
96-48-0 |
NEDD9 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of NEDD9 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1132 |
96-48-0 |
NEDD9 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of NEDD9 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1133 |
96-48-0 |
NEIL3 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NEIL3 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1134 |
96-48-0 |
NEIL3 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NEIL3 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1135 |
96-48-0 |
NEURL1B |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NEURL1B mRNA |
affects^cotreatment|increases^expression |
19167446 |
1136 |
96-48-0 |
NEURL1B |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NEURL1B mRNA |
affects^cotreatment|increases^expression |
19167446 |
1137 |
96-48-0 |
NFATC2IP |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NFATC2IP mRNA |
affects^cotreatment|increases^expression |
19167446 |
1138 |
96-48-0 |
NFATC2IP |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NFATC2IP mRNA |
affects^cotreatment|increases^expression |
19167446 |
1139 |
96-48-0 |
NFIL3 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of NFIL3 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1140 |
96-48-0 |
NFIL3 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of NFIL3 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1141 |
96-48-0 |
NINL |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of NINL mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1142 |
96-48-0 |
NINL |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of NINL mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1143 |
96-48-0 |
NMT2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of NMT2 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1144 |
96-48-0 |
NMT2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of NMT2 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1145 |
96-48-0 |
NMU |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NMU mRNA |
affects^cotreatment|increases^expression |
19167446 |
1146 |
96-48-0 |
NMU |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NMU mRNA |
affects^cotreatment|increases^expression |
19167446 |
1147 |
96-48-0 |
NOM1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NOM1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1148 |
96-48-0 |
NOM1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NOM1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1149 |
96-48-0 |
NPAS3 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of NPAS3 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1150 |
96-48-0 |
NPAS3 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of NPAS3 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1151 |
96-48-0 |
NPEPPS |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NPEPPS mRNA |
affects^cotreatment|increases^expression |
19167446 |
1152 |
96-48-0 |
NPEPPS |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NPEPPS mRNA |
affects^cotreatment|increases^expression |
19167446 |
1153 |
96-48-0 |
NPHP3 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of NPHP3 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1154 |
96-48-0 |
NPHP3 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of NPHP3 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1155 |
96-48-0 |
NPNT |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of NPNT mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1156 |
96-48-0 |
NPNT |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of NPNT mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1157 |
96-48-0 |
NPY1R |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NPY1R mRNA |
affects^cotreatment|increases^expression |
19167446 |
1158 |
96-48-0 |
NPY1R |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NPY1R mRNA |
affects^cotreatment|increases^expression |
19167446 |
1159 |
96-48-0 |
NQO1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of NQO1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1160 |
96-48-0 |
NQO1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of NQO1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1161 |
96-48-0 |
NQO2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NQO2 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1162 |
96-48-0 |
NQO2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NQO2 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1163 |
96-48-0 |
NR1I2 |
Homo sapiens |
2,3-bis(3'-hydroxybenzyl)butyrolactone results in increased activity of NR1I2 protein |
increases^activity |
15885729 |
1164 |
96-48-0 |
NR1I2 |
Homo sapiens |
2,3-bis(3'-hydroxybenzyl)butyrolactone results in increased activity of NR1I2 protein |
increases^activity |
15885729 |
1165 |
96-48-0 |
NR2F6 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NR2F6 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1166 |
96-48-0 |
NR2F6 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NR2F6 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1167 |
96-48-0 |
NR4A2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of NR4A2 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1168 |
96-48-0 |
NR4A2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of NR4A2 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1169 |
96-48-0 |
NRCAM |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of NRCAM mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1170 |
96-48-0 |
NRCAM |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of NRCAM mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1171 |
96-48-0 |
NRM |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NRM mRNA |
affects^cotreatment|increases^expression |
19167446 |
1172 |
96-48-0 |
NRM |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NRM mRNA |
affects^cotreatment|increases^expression |
19167446 |
1173 |
96-48-0 |
NSD2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NSD2 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1174 |
96-48-0 |
NSD2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NSD2 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1175 |
96-48-0 |
NT5E |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of NT5E mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1176 |
96-48-0 |
NT5E |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of NT5E mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1177 |
96-48-0 |
NTN4 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of NTN4 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1178 |
96-48-0 |
NTN4 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of NTN4 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1179 |
96-48-0 |
NUAK1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of NUAK1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1180 |
96-48-0 |
NUAK1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of NUAK1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1181 |
96-48-0 |
NUDT1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NUDT1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1182 |
96-48-0 |
NUDT1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NUDT1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1183 |
96-48-0 |
NUP107 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NUP107 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1184 |
96-48-0 |
NUP107 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NUP107 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1185 |
96-48-0 |
NUP155 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NUP155 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1186 |
96-48-0 |
NUP155 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NUP155 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1187 |
96-48-0 |
NUP210 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NUP210 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1188 |
96-48-0 |
NUP210 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NUP210 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1189 |
96-48-0 |
NUP62CL |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NUP62CL mRNA |
affects^cotreatment|increases^expression |
19167446 |
1190 |
96-48-0 |
NUP62CL |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NUP62CL mRNA |
affects^cotreatment|increases^expression |
19167446 |
1191 |
96-48-0 |
NUSAP1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NUSAP1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1192 |
96-48-0 |
NUSAP1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NUSAP1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1193 |
96-48-0 |
OAZ2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of OAZ2 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1194 |
96-48-0 |
OAZ2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of OAZ2 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1195 |
96-48-0 |
ODF2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ODF2 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1196 |
96-48-0 |
ODF2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ODF2 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1197 |
96-48-0 |
OIP5 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of OIP5 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1198 |
96-48-0 |
OIP5 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of OIP5 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1199 |
96-48-0 |
OLFM1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of OLFM1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1200 |
96-48-0 |
OLFM1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of OLFM1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1201 |
96-48-0 |
OPTN |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of OPTN mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1202 |
96-48-0 |
OPTN |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of OPTN mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1203 |
96-48-0 |
ORC1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ORC1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1204 |
96-48-0 |
ORC1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ORC1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1205 |
96-48-0 |
ORC6 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ORC6 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1206 |
96-48-0 |
ORC6 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ORC6 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1207 |
96-48-0 |
OSBPL2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of OSBPL2 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1208 |
96-48-0 |
OSBPL2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of OSBPL2 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1209 |
96-48-0 |
OSER1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of OSER1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1210 |
96-48-0 |
OSER1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of OSER1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1211 |
96-48-0 |
OTUD1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of OTUD1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1212 |
96-48-0 |
OTUD1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of OTUD1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1213 |
96-48-0 |
OXCT1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of OXCT1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1214 |
96-48-0 |
OXCT1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of OXCT1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1215 |
96-48-0 |
OXTR |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of OXTR mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1216 |
96-48-0 |
OXTR |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of OXTR mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1217 |
96-48-0 |
P4HB |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of P4HB mRNA |
affects^cotreatment|increases^expression |
19167446 |
1218 |
96-48-0 |
P4HB |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of P4HB mRNA |
affects^cotreatment|increases^expression |
19167446 |
1219 |
96-48-0 |
PAICS |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PAICS mRNA |
affects^cotreatment|increases^expression |
19167446 |
1220 |
96-48-0 |
PAICS |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PAICS mRNA |
affects^cotreatment|increases^expression |
19167446 |
1221 |
96-48-0 |
PAPSS2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PAPSS2 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1222 |
96-48-0 |
PAPSS2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PAPSS2 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1223 |
96-48-0 |
PARP1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PARP1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1224 |
96-48-0 |
PARP1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PARP1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1225 |
96-48-0 |
PARP2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PARP2 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1226 |
96-48-0 |
PARP2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PARP2 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1227 |
96-48-0 |
PARPBP |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PARPBP mRNA |
affects^cotreatment|increases^expression |
19167446 |
1228 |
96-48-0 |
PARPBP |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PARPBP mRNA |
affects^cotreatment|increases^expression |
19167446 |
1229 |
96-48-0 |
PARVA |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PARVA mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1230 |
96-48-0 |
PARVA |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PARVA mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1231 |
96-48-0 |
PAWR |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PAWR mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1232 |
96-48-0 |
PAWR |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PAWR mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1233 |
96-48-0 |
PBK |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PBK mRNA |
affects^cotreatment|increases^expression |
19167446 |
1234 |
96-48-0 |
PBK |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PBK mRNA |
affects^cotreatment|increases^expression |
19167446 |
1235 |
96-48-0 |
PCK2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PCK2 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1236 |
96-48-0 |
PCK2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PCK2 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1237 |
96-48-0 |
PCLAF |
Homo sapiens |
2,3-bis(3'-hydroxybenzyl)butyrolactone results in increased expression of PCLAF mRNA |
increases^expression |
19167446 |
1238 |
96-48-0 |
PCLAF |
Homo sapiens |
2,3-bis(3'-hydroxybenzyl)butyrolactone results in increased expression of PCLAF mRNA |
increases^expression |
19167446 |
1239 |
96-48-0 |
PCLAF |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PCLAF mRNA |
affects^cotreatment|increases^expression |
19167446 |
1240 |
96-48-0 |
PCLAF |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PCLAF mRNA |
affects^cotreatment|increases^expression |
19167446 |
1241 |
96-48-0 |
PCMTD1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PCMTD1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1242 |
96-48-0 |
PCMTD1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PCMTD1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1243 |
96-48-0 |
PCNA |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PCNA mRNA |
affects^cotreatment|increases^expression |
19167446 |
1244 |
96-48-0 |
PCNA |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PCNA mRNA |
affects^cotreatment|increases^expression |
19167446 |
1245 |
96-48-0 |
PCNT |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PCNT mRNA |
affects^cotreatment|increases^expression |
19167446 |
1246 |
96-48-0 |
PCNT |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PCNT mRNA |
affects^cotreatment|increases^expression |
19167446 |
1247 |
96-48-0 |
PCSK6 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PCSK6 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1248 |
96-48-0 |
PCSK6 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PCSK6 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1249 |
96-48-0 |
PCTK2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PCTK2 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1250 |
96-48-0 |
PCTK2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PCTK2 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1251 |
96-48-0 |
PDCD4 |
Homo sapiens |
2,3-bis(3'-hydroxybenzyl)butyrolactone results in increased expression of PDCD4 mRNA |
increases^expression |
19167446 |
1252 |
96-48-0 |
PDCD4 |
Homo sapiens |
2,3-bis(3'-hydroxybenzyl)butyrolactone results in increased expression of PDCD4 mRNA |
increases^expression |
19167446 |
1253 |
96-48-0 |
PDCD6IP |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PDCD6IP mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1254 |
96-48-0 |
PDCD6IP |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PDCD6IP mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1255 |
96-48-0 |
PDIA3 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PDIA3 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1256 |
96-48-0 |
PDIA3 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PDIA3 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1257 |
96-48-0 |
PDIA6 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PDIA6 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1258 |
96-48-0 |
PDIA6 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PDIA6 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1259 |
96-48-0 |
PDLIM1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PDLIM1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1260 |
96-48-0 |
PDLIM1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PDLIM1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1261 |
96-48-0 |
PDZK1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PDZK1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1262 |
96-48-0 |
PDZK1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PDZK1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1263 |
96-48-0 |
PFKL |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PFKL mRNA |
affects^cotreatment|increases^expression |
19167446 |
1264 |
96-48-0 |
PFKL |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PFKL mRNA |
affects^cotreatment|increases^expression |
19167446 |
1265 |
96-48-0 |
PGGT1B |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PGGT1B mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1266 |
96-48-0 |
PGGT1B |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PGGT1B mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1267 |
96-48-0 |
PGM2L1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PGM2L1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1268 |
96-48-0 |
PGM2L1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PGM2L1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1269 |
96-48-0 |
PGM3 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PGM3 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1270 |
96-48-0 |
PGM3 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PGM3 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1271 |
96-48-0 |
PGRMC1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PGRMC1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1272 |
96-48-0 |
PGRMC1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PGRMC1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1273 |
96-48-0 |
PGRMC2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PGRMC2 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1274 |
96-48-0 |
PGRMC2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PGRMC2 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1275 |
96-48-0 |
PHACTR2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PHACTR2 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1276 |
96-48-0 |
PHACTR2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PHACTR2 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1277 |
96-48-0 |
PHF19 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PHF19 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1278 |
96-48-0 |
PHF19 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PHF19 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1279 |
96-48-0 |
PHF20L1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PHF20L1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1280 |
96-48-0 |
PHF20L1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PHF20L1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1281 |
96-48-0 |
PHLDA2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PHLDA2 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1282 |
96-48-0 |
PHLDA2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PHLDA2 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1283 |
96-48-0 |
PHLDB2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PHLDB2 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1284 |
96-48-0 |
PHLDB2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PHLDB2 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1285 |
96-48-0 |
PIK3C3 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PIK3C3 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1286 |
96-48-0 |
PIK3C3 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PIK3C3 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1287 |
96-48-0 |
PIMREG |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PIMREG mRNA |
affects^cotreatment|increases^expression |
19167446 |
1288 |
96-48-0 |
PIMREG |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PIMREG mRNA |
affects^cotreatment|increases^expression |
19167446 |
1289 |
96-48-0 |
PKIB |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PKIB mRNA |
affects^cotreatment|increases^expression |
19167446 |
1290 |
96-48-0 |
PKIB |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PKIB mRNA |
affects^cotreatment|increases^expression |
19167446 |
1291 |
96-48-0 |
PKM |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PKM mRNA |
affects^cotreatment|increases^expression |
19167446 |
1292 |
96-48-0 |
PKM |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PKM mRNA |
affects^cotreatment|increases^expression |
19167446 |
1293 |
96-48-0 |
PKMYT1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PKMYT1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1294 |
96-48-0 |
PKMYT1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PKMYT1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1295 |
96-48-0 |
PLCXD1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PLCXD1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1296 |
96-48-0 |
PLCXD1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PLCXD1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1297 |
96-48-0 |
PLEKHA5 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PLEKHA5 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1298 |
96-48-0 |
PLEKHA5 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PLEKHA5 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1299 |
96-48-0 |
PLEKHB2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PLEKHB2 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1300 |
96-48-0 |
PLEKHB2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PLEKHB2 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1301 |
96-48-0 |
PLK1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PLK1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1302 |
96-48-0 |
PLK1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PLK1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1303 |
96-48-0 |
PLK4 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PLK4 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1304 |
96-48-0 |
PLK4 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PLK4 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1305 |
96-48-0 |
PLOD2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PLOD2 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1306 |
96-48-0 |
PLOD2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PLOD2 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1307 |
96-48-0 |
PMEPA1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PMEPA1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1308 |
96-48-0 |
PMEPA1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PMEPA1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1309 |
96-48-0 |
PMPCB |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PMPCB mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1310 |
96-48-0 |
PMPCB |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PMPCB mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1311 |
96-48-0 |
PNP |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PNP mRNA |
affects^cotreatment|increases^expression |
19167446 |
1312 |
96-48-0 |
PNP |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PNP mRNA |
affects^cotreatment|increases^expression |
19167446 |
1313 |
96-48-0 |
POLA1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of POLA1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1314 |
96-48-0 |
POLA1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of POLA1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1315 |
96-48-0 |
POLA2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of POLA2 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1316 |
96-48-0 |
POLA2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of POLA2 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1317 |
96-48-0 |
POLD1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of POLD1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1318 |
96-48-0 |
POLD1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of POLD1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1319 |
96-48-0 |
POLD2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of POLD2 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1320 |
96-48-0 |
POLD2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of POLD2 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1321 |
96-48-0 |
POLD3 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of POLD3 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1322 |
96-48-0 |
POLD3 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of POLD3 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1323 |
96-48-0 |
POLE |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of POLE mRNA |
affects^cotreatment|increases^expression |
19167446 |
1324 |
96-48-0 |
POLE |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of POLE mRNA |
affects^cotreatment|increases^expression |
19167446 |
1325 |
96-48-0 |
POLE2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of POLE2 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1326 |
96-48-0 |
POLE2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of POLE2 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1327 |
96-48-0 |
POLE3 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of POLE3 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1328 |
96-48-0 |
POLE3 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of POLE3 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1329 |
96-48-0 |
PPAT |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PPAT mRNA |
affects^cotreatment|increases^expression |
19167446 |
1330 |
96-48-0 |
PPAT |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PPAT mRNA |
affects^cotreatment|increases^expression |
19167446 |
1331 |
96-48-0 |
PPIF |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PPIF mRNA |
affects^cotreatment|increases^expression |
19167446 |
1332 |
96-48-0 |
PPIF |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PPIF mRNA |
affects^cotreatment|increases^expression |
19167446 |
1333 |
96-48-0 |
PPL |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PPL mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1334 |
96-48-0 |
PPL |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PPL mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1335 |
96-48-0 |
PPP1R10 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PPP1R10 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1336 |
96-48-0 |
PPP1R10 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PPP1R10 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1337 |
96-48-0 |
PPP2R2A |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PPP2R2A mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1338 |
96-48-0 |
PPP2R2A |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PPP2R2A mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1339 |
96-48-0 |
PPP2R3A |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PPP2R3A mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1340 |
96-48-0 |
PPP2R3A |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PPP2R3A mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1341 |
96-48-0 |
PPP3CC |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PPP3CC mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1342 |
96-48-0 |
PPP3CC |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PPP3CC mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1343 |
96-48-0 |
PRDX4 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PRDX4 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1344 |
96-48-0 |
PRDX4 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PRDX4 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1345 |
96-48-0 |
PREX1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PREX1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1346 |
96-48-0 |
PREX1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PREX1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1347 |
96-48-0 |
PRIM1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PRIM1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1348 |
96-48-0 |
PRIM1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PRIM1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1349 |
96-48-0 |
PRIM2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PRIM2 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1350 |
96-48-0 |
PRIM2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PRIM2 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1351 |
96-48-0 |
PRKDC |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PRKDC mRNA |
affects^cotreatment|increases^expression |
19167446 |
1352 |
96-48-0 |
PRKDC |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PRKDC mRNA |
affects^cotreatment|increases^expression |
19167446 |
1353 |
96-48-0 |
PRPF4 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PRPF4 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1354 |
96-48-0 |
PRPF4 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PRPF4 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1355 |
96-48-0 |
PRR14 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PRR14 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1356 |
96-48-0 |
PRR14 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PRR14 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1357 |
96-48-0 |
PRRC2A |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PRRC2A mRNA |
affects^cotreatment|increases^expression |
19167446 |
1358 |
96-48-0 |
PRRC2A |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PRRC2A mRNA |
affects^cotreatment|increases^expression |
19167446 |
1359 |
96-48-0 |
PRRC2C |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PRRC2C mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1360 |
96-48-0 |
PRRC2C |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PRRC2C mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1361 |
96-48-0 |
PRRT3 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PRRT3 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1362 |
96-48-0 |
PRRT3 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PRRT3 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1363 |
96-48-0 |
PRSS23 |
Homo sapiens |
2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of PRSS23 mRNA |
decreases^expression |
19167446 |
1364 |
96-48-0 |
PRSS23 |
Homo sapiens |
2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of PRSS23 mRNA |
decreases^expression |
19167446 |
1365 |
96-48-0 |
PRSS23 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PRSS23 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1366 |
96-48-0 |
PRSS23 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PRSS23 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1367 |
96-48-0 |
PSIP1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PSIP1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1368 |
96-48-0 |
PSIP1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PSIP1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1369 |
96-48-0 |
PSMC3 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PSMC3 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1370 |
96-48-0 |
PSMC3 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PSMC3 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1371 |
96-48-0 |
PSRC1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PSRC1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1372 |
96-48-0 |
PSRC1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PSRC1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1373 |
96-48-0 |
PTBP1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PTBP1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1374 |
96-48-0 |
PTBP1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PTBP1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1375 |
96-48-0 |
PTGES |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PTGES mRNA |
affects^cotreatment|increases^expression |
19167446 |
1376 |
96-48-0 |
PTGES |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PTGES mRNA |
affects^cotreatment|increases^expression |
19167446 |
1377 |
96-48-0 |
PTP4A1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PTP4A1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1378 |
96-48-0 |
PTP4A1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PTP4A1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1379 |
96-48-0 |
PTPN12 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PTPN12 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1380 |
96-48-0 |
PTPN12 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PTPN12 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1381 |
96-48-0 |
PTPN21 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PTPN21 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1382 |
96-48-0 |
PTPN21 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PTPN21 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1383 |
96-48-0 |
PTTG1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PTTG1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1384 |
96-48-0 |
PTTG1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PTTG1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1385 |
96-48-0 |
PUS3 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PUS3 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1386 |
96-48-0 |
PUS3 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PUS3 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1387 |
96-48-0 |
PYROXD1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PYROXD1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1388 |
96-48-0 |
PYROXD1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PYROXD1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1389 |
96-48-0 |
QSER1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of QSER1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1390 |
96-48-0 |
QSER1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of QSER1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1391 |
96-48-0 |
RAB2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of RAB2 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1392 |
96-48-0 |
RAB2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of RAB2 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1393 |
96-48-0 |
RAB31 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RAB31 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1394 |
96-48-0 |
RAB31 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RAB31 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1395 |
96-48-0 |
RAB32 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of RAB32 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1396 |
96-48-0 |
RAB32 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of RAB32 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1397 |
96-48-0 |
RAB40B |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of RAB40B mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1398 |
96-48-0 |
RAB40B |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of RAB40B mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1399 |
96-48-0 |
RAB8A |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RAB8A mRNA |
affects^cotreatment|increases^expression |
19167446 |
1400 |
96-48-0 |
RAB8A |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RAB8A mRNA |
affects^cotreatment|increases^expression |
19167446 |
1401 |
96-48-0 |
RACGAP1 |
Homo sapiens |
2,3-bis(3'-hydroxybenzyl)butyrolactone results in increased expression of RACGAP1 mRNA |
increases^expression |
19167446 |
1402 |
96-48-0 |
RACGAP1 |
Homo sapiens |
2,3-bis(3'-hydroxybenzyl)butyrolactone results in increased expression of RACGAP1 mRNA |
increases^expression |
19167446 |
1403 |
96-48-0 |
RACGAP1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RACGAP1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1404 |
96-48-0 |
RACGAP1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RACGAP1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1405 |
96-48-0 |
RAD21 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RAD21 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1406 |
96-48-0 |
RAD21 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RAD21 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1407 |
96-48-0 |
RAD51 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RAD51 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1408 |
96-48-0 |
RAD51 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RAD51 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1409 |
96-48-0 |
RAD51AP1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RAD51AP1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1410 |
96-48-0 |
RAD51AP1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RAD51AP1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1411 |
96-48-0 |
RAD51C |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RAD51C mRNA |
affects^cotreatment|increases^expression |
19167446 |
1412 |
96-48-0 |
RAD51C |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RAD51C mRNA |
affects^cotreatment|increases^expression |
19167446 |
1413 |
96-48-0 |
RAD54B |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RAD54B mRNA |
affects^cotreatment|increases^expression |
19167446 |
1414 |
96-48-0 |
RAD54B |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RAD54B mRNA |
affects^cotreatment|increases^expression |
19167446 |
1415 |
96-48-0 |
RAD54L |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RAD54L mRNA |
affects^cotreatment|increases^expression |
19167446 |
1416 |
96-48-0 |
RAD54L |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RAD54L mRNA |
affects^cotreatment|increases^expression |
19167446 |
1417 |
96-48-0 |
RANBP1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RANBP1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1418 |
96-48-0 |
RANBP1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RANBP1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1419 |
96-48-0 |
RANGAP1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RANGAP1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1420 |
96-48-0 |
RANGAP1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RANGAP1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1421 |
96-48-0 |
RAPGEF2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of RAPGEF2 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1422 |
96-48-0 |
RAPGEF2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of RAPGEF2 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1423 |
96-48-0 |
RAPGEFL1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RAPGEFL1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1424 |
96-48-0 |
RAPGEFL1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RAPGEFL1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1425 |
96-48-0 |
RASD1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of RASD1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1426 |
96-48-0 |
RASD1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of RASD1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1427 |
96-48-0 |
RASEF |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of RASEF mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1428 |
96-48-0 |
RASEF |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of RASEF mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1429 |
96-48-0 |
RASL11B |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of RASL11B mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1430 |
96-48-0 |
RASL11B |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of RASL11B mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1431 |
96-48-0 |
RASSF3 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of RASSF3 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1432 |
96-48-0 |
RASSF3 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of RASSF3 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1433 |
96-48-0 |
RAVER1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RAVER1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1434 |
96-48-0 |
RAVER1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RAVER1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1435 |
96-48-0 |
RB1CC1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of RB1CC1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1436 |
96-48-0 |
RB1CC1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of RB1CC1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1437 |
96-48-0 |
RBBP4 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RBBP4 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1438 |
96-48-0 |
RBBP4 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RBBP4 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1439 |
96-48-0 |
RBBP8 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RBBP8 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1440 |
96-48-0 |
RBBP8 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RBBP8 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1441 |
96-48-0 |
RBBP9 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RBBP9 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1442 |
96-48-0 |
RBBP9 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RBBP9 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1443 |
96-48-0 |
RBFOX2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of RBFOX2 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1444 |
96-48-0 |
RBFOX2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of RBFOX2 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1445 |
96-48-0 |
RBM10 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RBM10 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1446 |
96-48-0 |
RBM10 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RBM10 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1447 |
96-48-0 |
RBM15 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RBM15 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1448 |
96-48-0 |
RBM15 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RBM15 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1449 |
96-48-0 |
RBMS1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of RBMS1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1450 |
96-48-0 |
RBMS1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of RBMS1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1451 |
96-48-0 |
RCCD1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RCCD1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1452 |
96-48-0 |
RCCD1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RCCD1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1453 |
96-48-0 |
RCOR3 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of RCOR3 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1454 |
96-48-0 |
RCOR3 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of RCOR3 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1455 |
96-48-0 |
RDM1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RDM1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1456 |
96-48-0 |
RDM1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RDM1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1457 |
96-48-0 |
RECQL4 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RECQL4 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1458 |
96-48-0 |
RECQL4 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RECQL4 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1459 |
96-48-0 |
REEP3 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of REEP3 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1460 |
96-48-0 |
REEP3 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of REEP3 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1461 |
96-48-0 |
REEP5 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of REEP5 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1462 |
96-48-0 |
REEP5 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of REEP5 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1463 |
96-48-0 |
RERG |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RERG mRNA |
affects^cotreatment|increases^expression |
19167446 |
1464 |
96-48-0 |
RERG |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RERG mRNA |
affects^cotreatment|increases^expression |
19167446 |
1465 |
96-48-0 |
RET |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RET mRNA |
affects^cotreatment|increases^expression |
19167446 |
1466 |
96-48-0 |
RET |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RET mRNA |
affects^cotreatment|increases^expression |
19167446 |
1467 |
96-48-0 |
RFC2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RFC2 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1468 |
96-48-0 |
RFC2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RFC2 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1469 |
96-48-0 |
RFC3 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RFC3 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1470 |
96-48-0 |
RFC3 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RFC3 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1471 |
96-48-0 |
RFC4 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RFC4 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1472 |
96-48-0 |
RFC4 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RFC4 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1473 |
96-48-0 |
RFC5 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RFC5 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1474 |
96-48-0 |
RFC5 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RFC5 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1475 |
96-48-0 |
RFTN1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of RFTN1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1476 |
96-48-0 |
RFTN1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of RFTN1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1477 |
96-48-0 |
RGS2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of RGS2 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1478 |
96-48-0 |
RGS2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of RGS2 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1479 |
96-48-0 |
RHBDF1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of RHBDF1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1480 |
96-48-0 |
RHBDF1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of RHBDF1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1481 |
96-48-0 |
RHNO1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RHNO1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1482 |
96-48-0 |
RHNO1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RHNO1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1483 |
96-48-0 |
RHOQ |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of RHOQ mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1484 |
96-48-0 |
RHOQ |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of RHOQ mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1485 |
96-48-0 |
RHOT1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of RHOT1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1486 |
96-48-0 |
RHOT1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of RHOT1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1487 |
96-48-0 |
RMDN2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of RMDN2 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1488 |
96-48-0 |
RMDN2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of RMDN2 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1489 |
96-48-0 |
RMI1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RMI1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1490 |
96-48-0 |
RMI1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RMI1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1491 |
96-48-0 |
RMI2 |
Homo sapiens |
2,3-bis(3'-hydroxybenzyl)butyrolactone results in increased expression of RMI2 mRNA |
increases^expression |
19167446 |
1492 |
96-48-0 |
RMI2 |
Homo sapiens |
2,3-bis(3'-hydroxybenzyl)butyrolactone results in increased expression of RMI2 mRNA |
increases^expression |
19167446 |
1493 |
96-48-0 |
RMI2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RMI2 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1494 |
96-48-0 |
RMI2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RMI2 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1495 |
96-48-0 |
RNASEH2A |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RNASEH2A mRNA |
affects^cotreatment|increases^expression |
19167446 |
1496 |
96-48-0 |
RNASEH2A |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RNASEH2A mRNA |
affects^cotreatment|increases^expression |
19167446 |
1497 |
96-48-0 |
RNF187 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RNF187 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1498 |
96-48-0 |
RNF187 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RNF187 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1499 |
96-48-0 |
RNF19A |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of RNF19A mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1500 |
96-48-0 |
RNF19A |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of RNF19A mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1501 |
96-48-0 |
RNF26 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RNF26 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1502 |
96-48-0 |
RNF26 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RNF26 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1503 |
96-48-0 |
ROCK2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ROCK2 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1504 |
96-48-0 |
ROCK2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ROCK2 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1505 |
96-48-0 |
RPA1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RPA1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1506 |
96-48-0 |
RPA1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RPA1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1507 |
96-48-0 |
RPA3 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RPA3 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1508 |
96-48-0 |
RPA3 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RPA3 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1509 |
96-48-0 |
RPL39L |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RPL39L mRNA |
affects^cotreatment|increases^expression |
19167446 |
1510 |
96-48-0 |
RPL39L |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RPL39L mRNA |
affects^cotreatment|increases^expression |
19167446 |
1511 |
96-48-0 |
RRAGC |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of RRAGC mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1512 |
96-48-0 |
RRAGC |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of RRAGC mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1513 |
96-48-0 |
RRM1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RRM1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1514 |
96-48-0 |
RRM1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RRM1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1515 |
96-48-0 |
RRM2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RRM2 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1516 |
96-48-0 |
RRM2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RRM2 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1517 |
96-48-0 |
RSRC1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RSRC1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1518 |
96-48-0 |
RSRC1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RSRC1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1519 |
96-48-0 |
RSU1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of RSU1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1520 |
96-48-0 |
RSU1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of RSU1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1521 |
96-48-0 |
RUNDC3B |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of RUNDC3B mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1522 |
96-48-0 |
RUNDC3B |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of RUNDC3B mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1523 |
96-48-0 |
S100A10 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of S100A10 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1524 |
96-48-0 |
S100A10 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of S100A10 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1525 |
96-48-0 |
S1PR3 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of S1PR3 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1526 |
96-48-0 |
S1PR3 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of S1PR3 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1527 |
96-48-0 |
SAE1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SAE1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1528 |
96-48-0 |
SAE1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SAE1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1529 |
96-48-0 |
SALL4 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SALL4 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1530 |
96-48-0 |
SALL4 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SALL4 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1531 |
96-48-0 |
SASH1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SASH1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1532 |
96-48-0 |
SASH1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SASH1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1533 |
96-48-0 |
SAT1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SAT1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1534 |
96-48-0 |
SAT1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SAT1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1535 |
96-48-0 |
SCARB1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SCARB1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1536 |
96-48-0 |
SCARB1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SCARB1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1537 |
96-48-0 |
SCARB2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SCARB2 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1538 |
96-48-0 |
SCARB2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SCARB2 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1539 |
96-48-0 |
SCCPDH |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SCCPDH mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1540 |
96-48-0 |
SCCPDH |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SCCPDH mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1541 |
96-48-0 |
SELENOP |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SELENOP mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1542 |
96-48-0 |
SELENOP |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SELENOP mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1543 |
96-48-0 |
SEPHS1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SEPHS1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1544 |
96-48-0 |
SEPHS1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SEPHS1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1545 |
96-48-0 |
SERINC5 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SERINC5 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1546 |
96-48-0 |
SERINC5 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SERINC5 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1547 |
96-48-0 |
SF1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SF1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1548 |
96-48-0 |
SF1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SF1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1549 |
96-48-0 |
SF3B3 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SF3B3 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1550 |
96-48-0 |
SF3B3 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SF3B3 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1551 |
96-48-0 |
SFN |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SFN mRNA |
affects^cotreatment|increases^expression |
19167446 |
1552 |
96-48-0 |
SFN |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SFN mRNA |
affects^cotreatment|increases^expression |
19167446 |
1553 |
96-48-0 |
SFXN2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SFXN2 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1554 |
96-48-0 |
SFXN2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SFXN2 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1555 |
96-48-0 |
SGCG |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SGCG mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1556 |
96-48-0 |
SGCG |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SGCG mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1557 |
96-48-0 |
SGK3 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SGK3 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1558 |
96-48-0 |
SGK3 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SGK3 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1559 |
96-48-0 |
SGO1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SGO1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1560 |
96-48-0 |
SGO1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SGO1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1561 |
96-48-0 |
SGO2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SGO2 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1562 |
96-48-0 |
SGO2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SGO2 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1563 |
96-48-0 |
SH3BGRL |
Homo sapiens |
2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of SH3BGRL mRNA |
decreases^expression |
19167446 |
1564 |
96-48-0 |
SH3BGRL |
Homo sapiens |
2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of SH3BGRL mRNA |
decreases^expression |
19167446 |
1565 |
96-48-0 |
SH3BGRL |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SH3BGRL mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1566 |
96-48-0 |
SH3BGRL |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SH3BGRL mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1567 |
96-48-0 |
SH3BP4 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SH3BP4 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1568 |
96-48-0 |
SH3BP4 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SH3BP4 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1569 |
96-48-0 |
SH3KBP1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SH3KBP1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1570 |
96-48-0 |
SH3KBP1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SH3KBP1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1571 |
96-48-0 |
SHCBP1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SHCBP1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1572 |
96-48-0 |
SHCBP1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SHCBP1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1573 |
96-48-0 |
SHISA2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SHISA2 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1574 |
96-48-0 |
SHISA2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SHISA2 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1575 |
96-48-0 |
SHMT1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SHMT1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1576 |
96-48-0 |
SHMT1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SHMT1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1577 |
96-48-0 |
SHMT2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SHMT2 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1578 |
96-48-0 |
SHMT2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SHMT2 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1579 |
96-48-0 |
SKA1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SKA1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1580 |
96-48-0 |
SKA1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SKA1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1581 |
96-48-0 |
SKA2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SKA2 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1582 |
96-48-0 |
SKA2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SKA2 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1583 |
96-48-0 |
SKA3 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SKA3 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1584 |
96-48-0 |
SKA3 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SKA3 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1585 |
96-48-0 |
SKP2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SKP2 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1586 |
96-48-0 |
SKP2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SKP2 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1587 |
96-48-0 |
SLBP |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SLBP mRNA |
affects^cotreatment|increases^expression |
19167446 |
1588 |
96-48-0 |
SLBP |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SLBP mRNA |
affects^cotreatment|increases^expression |
19167446 |
1589 |
96-48-0 |
SLC12A2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SLC12A2 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1590 |
96-48-0 |
SLC12A2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SLC12A2 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1591 |
96-48-0 |
SLC12A4 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SLC12A4 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1592 |
96-48-0 |
SLC12A4 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SLC12A4 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1593 |
96-48-0 |
SLC12A8 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SLC12A8 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1594 |
96-48-0 |
SLC12A8 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SLC12A8 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1595 |
96-48-0 |
SLC1A4 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SLC1A4 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1596 |
96-48-0 |
SLC1A4 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SLC1A4 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1597 |
96-48-0 |
SLC25A11 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SLC25A11 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1598 |
96-48-0 |
SLC25A11 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SLC25A11 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1599 |
96-48-0 |
SLC25A39 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SLC25A39 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1600 |
96-48-0 |
SLC25A39 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SLC25A39 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1601 |
96-48-0 |
SLC26A11 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SLC26A11 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1602 |
96-48-0 |
SLC26A11 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SLC26A11 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1603 |
96-48-0 |
SLC27A2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SLC27A2 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1604 |
96-48-0 |
SLC27A2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SLC27A2 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1605 |
96-48-0 |
SLC27A3 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SLC27A3 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1606 |
96-48-0 |
SLC27A3 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SLC27A3 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1607 |
96-48-0 |
SLC29A1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SLC29A1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1608 |
96-48-0 |
SLC29A1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SLC29A1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1609 |
96-48-0 |
SLC2A4RG |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SLC2A4RG mRNA |
affects^cotreatment|increases^expression |
19167446 |
1610 |
96-48-0 |
SLC2A4RG |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SLC2A4RG mRNA |
affects^cotreatment|increases^expression |
19167446 |
1611 |
96-48-0 |
SLC35D2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SLC35D2 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1612 |
96-48-0 |
SLC35D2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SLC35D2 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1613 |
96-48-0 |
SLC37A4 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SLC37A4 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1614 |
96-48-0 |
SLC37A4 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SLC37A4 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1615 |
96-48-0 |
SLC39A8 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SLC39A8 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1616 |
96-48-0 |
SLC39A8 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SLC39A8 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1617 |
96-48-0 |
SLC6A14 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SLC6A14 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1618 |
96-48-0 |
SLC6A14 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SLC6A14 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1619 |
96-48-0 |
SLC7A1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SLC7A1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1620 |
96-48-0 |
SLC7A1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SLC7A1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1621 |
96-48-0 |
SLC7A11 |
Homo sapiens |
2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of SLC7A11 mRNA |
decreases^expression |
19167446 |
1622 |
96-48-0 |
SLC7A11 |
Homo sapiens |
2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of SLC7A11 mRNA |
decreases^expression |
19167446 |
1623 |
96-48-0 |
SLC7A11 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SLC7A11 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1624 |
96-48-0 |
SLC7A11 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SLC7A11 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1625 |
96-48-0 |
SLC7A5 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SLC7A5 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1626 |
96-48-0 |
SLC7A5 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SLC7A5 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1627 |
96-48-0 |
SLC9A3R1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SLC9A3R1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1628 |
96-48-0 |
SLC9A3R1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SLC9A3R1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1629 |
96-48-0 |
SLF1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SLF1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1630 |
96-48-0 |
SLF1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SLF1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1631 |
96-48-0 |
SMAD2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SMAD2 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1632 |
96-48-0 |
SMAD2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SMAD2 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1633 |
96-48-0 |
SMAD3 |
Homo sapiens |
2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of SMAD3 mRNA |
decreases^expression |
19167446 |
1634 |
96-48-0 |
SMAD3 |
Homo sapiens |
2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of SMAD3 mRNA |
decreases^expression |
19167446 |
1635 |
96-48-0 |
SMAD3 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SMAD3 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1636 |
96-48-0 |
SMAD3 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SMAD3 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1637 |
96-48-0 |
SMC1A |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SMC1A mRNA |
affects^cotreatment|increases^expression |
19167446 |
1638 |
96-48-0 |
SMC1A |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SMC1A mRNA |
affects^cotreatment|increases^expression |
19167446 |
1639 |
96-48-0 |
SMC2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SMC2 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1640 |
96-48-0 |
SMC2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SMC2 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1641 |
96-48-0 |
SMC4 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SMC4 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1642 |
96-48-0 |
SMC4 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SMC4 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1643 |
96-48-0 |
SMYD2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SMYD2 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1644 |
96-48-0 |
SMYD2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SMYD2 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1645 |
96-48-0 |
SNHG7 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SNHG7 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1646 |
96-48-0 |
SNHG7 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SNHG7 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1647 |
96-48-0 |
SNN |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SNN mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1648 |
96-48-0 |
SNN |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SNN mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1649 |
96-48-0 |
SNORA24 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SNORA24 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1650 |
96-48-0 |
SNORA24 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SNORA24 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1651 |
96-48-0 |
SNORD52 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SNORD52 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1652 |
96-48-0 |
SNORD52 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SNORD52 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1653 |
96-48-0 |
SNRNP25 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SNRNP25 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1654 |
96-48-0 |
SNRNP25 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SNRNP25 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1655 |
96-48-0 |
SNRPA1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SNRPA1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1656 |
96-48-0 |
SNRPA1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SNRPA1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1657 |
96-48-0 |
SNRPB |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SNRPB mRNA |
affects^cotreatment|increases^expression |
19167446 |
1658 |
96-48-0 |
SNRPB |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SNRPB mRNA |
affects^cotreatment|increases^expression |
19167446 |
1659 |
96-48-0 |
SNX10 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SNX10 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1660 |
96-48-0 |
SNX10 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SNX10 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1661 |
96-48-0 |
SNX24 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SNX24 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1662 |
96-48-0 |
SNX24 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SNX24 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1663 |
96-48-0 |
SNX29 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SNX29 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1664 |
96-48-0 |
SNX29 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SNX29 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1665 |
96-48-0 |
SNX6 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SNX6 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1666 |
96-48-0 |
SNX6 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SNX6 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1667 |
96-48-0 |
SNX9 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SNX9 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1668 |
96-48-0 |
SNX9 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SNX9 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1669 |
96-48-0 |
SOCS2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SOCS2 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1670 |
96-48-0 |
SOCS2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SOCS2 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1671 |
96-48-0 |
SOX3 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SOX3 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1672 |
96-48-0 |
SOX3 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SOX3 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1673 |
96-48-0 |
SOX4 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SOX4 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1674 |
96-48-0 |
SOX4 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SOX4 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1675 |
96-48-0 |
SOX9 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SOX9 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1676 |
96-48-0 |
SOX9 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SOX9 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1677 |
96-48-0 |
SPAG5 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SPAG5 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1678 |
96-48-0 |
SPAG5 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SPAG5 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1679 |
96-48-0 |
SPATA7 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SPATA7 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1680 |
96-48-0 |
SPATA7 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SPATA7 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1681 |
96-48-0 |
SPC24 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SPC24 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1682 |
96-48-0 |
SPC24 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SPC24 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1683 |
96-48-0 |
SPC25 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SPC25 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1684 |
96-48-0 |
SPC25 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SPC25 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1685 |
96-48-0 |
SPDL1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SPDL1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1686 |
96-48-0 |
SPDL1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SPDL1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1687 |
96-48-0 |
SPIN4 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SPIN4 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1688 |
96-48-0 |
SPIN4 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SPIN4 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1689 |
96-48-0 |
SPRED2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SPRED2 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1690 |
96-48-0 |
SPRED2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SPRED2 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1691 |
96-48-0 |
SQOR |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SQOR mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1692 |
96-48-0 |
SQOR |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SQOR mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1693 |
96-48-0 |
SQSTM1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SQSTM1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1694 |
96-48-0 |
SQSTM1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SQSTM1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1695 |
96-48-0 |
SRD5A3 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SRD5A3 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1696 |
96-48-0 |
SRD5A3 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SRD5A3 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1697 |
96-48-0 |
SRI |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SRI mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1698 |
96-48-0 |
SRI |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SRI mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1699 |
96-48-0 |
SRM |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SRM mRNA |
affects^cotreatment|increases^expression |
19167446 |
1700 |
96-48-0 |
SRM |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SRM mRNA |
affects^cotreatment|increases^expression |
19167446 |
1701 |
96-48-0 |
SRPRB |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SRPRB mRNA |
affects^cotreatment|increases^expression |
19167446 |
1702 |
96-48-0 |
SRPRB |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SRPRB mRNA |
affects^cotreatment|increases^expression |
19167446 |
1703 |
96-48-0 |
SRSF1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SRSF1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1704 |
96-48-0 |
SRSF1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SRSF1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1705 |
96-48-0 |
SSBP2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SSBP2 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1706 |
96-48-0 |
SSBP2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SSBP2 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1707 |
96-48-0 |
SSRP1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SSRP1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1708 |
96-48-0 |
SSRP1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SSRP1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1709 |
96-48-0 |
ST8SIA4 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ST8SIA4 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1710 |
96-48-0 |
ST8SIA4 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ST8SIA4 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1711 |
96-48-0 |
STIL |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of STIL mRNA |
affects^cotreatment|increases^expression |
19167446 |
1712 |
96-48-0 |
STIL |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of STIL mRNA |
affects^cotreatment|increases^expression |
19167446 |
1713 |
96-48-0 |
STK38L |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of STK38L mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1714 |
96-48-0 |
STK38L |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of STK38L mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1715 |
96-48-0 |
STMN1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of STMN1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1716 |
96-48-0 |
STMN1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of STMN1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1717 |
96-48-0 |
STON2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of STON2 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1718 |
96-48-0 |
STON2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of STON2 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1719 |
96-48-0 |
STRN3 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of STRN3 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1720 |
96-48-0 |
STRN3 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of STRN3 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1721 |
96-48-0 |
STX3 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of STX3 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1722 |
96-48-0 |
STX3 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of STX3 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1723 |
96-48-0 |
STX7 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of STX7 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1724 |
96-48-0 |
STX7 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of STX7 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1725 |
96-48-0 |
SULF2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SULF2 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1726 |
96-48-0 |
SULF2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SULF2 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1727 |
96-48-0 |
SUPT16H |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SUPT16H mRNA |
affects^cotreatment|increases^expression |
19167446 |
1728 |
96-48-0 |
SUPT16H |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SUPT16H mRNA |
affects^cotreatment|increases^expression |
19167446 |
1729 |
96-48-0 |
SUV39H2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SUV39H2 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1730 |
96-48-0 |
SUV39H2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SUV39H2 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1731 |
96-48-0 |
SWAP70 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SWAP70 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1732 |
96-48-0 |
SWAP70 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SWAP70 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1733 |
96-48-0 |
SYCE2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SYCE2 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1734 |
96-48-0 |
SYCE2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SYCE2 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1735 |
96-48-0 |
SYDE2 |
Homo sapiens |
2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of SYDE2 mRNA |
decreases^expression |
19167446 |
1736 |
96-48-0 |
SYDE2 |
Homo sapiens |
2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of SYDE2 mRNA |
decreases^expression |
19167446 |
1737 |
96-48-0 |
SYDE2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SYDE2 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1738 |
96-48-0 |
SYDE2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SYDE2 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1739 |
96-48-0 |
SYNGR3 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SYNGR3 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1740 |
96-48-0 |
SYNGR3 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SYNGR3 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1741 |
96-48-0 |
SYTL2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SYTL2 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1742 |
96-48-0 |
SYTL2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SYTL2 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1743 |
96-48-0 |
SYTL4 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SYTL4 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1744 |
96-48-0 |
SYTL4 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SYTL4 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1745 |
96-48-0 |
SYTL5 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SYTL5 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1746 |
96-48-0 |
SYTL5 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SYTL5 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1747 |
96-48-0 |
TACC3 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TACC3 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1748 |
96-48-0 |
TACC3 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TACC3 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1749 |
96-48-0 |
TACSTD2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TACSTD2 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1750 |
96-48-0 |
TACSTD2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TACSTD2 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1751 |
96-48-0 |
TAF5 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TAF5 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1752 |
96-48-0 |
TAF5 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TAF5 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1753 |
96-48-0 |
TANC2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TANC2 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1754 |
96-48-0 |
TANC2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TANC2 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1755 |
96-48-0 |
TAOK3 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TAOK3 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1756 |
96-48-0 |
TAOK3 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TAOK3 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1757 |
96-48-0 |
TARS2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TARS2 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1758 |
96-48-0 |
TARS2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TARS2 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1759 |
96-48-0 |
TBCD |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TBCD mRNA |
affects^cotreatment|increases^expression |
19167446 |
1760 |
96-48-0 |
TBCD |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TBCD mRNA |
affects^cotreatment|increases^expression |
19167446 |
1761 |
96-48-0 |
TBL1X |
Homo sapiens |
2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of TBL1X mRNA |
decreases^expression |
19167446 |
1762 |
96-48-0 |
TBL1X |
Homo sapiens |
2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of TBL1X mRNA |
decreases^expression |
19167446 |
1763 |
96-48-0 |
TCF19 |
Homo sapiens |
2,3-bis(3'-hydroxybenzyl)butyrolactone results in increased expression of TCF19 mRNA |
increases^expression |
19167446 |
1764 |
96-48-0 |
TCF19 |
Homo sapiens |
2,3-bis(3'-hydroxybenzyl)butyrolactone results in increased expression of TCF19 mRNA |
increases^expression |
19167446 |
1765 |
96-48-0 |
TCF19 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TCF19 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1766 |
96-48-0 |
TCF19 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TCF19 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1767 |
96-48-0 |
TCF7L1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TCF7L1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1768 |
96-48-0 |
TCF7L1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TCF7L1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1769 |
96-48-0 |
TDP1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TDP1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1770 |
96-48-0 |
TDP1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TDP1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1771 |
96-48-0 |
TEX30 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TEX30 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1772 |
96-48-0 |
TEX30 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TEX30 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1773 |
96-48-0 |
TFAP2C |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TFAP2C mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1774 |
96-48-0 |
TFAP2C |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TFAP2C mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1775 |
96-48-0 |
TFDP1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TFDP1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1776 |
96-48-0 |
TFDP1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TFDP1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1777 |
96-48-0 |
TFF1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TFF1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1778 |
96-48-0 |
TFF1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TFF1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1779 |
96-48-0 |
TFF3 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TFF3 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1780 |
96-48-0 |
TFF3 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TFF3 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1781 |
96-48-0 |
TFPI |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TFPI mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1782 |
96-48-0 |
TFPI |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TFPI mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1783 |
96-48-0 |
TGFB2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TGFB2 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1784 |
96-48-0 |
TGFB2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TGFB2 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1785 |
96-48-0 |
TGFBR1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TGFBR1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1786 |
96-48-0 |
TGFBR1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TGFBR1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1787 |
96-48-0 |
TGIF1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TGIF1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1788 |
96-48-0 |
TGIF1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TGIF1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1789 |
96-48-0 |
TGIF2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TGIF2 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1790 |
96-48-0 |
TGIF2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TGIF2 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1791 |
96-48-0 |
THBS1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of THBS1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1792 |
96-48-0 |
THBS1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of THBS1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1793 |
96-48-0 |
THEM6 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of THEM6 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1794 |
96-48-0 |
THEM6 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of THEM6 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1795 |
96-48-0 |
THSD4 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of THSD4 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1796 |
96-48-0 |
THSD4 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of THSD4 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1797 |
96-48-0 |
TICRR |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TICRR mRNA |
affects^cotreatment|increases^expression |
19167446 |
1798 |
96-48-0 |
TICRR |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TICRR mRNA |
affects^cotreatment|increases^expression |
19167446 |
1799 |
96-48-0 |
TIGAR |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TIGAR mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1800 |
96-48-0 |
TIGAR |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TIGAR mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1801 |
96-48-0 |
TIMELESS |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TIMELESS mRNA |
affects^cotreatment|increases^expression |
19167446 |
1802 |
96-48-0 |
TIMELESS |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TIMELESS mRNA |
affects^cotreatment|increases^expression |
19167446 |
1803 |
96-48-0 |
TIMP2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TIMP2 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1804 |
96-48-0 |
TIMP2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TIMP2 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1805 |
96-48-0 |
TIPIN |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TIPIN mRNA |
affects^cotreatment|increases^expression |
19167446 |
1806 |
96-48-0 |
TIPIN |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TIPIN mRNA |
affects^cotreatment|increases^expression |
19167446 |
1807 |
96-48-0 |
TK1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TK1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1808 |
96-48-0 |
TK1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TK1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1809 |
96-48-0 |
TKFC |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TKFC mRNA |
affects^cotreatment|increases^expression |
19167446 |
1810 |
96-48-0 |
TKFC |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TKFC mRNA |
affects^cotreatment|increases^expression |
19167446 |
1811 |
96-48-0 |
TLE1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TLE1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1812 |
96-48-0 |
TLE1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TLE1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1813 |
96-48-0 |
TM4SF1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TM4SF1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1814 |
96-48-0 |
TM4SF1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TM4SF1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1815 |
96-48-0 |
TMCC1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TMCC1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1816 |
96-48-0 |
TMCC1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TMCC1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1817 |
96-48-0 |
TMED8 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TMED8 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1818 |
96-48-0 |
TMED8 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TMED8 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1819 |
96-48-0 |
TMEM106C |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TMEM106C mRNA |
affects^cotreatment|increases^expression |
19167446 |
1820 |
96-48-0 |
TMEM106C |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TMEM106C mRNA |
affects^cotreatment|increases^expression |
19167446 |
1821 |
96-48-0 |
TMEM164 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TMEM164 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1822 |
96-48-0 |
TMEM164 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TMEM164 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1823 |
96-48-0 |
TMEM237 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TMEM237 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1824 |
96-48-0 |
TMEM237 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TMEM237 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1825 |
96-48-0 |
TMEM38B |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TMEM38B mRNA |
affects^cotreatment|increases^expression |
19167446 |
1826 |
96-48-0 |
TMEM38B |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TMEM38B mRNA |
affects^cotreatment|increases^expression |
19167446 |
1827 |
96-48-0 |
TMEM45B |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TMEM45B mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1828 |
96-48-0 |
TMEM45B |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TMEM45B mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1829 |
96-48-0 |
TMEM64 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TMEM64 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1830 |
96-48-0 |
TMEM64 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TMEM64 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1831 |
96-48-0 |
TMEM65 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TMEM65 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1832 |
96-48-0 |
TMEM65 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TMEM65 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1833 |
96-48-0 |
TMEM97 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TMEM97 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1834 |
96-48-0 |
TMEM97 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TMEM97 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1835 |
96-48-0 |
TMPO |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TMPO mRNA |
affects^cotreatment|increases^expression |
19167446 |
1836 |
96-48-0 |
TMPO |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TMPO mRNA |
affects^cotreatment|increases^expression |
19167446 |
1837 |
96-48-0 |
TMPRSS3 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TMPRSS3 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1838 |
96-48-0 |
TMPRSS3 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TMPRSS3 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1839 |
96-48-0 |
TMSB15A |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TMSB15A mRNA |
affects^cotreatment|increases^expression |
19167446 |
1840 |
96-48-0 |
TMSB15A |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TMSB15A mRNA |
affects^cotreatment|increases^expression |
19167446 |
1841 |
96-48-0 |
TMTC2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TMTC2 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1842 |
96-48-0 |
TMTC2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TMTC2 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1843 |
96-48-0 |
TNFAIP1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TNFAIP1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1844 |
96-48-0 |
TNFAIP1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TNFAIP1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1845 |
96-48-0 |
TNFRSF12A |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TNFRSF12A mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1846 |
96-48-0 |
TNFRSF12A |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TNFRSF12A mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1847 |
96-48-0 |
TNFRSF21 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TNFRSF21 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1848 |
96-48-0 |
TNFRSF21 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TNFRSF21 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1849 |
96-48-0 |
TOP2A |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TOP2A mRNA |
affects^cotreatment|increases^expression |
19167446 |
1850 |
96-48-0 |
TOP2A |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TOP2A mRNA |
affects^cotreatment|increases^expression |
19167446 |
1851 |
96-48-0 |
TOPBP1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TOPBP1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1852 |
96-48-0 |
TOPBP1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TOPBP1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1853 |
96-48-0 |
TP53INP1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TP53INP1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1854 |
96-48-0 |
TP53INP1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TP53INP1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1855 |
96-48-0 |
TPD52 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TPD52 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1856 |
96-48-0 |
TPD52 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TPD52 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1857 |
96-48-0 |
TPD52L1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TPD52L1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1858 |
96-48-0 |
TPD52L1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TPD52L1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1859 |
96-48-0 |
TPI1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TPI1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1860 |
96-48-0 |
TPI1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TPI1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1861 |
96-48-0 |
TPM1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TPM1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1862 |
96-48-0 |
TPM1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TPM1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1863 |
96-48-0 |
TPX2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TPX2 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1864 |
96-48-0 |
TPX2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TPX2 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1865 |
96-48-0 |
TRERF1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TRERF1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1866 |
96-48-0 |
TRERF1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TRERF1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1867 |
96-48-0 |
TRIB1 |
Homo sapiens |
2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of TRIB1 mRNA |
decreases^expression |
19167446 |
1868 |
96-48-0 |
TRIB1 |
Homo sapiens |
2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of TRIB1 mRNA |
decreases^expression |
19167446 |
1869 |
96-48-0 |
TRIB1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TRIB1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1870 |
96-48-0 |
TRIB1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TRIB1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1871 |
96-48-0 |
TRIM59 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TRIM59 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1872 |
96-48-0 |
TRIM59 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TRIM59 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1873 |
96-48-0 |
TRIP13 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TRIP13 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1874 |
96-48-0 |
TRIP13 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TRIP13 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1875 |
96-48-0 |
TSC22D3 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TSC22D3 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1876 |
96-48-0 |
TSC22D3 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TSC22D3 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1877 |
96-48-0 |
TSN |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TSN mRNA |
affects^cotreatment|increases^expression |
19167446 |
1878 |
96-48-0 |
TSN |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TSN mRNA |
affects^cotreatment|increases^expression |
19167446 |
1879 |
96-48-0 |
TSPAN31 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TSPAN31 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1880 |
96-48-0 |
TSPAN31 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TSPAN31 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1881 |
96-48-0 |
TSPYL1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TSPYL1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1882 |
96-48-0 |
TSPYL1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TSPYL1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1883 |
96-48-0 |
TTC39B |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TTC39B mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1884 |
96-48-0 |
TTC39B |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TTC39B mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1885 |
96-48-0 |
TTK |
Homo sapiens |
2,3-bis(3'-hydroxybenzyl)butyrolactone results in increased expression of TTK mRNA |
increases^expression |
19167446 |
1886 |
96-48-0 |
TTK |
Homo sapiens |
2,3-bis(3'-hydroxybenzyl)butyrolactone results in increased expression of TTK mRNA |
increases^expression |
19167446 |
1887 |
96-48-0 |
TTK |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TTK mRNA |
affects^cotreatment|increases^expression |
19167446 |
1888 |
96-48-0 |
TTK |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TTK mRNA |
affects^cotreatment|increases^expression |
19167446 |
1889 |
96-48-0 |
TUBA2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TUBA2 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1890 |
96-48-0 |
TUBA2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TUBA2 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1891 |
96-48-0 |
TUBB |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TUBB mRNA |
affects^cotreatment|increases^expression |
19167446 |
1892 |
96-48-0 |
TUBB |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TUBB mRNA |
affects^cotreatment|increases^expression |
19167446 |
1893 |
96-48-0 |
TUBB2A |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TUBB2A mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1894 |
96-48-0 |
TUBB2A |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TUBB2A mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1895 |
96-48-0 |
TUBB4B |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TUBB4B mRNA |
affects^cotreatment|increases^expression |
19167446 |
1896 |
96-48-0 |
TUBB4B |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TUBB4B mRNA |
affects^cotreatment|increases^expression |
19167446 |
1897 |
96-48-0 |
TUBD1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TUBD1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1898 |
96-48-0 |
TUBD1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TUBD1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1899 |
96-48-0 |
TUBG1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TUBG1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1900 |
96-48-0 |
TUBG1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TUBG1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1901 |
96-48-0 |
TUBGCP4 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TUBGCP4 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1902 |
96-48-0 |
TUBGCP4 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TUBGCP4 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1903 |
96-48-0 |
TUFT1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TUFT1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1904 |
96-48-0 |
TUFT1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TUFT1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1905 |
96-48-0 |
TULP4 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TULP4 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1906 |
96-48-0 |
TULP4 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TULP4 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1907 |
96-48-0 |
TWIST1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TWIST1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1908 |
96-48-0 |
TWIST1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TWIST1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1909 |
96-48-0 |
TYMS |
Homo sapiens |
2,3-bis(3'-hydroxybenzyl)butyrolactone results in increased expression of TYMS mRNA |
increases^expression |
19167446 |
1910 |
96-48-0 |
TYMS |
Homo sapiens |
2,3-bis(3'-hydroxybenzyl)butyrolactone results in increased expression of TYMS mRNA |
increases^expression |
19167446 |
1911 |
96-48-0 |
TYMS |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TYMS mRNA |
affects^cotreatment|increases^expression |
19167446 |
1912 |
96-48-0 |
TYMS |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TYMS mRNA |
affects^cotreatment|increases^expression |
19167446 |
1913 |
96-48-0 |
UBE2B |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of UBE2B mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1914 |
96-48-0 |
UBE2B |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of UBE2B mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1915 |
96-48-0 |
UBE2H |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of UBE2H mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1916 |
96-48-0 |
UBE2H |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of UBE2H mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1917 |
96-48-0 |
UBE2J1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of UBE2J1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1918 |
96-48-0 |
UBE2J1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of UBE2J1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1919 |
96-48-0 |
UBE2QL1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of UBE2QL1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1920 |
96-48-0 |
UBE2QL1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of UBE2QL1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1921 |
96-48-0 |
UBE2T |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of UBE2T mRNA |
affects^cotreatment|increases^expression |
19167446 |
1922 |
96-48-0 |
UBE2T |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of UBE2T mRNA |
affects^cotreatment|increases^expression |
19167446 |
1923 |
96-48-0 |
UBE2W |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of UBE2W mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1924 |
96-48-0 |
UBE2W |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of UBE2W mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1925 |
96-48-0 |
UBR7 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of UBR7 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1926 |
96-48-0 |
UBR7 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of UBR7 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1927 |
96-48-0 |
UCHL5 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of UCHL5 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1928 |
96-48-0 |
UCHL5 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of UCHL5 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1929 |
96-48-0 |
UCK2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of UCK2 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1930 |
96-48-0 |
UCK2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of UCK2 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1931 |
96-48-0 |
UHRF1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of UHRF1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1932 |
96-48-0 |
UHRF1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of UHRF1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1933 |
96-48-0 |
UNG |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of UNG mRNA |
affects^cotreatment|increases^expression |
19167446 |
1934 |
96-48-0 |
UNG |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of UNG mRNA |
affects^cotreatment|increases^expression |
19167446 |
1935 |
96-48-0 |
UPF3B |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of UPF3B mRNA |
affects^cotreatment|increases^expression |
19167446 |
1936 |
96-48-0 |
UPF3B |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of UPF3B mRNA |
affects^cotreatment|increases^expression |
19167446 |
1937 |
96-48-0 |
USP1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of USP1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1938 |
96-48-0 |
USP1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of USP1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1939 |
96-48-0 |
USP3 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of USP3 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1940 |
96-48-0 |
USP3 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of USP3 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1941 |
96-48-0 |
UST |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of UST mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1942 |
96-48-0 |
UST |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of UST mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1943 |
96-48-0 |
VARS2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of VARS2 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1944 |
96-48-0 |
VARS2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of VARS2 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1945 |
96-48-0 |
VEGFA |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of VEGFA mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1946 |
96-48-0 |
VEGFA |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of VEGFA mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1947 |
96-48-0 |
VKORC1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of VKORC1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1948 |
96-48-0 |
VKORC1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of VKORC1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1949 |
96-48-0 |
VRK1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of VRK1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1950 |
96-48-0 |
VRK1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of VRK1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1951 |
96-48-0 |
WDHD1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of WDHD1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1952 |
96-48-0 |
WDHD1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of WDHD1 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1953 |
96-48-0 |
WDR34 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of WDR34 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1954 |
96-48-0 |
WDR34 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of WDR34 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1955 |
96-48-0 |
WDR54 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of WDR54 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1956 |
96-48-0 |
WDR54 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of WDR54 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1957 |
96-48-0 |
WDR76 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of WDR76 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1958 |
96-48-0 |
WDR76 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of WDR76 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1959 |
96-48-0 |
WIPI1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of WIPI1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1960 |
96-48-0 |
WIPI1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of WIPI1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1961 |
96-48-0 |
WISP2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of WISP2 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1962 |
96-48-0 |
WISP2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of WISP2 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1963 |
96-48-0 |
WIZ |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of WIZ mRNA |
affects^cotreatment|increases^expression |
19167446 |
1964 |
96-48-0 |
WIZ |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of WIZ mRNA |
affects^cotreatment|increases^expression |
19167446 |
1965 |
96-48-0 |
YPEL2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of YPEL2 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1966 |
96-48-0 |
YPEL2 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of YPEL2 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1967 |
96-48-0 |
YPEL5 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of YPEL5 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1968 |
96-48-0 |
YPEL5 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of YPEL5 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1969 |
96-48-0 |
YWHAE |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of YWHAE mRNA |
affects^cotreatment|increases^expression |
19167446 |
1970 |
96-48-0 |
YWHAE |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of YWHAE mRNA |
affects^cotreatment|increases^expression |
19167446 |
1971 |
96-48-0 |
ZBTB26 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ZBTB26 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1972 |
96-48-0 |
ZBTB26 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ZBTB26 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1973 |
96-48-0 |
ZBTB4 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ZBTB4 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1974 |
96-48-0 |
ZBTB4 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ZBTB4 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1975 |
96-48-0 |
ZC2HC1A |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ZC2HC1A mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1976 |
96-48-0 |
ZC2HC1A |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ZC2HC1A mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1977 |
96-48-0 |
ZC3H12A |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ZC3H12A mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1978 |
96-48-0 |
ZC3H12A |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ZC3H12A mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1979 |
96-48-0 |
ZDHHC7 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ZDHHC7 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1980 |
96-48-0 |
ZDHHC7 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ZDHHC7 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1981 |
96-48-0 |
ZFAND2A |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ZFAND2A mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1982 |
96-48-0 |
ZFAND2A |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ZFAND2A mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1983 |
96-48-0 |
ZFYVE1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ZFYVE1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1984 |
96-48-0 |
ZFYVE1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ZFYVE1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1985 |
96-48-0 |
ZKSCAN1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ZKSCAN1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1986 |
96-48-0 |
ZKSCAN1 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ZKSCAN1 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1987 |
96-48-0 |
ZMYM5 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ZMYM5 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1988 |
96-48-0 |
ZMYM5 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ZMYM5 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1989 |
96-48-0 |
ZNF160 |
Homo sapiens |
2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of ZNF160 mRNA |
decreases^expression |
19167446 |
1990 |
96-48-0 |
ZNF160 |
Homo sapiens |
2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of ZNF160 mRNA |
decreases^expression |
19167446 |
1991 |
96-48-0 |
ZNF277 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ZNF277 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1992 |
96-48-0 |
ZNF277 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ZNF277 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1993 |
96-48-0 |
ZNF292 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ZNF292 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1994 |
96-48-0 |
ZNF292 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ZNF292 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1995 |
96-48-0 |
ZNF354A |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ZNF354A mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1996 |
96-48-0 |
ZNF354A |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ZNF354A mRNA |
affects^cotreatment|decreases^expression |
19167446 |
1997 |
96-48-0 |
ZNF367 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ZNF367 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1998 |
96-48-0 |
ZNF367 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ZNF367 mRNA |
affects^cotreatment|increases^expression |
19167446 |
1999 |
96-48-0 |
ZNF467 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ZNF467 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
2000 |
96-48-0 |
ZNF467 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ZNF467 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
2001 |
96-48-0 |
ZNF641 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ZNF641 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
2002 |
96-48-0 |
ZNF641 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ZNF641 mRNA |
affects^cotreatment|decreases^expression |
19167446 |
2003 |
96-48-0 |
ZNF703 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ZNF703 mRNA |
affects^cotreatment|increases^expression |
19167446 |
2004 |
96-48-0 |
ZNF703 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ZNF703 mRNA |
affects^cotreatment|increases^expression |
19167446 |
2005 |
96-48-0 |
ZNF718 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ZNF718 mRNA |
affects^cotreatment|increases^expression |
19167446 |
2006 |
96-48-0 |
ZNF718 |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ZNF718 mRNA |
affects^cotreatment|increases^expression |
19167446 |
2007 |
96-48-0 |
ZWILCH |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ZWILCH mRNA |
affects^cotreatment|increases^expression |
19167446 |
2008 |
96-48-0 |
ZWILCH |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ZWILCH mRNA |
affects^cotreatment|increases^expression |
19167446 |
2009 |
96-48-0 |
ZWINT |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ZWINT mRNA |
affects^cotreatment|increases^expression |
19167446 |
2010 |
96-48-0 |
ZWINT |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ZWINT mRNA |
affects^cotreatment|increases^expression |
19167446 |
2011 |
96-48-0 |
ZXDB |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ZXDB mRNA |
affects^cotreatment|decreases^expression |
19167446 |
2012 |
96-48-0 |
ZXDB |
Homo sapiens |
[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ZXDB mRNA |
affects^cotreatment|decreases^expression |
19167446 |
2013 |
96-48-0 |
FGF2 |
|
3-benzyl-5-((2-nitrophenoxy)methyl)dihydrofuran-2(3H)-one affects the susceptibility to FGF2 protein |
affects^response to substance |
19199859 |
2014 |
96-48-0 |
FGF2 |
|
3-benzyl-5-((2-nitrophenoxy)methyl)dihydrofuran-2(3H)-one affects the susceptibility to FGF2 protein |
affects^response to substance |
19199859 |
2015 |
96-48-0 |
ATG5 |
Homo sapiens |
4-acetylantroquinonol B results in decreased expression of ATG5 protein |
decreases^expression |
28408137 |
2016 |
96-48-0 |
ATG5 |
Homo sapiens |
4-acetylantroquinonol B results in decreased expression of ATG5 protein |
decreases^expression |
28408137 |
2017 |
96-48-0 |
ATG7 |
Homo sapiens |
4-acetylantroquinonol B results in decreased expression of ATG7 protein |
decreases^expression |
28408137 |
2018 |
96-48-0 |
ATG7 |
Homo sapiens |
4-acetylantroquinonol B results in decreased expression of ATG7 protein |
decreases^expression |
28408137 |
2019 |
96-48-0 |
CTNNB1 |
Homo sapiens |
4-acetylantroquinonol B results in decreased expression of CTNNB1 mRNA |
decreases^expression |
26235807 |
2020 |
96-48-0 |
CTNNB1 |
Homo sapiens |
4-acetylantroquinonol B results in decreased expression of CTNNB1 mRNA |
decreases^expression |
26235807 |
2021 |
96-48-0 |
EZH2 |
Homo sapiens |
4-acetylantroquinonol B results in decreased expression of EZH2 protein |
decreases^expression |
26235807 |
2022 |
96-48-0 |
EZH2 |
Homo sapiens |
4-acetylantroquinonol B results in decreased expression of EZH2 protein |
decreases^expression |
26235807 |
2023 |
96-48-0 |
JAK2 |
Homo sapiens |
4-acetylantroquinonol B results in decreased expression of JAK2 protein |
decreases^expression |
26235807 |
2024 |
96-48-0 |
JAK2 |
Homo sapiens |
4-acetylantroquinonol B results in decreased expression of JAK2 protein |
decreases^expression |
26235807 |
2025 |
96-48-0 |
JAK2 |
Homo sapiens |
4-acetylantroquinonol B results in decreased expression of JAK2 protein modified form |
decreases^expression |
26235807 |
2026 |
96-48-0 |
JAK2 |
Homo sapiens |
4-acetylantroquinonol B results in decreased expression of JAK2 protein modified form |
decreases^expression |
26235807 |
2027 |
96-48-0 |
LGR5 |
Homo sapiens |
4-acetylantroquinonol B results in decreased expression of LGR5 mRNA |
decreases^expression |
26235807 |
2028 |
96-48-0 |
LGR5 |
Homo sapiens |
4-acetylantroquinonol B results in decreased expression of LGR5 mRNA |
decreases^expression |
26235807 |
2029 |
96-48-0 |
LGR5 |
Homo sapiens |
4-acetylantroquinonol B results in decreased expression of LGR5 protein |
decreases^expression |
26235807 |
2030 |
96-48-0 |
LGR5 |
Homo sapiens |
4-acetylantroquinonol B results in decreased expression of LGR5 protein |
decreases^expression |
26235807 |
2031 |
96-48-0 |
NANOG |
Homo sapiens |
4-acetylantroquinonol B results in decreased expression of NANOG protein |
decreases^expression |
26235807 |
2032 |
96-48-0 |
NANOG |
Homo sapiens |
4-acetylantroquinonol B results in decreased expression of NANOG protein |
decreases^expression |
26235807 |
2033 |
96-48-0 |
SMO |
Homo sapiens |
4-acetylantroquinonol B results in decreased expression of SMO mRNA |
decreases^expression |
26235807 |
2034 |
96-48-0 |
SMO |
Homo sapiens |
4-acetylantroquinonol B results in decreased expression of SMO mRNA |
decreases^expression |
26235807 |
2035 |
96-48-0 |
SOX2 |
Homo sapiens |
4-acetylantroquinonol B results in decreased expression of SOX2 mRNA |
decreases^expression |
26235807 |
2036 |
96-48-0 |
SOX2 |
Homo sapiens |
4-acetylantroquinonol B results in decreased expression of SOX2 mRNA |
decreases^expression |
26235807 |
2037 |
96-48-0 |
SUZ12 |
Homo sapiens |
4-acetylantroquinonol B results in decreased expression of SUZ12 protein |
decreases^expression |
26235807 |
2038 |
96-48-0 |
SUZ12 |
Homo sapiens |
4-acetylantroquinonol B results in decreased expression of SUZ12 protein |
decreases^expression |
26235807 |
2039 |
96-48-0 |
TYK2 |
Homo sapiens |
4-acetylantroquinonol B results in decreased expression of TYK2 protein |
decreases^expression |
26235807 |
2040 |
96-48-0 |
TYK2 |
Homo sapiens |
4-acetylantroquinonol B results in decreased expression of TYK2 protein |
decreases^expression |
26235807 |
2041 |
96-48-0 |
HPGDS |
Mus musculus |
[Selenium deficiency co-treated with 4-(benzo(b)thiophen-2-yl)-3-bromo-5-hydroxydihydrofuran-2(3H)-one co-treated with Lipopolysaccharides] results in increased expression of HPGDS mRNA |
affects^cotreatment|increases^expression |
21669866 |
2042 |
96-48-0 |
HPGDS |
Mus musculus |
[Selenium deficiency co-treated with 4-(benzo(b)thiophen-2-yl)-3-bromo-5-hydroxydihydrofuran-2(3H)-one co-treated with Lipopolysaccharides] results in increased expression of HPGDS mRNA |
affects^cotreatment|increases^expression |
21669866 |
2043 |
96-48-0 |
HPGDS |
Mus musculus |
[Selenium deficiency co-treated with 4-(benzo(b)thiophen-2-yl)-3-bromo-5-hydroxydihydrofuran-2(3H)-one co-treated with Lipopolysaccharides] results in increased expression of HPGDS protein |
affects^cotreatment|increases^expression |
21669866 |
2044 |
96-48-0 |
HPGDS |
Mus musculus |
[Selenium deficiency co-treated with 4-(benzo(b)thiophen-2-yl)-3-bromo-5-hydroxydihydrofuran-2(3H)-one co-treated with Lipopolysaccharides] results in increased expression of HPGDS protein |
affects^cotreatment|increases^expression |
21669866 |
2045 |
96-48-0 |
BIRC2 |
Homo sapiens |
4-methylene-2-octyl-5-oxofuran-3-carboxylic acid results in decreased expression of BIRC2 protein |
decreases^expression |
21442130 |
2046 |
96-48-0 |
BIRC2 |
Homo sapiens |
4-methylene-2-octyl-5-oxofuran-3-carboxylic acid results in decreased expression of BIRC2 protein |
decreases^expression |
21442130 |
2047 |
96-48-0 |
BIRC3 |
Homo sapiens |
4-methylene-2-octyl-5-oxofuran-3-carboxylic acid results in decreased expression of BIRC3 protein |
decreases^expression |
21442130 |
2048 |
96-48-0 |
BIRC3 |
Homo sapiens |
4-methylene-2-octyl-5-oxofuran-3-carboxylic acid results in decreased expression of BIRC3 protein |
decreases^expression |
21442130 |
2049 |
96-48-0 |
CASP3 |
Homo sapiens |
[4-methylene-2-octyl-5-oxofuran-3-carboxylic acid co-treated with Cisplatin] results in increased cleavage of and results in decreased expression of CASP3 protein |
affects^cotreatment|decreases^expression|increases^cleavage |
21442130 |
2050 |
96-48-0 |
CASP3 |
Homo sapiens |
[4-methylene-2-octyl-5-oxofuran-3-carboxylic acid co-treated with Cisplatin] results in increased cleavage of and results in decreased expression of CASP3 protein |
affects^cotreatment|decreases^expression|increases^cleavage |
21442130 |
2051 |
96-48-0 |
CASP3 |
Homo sapiens |
[4-methylene-2-octyl-5-oxofuran-3-carboxylic acid co-treated with Cisplatin] results in increased cleavage of and results in increased activity of CASP3 protein |
affects^cotreatment|increases^activity|increases^cleavage |
21442130 |
2052 |
96-48-0 |
CASP3 |
Homo sapiens |
[4-methylene-2-octyl-5-oxofuran-3-carboxylic acid co-treated with Cisplatin] results in increased cleavage of and results in increased activity of CASP3 protein |
affects^cotreatment|increases^activity|increases^cleavage |
21442130 |
2053 |
96-48-0 |
CASP3 |
Homo sapiens |
4-methylene-2-octyl-5-oxofuran-3-carboxylic acid results in increased cleavage of and results in increased activity of CASP3 protein |
increases^activity|increases^cleavage |
21442130 |
2054 |
96-48-0 |
CASP3 |
Homo sapiens |
4-methylene-2-octyl-5-oxofuran-3-carboxylic acid results in increased cleavage of and results in increased activity of CASP3 protein |
increases^activity|increases^cleavage |
21442130 |
2055 |
96-48-0 |
CASP9 |
Homo sapiens |
[4-methylene-2-octyl-5-oxofuran-3-carboxylic acid co-treated with Cisplatin] results in increased activity of CASP9 protein |
affects^cotreatment|increases^activity |
21442130 |
2056 |
96-48-0 |
CASP9 |
Homo sapiens |
[4-methylene-2-octyl-5-oxofuran-3-carboxylic acid co-treated with Cisplatin] results in increased activity of CASP9 protein |
affects^cotreatment|increases^activity |
21442130 |
2057 |
96-48-0 |
CASP9 |
Homo sapiens |
4-methylene-2-octyl-5-oxofuran-3-carboxylic acid results in increased activity of CASP9 protein |
increases^activity |
21442130 |
2058 |
96-48-0 |
CASP9 |
Homo sapiens |
4-methylene-2-octyl-5-oxofuran-3-carboxylic acid results in increased activity of CASP9 protein |
increases^activity |
21442130 |
2059 |
96-48-0 |
CEBPA |
Mus musculus |
4-methylene-2-octyl-5-oxofuran-3-carboxylic acid results in decreased expression of CEBPA mRNA |
decreases^expression |
15707987 |
2060 |
96-48-0 |
CEBPA |
Mus musculus |
4-methylene-2-octyl-5-oxofuran-3-carboxylic acid results in decreased expression of CEBPA mRNA |
decreases^expression |
15707987 |
2061 |
96-48-0 |
DDIT3 |
Homo sapiens |
4-methylene-2-octyl-5-oxofuran-3-carboxylic acid results in increased expression of DDIT3 mRNA |
increases^expression |
17283163 |
2062 |
96-48-0 |
DDIT3 |
Homo sapiens |
4-methylene-2-octyl-5-oxofuran-3-carboxylic acid results in increased expression of DDIT3 mRNA |
increases^expression |
17283163 |
2063 |
96-48-0 |
FASN |
Homo sapiens |
4-methylene-2-octyl-5-oxofuran-3-carboxylic acid binds to and results in decreased activity of FASN protein |
affects^binding|decreases^activity |
17847090 |
2064 |
96-48-0 |
FASN |
Homo sapiens |
4-methylene-2-octyl-5-oxofuran-3-carboxylic acid binds to and results in decreased activity of FASN protein |
affects^binding|decreases^activity |
17847090 |
2065 |
96-48-0 |
FASN |
Homo sapiens |
[4-methylene-2-octyl-5-oxofuran-3-carboxylic acid co-treated with Cisplatin] results in decreased expression of FASN protein |
affects^cotreatment|decreases^expression |
21442130 |
2066 |
96-48-0 |
FASN |
Homo sapiens |
[4-methylene-2-octyl-5-oxofuran-3-carboxylic acid co-treated with Cisplatin] results in decreased expression of FASN protein |
affects^cotreatment|decreases^expression |
21442130 |
2067 |
96-48-0 |
FASN |
Homo sapiens |
4-methylene-2-octyl-5-oxofuran-3-carboxylic acid results in decreased activity of FASN protein |
decreases^activity |
21442130 |
2068 |
96-48-0 |
FASN |
Homo sapiens |
4-methylene-2-octyl-5-oxofuran-3-carboxylic acid results in decreased activity of FASN protein |
decreases^activity |
21442130 |
2069 |
96-48-0 |
FASN |
Homo sapiens |
[4-methylene-2-octyl-5-oxofuran-3-carboxylic acid results in decreased activity of FASN protein] which results in increased susceptibility to Cisplatin |
decreases^activity|increases^response to substance |
21442130 |
2070 |
96-48-0 |
FASN |
Homo sapiens |
[4-methylene-2-octyl-5-oxofuran-3-carboxylic acid results in decreased activity of FASN protein] which results in increased susceptibility to Cisplatin |
decreases^activity|increases^response to substance |
21442130 |
2071 |
96-48-0 |
FASN |
Mus musculus |
4-methylene-2-octyl-5-oxofuran-3-carboxylic acid results in decreased expression of FASN mRNA |
decreases^expression |
15707987 |
2072 |
96-48-0 |
FASN |
Mus musculus |
4-methylene-2-octyl-5-oxofuran-3-carboxylic acid results in decreased expression of FASN mRNA |
decreases^expression |
15707987 |
2073 |
96-48-0 |
FOS |
Mus musculus |
4-methylene-2-octyl-5-oxofuran-3-carboxylic acid affects the expression of FOS protein |
affects^expression |
12724522 |
2074 |
96-48-0 |
FOS |
Mus musculus |
4-methylene-2-octyl-5-oxofuran-3-carboxylic acid affects the expression of FOS protein |
affects^expression |
12724522 |
2075 |
96-48-0 |
MET |
Homo sapiens |
4-methylene-2-octyl-5-oxofuran-3-carboxylic acid results in decreased expression of MET protein |
decreases^expression |
25971889 |
2076 |
96-48-0 |
MET |
Homo sapiens |
4-methylene-2-octyl-5-oxofuran-3-carboxylic acid results in decreased expression of MET protein |
decreases^expression |
25971889 |
2077 |
96-48-0 |
PPARG |
Mus musculus |
4-methylene-2-octyl-5-oxofuran-3-carboxylic acid results in decreased expression of PPARG mRNA |
decreases^expression |
15707987 |
2078 |
96-48-0 |
PPARG |
Mus musculus |
4-methylene-2-octyl-5-oxofuran-3-carboxylic acid results in decreased expression of PPARG mRNA |
decreases^expression |
15707987 |
2079 |
96-48-0 |
PPP1R15A |
Homo sapiens |
[4-methylene-2-octyl-5-oxofuran-3-carboxylic acid co-treated with Thapsigargin] results in increased expression of PPP1R15A mRNA |
affects^cotreatment|increases^expression |
17283163 |
2080 |
96-48-0 |
PPP1R15A |
Homo sapiens |
[4-methylene-2-octyl-5-oxofuran-3-carboxylic acid co-treated with Thapsigargin] results in increased expression of PPP1R15A mRNA |
affects^cotreatment|increases^expression |
17283163 |
2081 |
96-48-0 |
TOP2A |
Homo sapiens |
4-methylene-2-octyl-5-oxofuran-3-carboxylic acid results in decreased expression of TOP2A protein |
decreases^expression |
17089011 |
2082 |
96-48-0 |
TOP2A |
Homo sapiens |
4-methylene-2-octyl-5-oxofuran-3-carboxylic acid results in decreased expression of TOP2A protein |
decreases^expression |
17089011 |
2083 |
96-48-0 |
XIAP |
Homo sapiens |
4-methylene-2-octyl-5-oxofuran-3-carboxylic acid results in decreased expression of XIAP protein |
decreases^expression |
21442130 |
2084 |
96-48-0 |
XIAP |
Homo sapiens |
4-methylene-2-octyl-5-oxofuran-3-carboxylic acid results in decreased expression of XIAP protein |
decreases^expression |
21442130 |
2085 |
96-48-0 |
GSTA1 |
Mus musculus |
angelica lactone results in increased expression of GSTA1 protein |
increases^expression |
11309284 |
2086 |
96-48-0 |
GSTA1 |
Mus musculus |
angelica lactone results in increased expression of GSTA1 protein |
increases^expression |
11309284 |
2087 |
96-48-0 |
GSTA2 |
Mus musculus |
angelica lactone results in increased expression of GSTA2 protein |
increases^expression |
11309284 |
2088 |
96-48-0 |
GSTA2 |
Mus musculus |
angelica lactone results in increased expression of GSTA2 protein |
increases^expression |
11309284 |
2089 |
96-48-0 |
GSTA3 |
Mus musculus |
angelica lactone results in increased expression of GSTA3 protein |
increases^expression |
11309284 |
2090 |
96-48-0 |
GSTA3 |
Mus musculus |
angelica lactone results in increased expression of GSTA3 protein |
increases^expression |
11309284 |
2091 |
96-48-0 |
GSTA4 |
Mus musculus |
angelica lactone results in increased expression of GSTA4 protein |
increases^expression |
11309284 |
2092 |
96-48-0 |
GSTA4 |
Mus musculus |
angelica lactone results in increased expression of GSTA4 protein |
increases^expression |
11309284 |
2093 |
96-48-0 |
GSTM1 |
Mus musculus |
angelica lactone results in increased expression of GSTM1 protein |
increases^expression |
11309284 |
2094 |
96-48-0 |
GSTM1 |
Mus musculus |
angelica lactone results in increased expression of GSTM1 protein |
increases^expression |
11309284 |
2095 |
96-48-0 |
GSTM5 |
Mus musculus |
angelica lactone results in increased expression of GSTM5 protein |
increases^expression |
11309284 |
2096 |
96-48-0 |
GSTM5 |
Mus musculus |
angelica lactone results in increased expression of GSTM5 protein |
increases^expression |
11309284 |
2097 |
96-48-0 |
GSTP1 |
Mus musculus |
angelica lactone results in increased expression of GSTP1 protein |
increases^expression |
11309284 |
2098 |
96-48-0 |
GSTP1 |
Mus musculus |
angelica lactone results in increased expression of GSTP1 protein |
increases^expression |
11309284 |
2099 |
96-48-0 |
GSTP2 |
Mus musculus |
angelica lactone results in increased expression of GSTP2 protein |
increases^expression |
11309284 |
2100 |
96-48-0 |
GSTP2 |
Mus musculus |
angelica lactone results in increased expression of GSTP2 protein |
increases^expression |
11309284 |
2101 |
96-48-0 |
GSTT1 |
Rattus norvegicus |
angelica lactone results in increased expression of GSTT1 protein |
increases^expression |
9855024 |
2102 |
96-48-0 |
GSTT1 |
Rattus norvegicus |
angelica lactone results in increased expression of GSTT1 protein |
increases^expression |
9855024 |
2103 |
96-48-0 |
NFE2L2 |
Mus musculus |
angelica lactone affects the activity of NFE2L2 protein |
affects^activity |
11309284 |
2104 |
96-48-0 |
NFE2L2 |
Mus musculus |
angelica lactone affects the activity of NFE2L2 protein |
affects^activity |
11309284 |
2105 |
96-48-0 |
NQO1 |
Mus musculus |
angelica lactone results in increased expression of NQO1 protein |
increases^expression |
11309284 |
2106 |
96-48-0 |
NQO1 |
Mus musculus |
angelica lactone results in increased expression of NQO1 protein |
increases^expression |
11309284 |
2107 |
96-48-0 |
NOS2 |
Mus musculus |
cacospongionolide B inhibits the reaction [Zymosan results in increased expression of NOS2 protein] |
decreases^reaction|increases^expression |
12721113 |
2108 |
96-48-0 |
NOS2 |
Mus musculus |
cacospongionolide B inhibits the reaction [Zymosan results in increased expression of NOS2 protein] |
decreases^reaction|increases^expression |
12721113 |
2109 |
96-48-0 |
PTGS2 |
Mus musculus |
cacospongionolide B inhibits the reaction [Zymosan results in increased expression of PTGS2 protein] |
decreases^reaction|increases^expression |
12721113 |
2110 |
96-48-0 |
PTGS2 |
Mus musculus |
cacospongionolide B inhibits the reaction [Zymosan results in increased expression of PTGS2 protein] |
decreases^reaction|increases^expression |
12721113 |
2111 |
96-48-0 |
TNF |
Homo sapiens |
cacospongionolide B inhibits the reaction [Zymosan results in increased expression of TNF protein] |
decreases^reaction|increases^expression |
12721113 |
2112 |
96-48-0 |
TNF |
Homo sapiens |
cacospongionolide B inhibits the reaction [Zymosan results in increased expression of TNF protein] |
decreases^reaction|increases^expression |
12721113 |
2113 |
96-48-0 |
TNF |
Mus musculus |
cacospongionolide B inhibits the reaction [Zymosan results in increased expression of TNF mRNA] |
decreases^reaction|increases^expression |
12721113 |
2114 |
96-48-0 |
TNF |
Mus musculus |
cacospongionolide B inhibits the reaction [Zymosan results in increased expression of TNF mRNA] |
decreases^reaction|increases^expression |
12721113 |
2115 |
96-48-0 |
PTGS2 |
Rattus norvegicus |
L 748706 results in decreased activity of PTGS2 protein |
decreases^activity |
15878914 |
2116 |
96-48-0 |
PTGS2 |
Rattus norvegicus |
L 748706 results in decreased activity of PTGS2 protein |
decreases^activity |
15878914 |
2117 |
96-48-0 |
PTGS2 |
Rattus norvegicus |
Piroxicam promotes the reaction [L 748706 results in decreased activity of PTGS2 protein] |
decreases^activity|increases^reaction |
15878914 |
2118 |
96-48-0 |
PTGS2 |
Rattus norvegicus |
Piroxicam promotes the reaction [L 748706 results in decreased activity of PTGS2 protein] |
decreases^activity|increases^reaction |
15878914 |
2119 |
96-48-0 |
APP |
Mus musculus |
ligustilide results in decreased expression of APP protein |
decreases^expression |
23973442 |
2120 |
96-48-0 |
APP |
Mus musculus |
ligustilide results in decreased expression of APP protein |
decreases^expression |
23973442 |
2121 |
96-48-0 |
CAT |
Mus musculus |
ligustilide results in increased expression of and results in increased activity of CAT protein |
increases^activity|increases^expression |
23973442 |
2122 |
96-48-0 |
CAT |
Mus musculus |
ligustilide results in increased expression of and results in increased activity of CAT protein |
increases^activity|increases^expression |
23973442 |
2123 |
96-48-0 |
CYP3A4 |
Homo sapiens |
[ligustilide results in increased activity of NR1I2 protein] which results in increased expression of CYP3A4 mRNA |
increases^activity|increases^expression |
21524698 |
2124 |
96-48-0 |
CYP3A4 |
Homo sapiens |
[ligustilide results in increased activity of NR1I2 protein] which results in increased expression of CYP3A4 mRNA |
increases^activity|increases^expression |
21524698 |
2125 |
96-48-0 |
HMOX1 |
Mus musculus |
ligustilide results in increased expression of HMOX1 mRNA |
increases^expression |
23441843 |
2126 |
96-48-0 |
HMOX1 |
Mus musculus |
ligustilide results in increased expression of HMOX1 mRNA |
increases^expression |
23441843 |
2127 |
96-48-0 |
HMOX1 |
Mus musculus |
ligustilide results in increased expression of HMOX1 protein |
increases^expression |
23441843 |
2128 |
96-48-0 |
HMOX1 |
Mus musculus |
ligustilide results in increased expression of HMOX1 protein |
increases^expression |
23441843 |
2129 |
96-48-0 |
KL |
Homo sapiens |
ligustilide results in increased expression of KL mRNA |
increases^expression |
23973442 |
2130 |
96-48-0 |
KL |
Homo sapiens |
ligustilide results in increased expression of KL mRNA |
increases^expression |
23973442 |
2131 |
96-48-0 |
KL |
Homo sapiens |
ligustilide results in increased expression of KL protein |
increases^expression |
23973442 |
2132 |
96-48-0 |
KL |
Homo sapiens |
ligustilide results in increased expression of KL protein |
increases^expression |
23973442 |
2133 |
96-48-0 |
NQO1 |
Mus musculus |
ligustilide results in increased expression of NQO1 mRNA |
increases^expression |
23441843 |
2134 |
96-48-0 |
NQO1 |
Mus musculus |
ligustilide results in increased expression of NQO1 mRNA |
increases^expression |
23441843 |
2135 |
96-48-0 |
NQO1 |
Mus musculus |
ligustilide results in increased expression of NQO1 protein |
increases^expression |
23441843 |
2136 |
96-48-0 |
NQO1 |
Mus musculus |
ligustilide results in increased expression of NQO1 protein |
increases^expression |
23441843 |
2137 |
96-48-0 |
NR1I2 |
Homo sapiens |
ligustilide results in increased activity of NR1I2 protein |
increases^activity |
21524698 |
2138 |
96-48-0 |
NR1I2 |
Homo sapiens |
ligustilide results in increased activity of NR1I2 protein |
increases^activity |
21524698 |
2139 |
96-48-0 |
SOD2 |
Mus musculus |
ligustilide results in increased expression of and results in increased activity of SOD2 protein |
increases^activity|increases^expression |
23973442 |
2140 |
96-48-0 |
SOD2 |
Mus musculus |
ligustilide results in increased expression of and results in increased activity of SOD2 protein |
increases^activity|increases^expression |
23973442 |
2141 |
96-48-0 |
UGT1A1 |
Mus musculus |
ligustilide results in increased expression of UGT1A1 protein |
increases^expression |
23441843 |
2142 |
96-48-0 |
UGT1A1 |
Mus musculus |
ligustilide results in increased expression of UGT1A1 protein |
increases^expression |
23441843 |
2143 |
96-48-0 |
ALB |
Bos taurus |
methyl 2-(7-hydroxy-2-oxonaphtho(1,2-b)furan-3(2H)-yliden)acetate binds to and affects the folding of ALB protein |
affects^binding|affects^folding |
22074127 |
2144 |
96-48-0 |
ALB |
Bos taurus |
methyl 2-(7-hydroxy-2-oxonaphtho(1,2-b)furan-3(2H)-yliden)acetate binds to and affects the folding of ALB protein |
affects^binding|affects^folding |
22074127 |
2145 |
96-48-0 |
CASP3 |
Mus musculus |
N-(3-oxododecanoyl)homoserine lactone results in increased activity of CASP3 protein |
increases^activity |
25627690 |
2146 |
96-48-0 |
CASP3 |
Mus musculus |
N-(3-oxododecanoyl)homoserine lactone results in increased activity of CASP3 protein |
increases^activity |
25627690 |
2147 |
96-48-0 |
CASP7 |
Mus musculus |
N-(3-oxododecanoyl)homoserine lactone results in increased activity of CASP7 protein |
increases^activity |
25627690 |
2148 |
96-48-0 |
CASP7 |
Mus musculus |
N-(3-oxododecanoyl)homoserine lactone results in increased activity of CASP7 protein |
increases^activity |
25627690 |
2149 |
96-48-0 |
P2RY2 |
Homo sapiens |
Ibuprofen inhibits the reaction [N-(3-oxododecanoyl)homoserine lactone results in decreased expression of P2RY2 mRNA] |
decreases^expression|decreases^reaction |
10496880 |
2150 |
96-48-0 |
P2RY2 |
Homo sapiens |
Ibuprofen inhibits the reaction [N-(3-oxododecanoyl)homoserine lactone results in decreased expression of P2RY2 mRNA] |
decreases^expression|decreases^reaction |
10496880 |
2151 |
96-48-0 |
P2RY2 |
Homo sapiens |
N-(3-oxododecanoyl)homoserine lactone results in decreased expression of P2RY2 mRNA |
decreases^expression |
10496880 |
2152 |
96-48-0 |
P2RY2 |
Homo sapiens |
N-(3-oxododecanoyl)homoserine lactone results in decreased expression of P2RY2 mRNA |
decreases^expression |
10496880 |
2153 |
96-48-0 |
P2RY4 |
Homo sapiens |
N-(3-oxododecanoyl)homoserine lactone results in decreased expression of P2RY4 mRNA |
decreases^expression |
10496880 |
2154 |
96-48-0 |
P2RY4 |
Homo sapiens |
N-(3-oxododecanoyl)homoserine lactone results in decreased expression of P2RY4 mRNA |
decreases^expression |
10496880 |
2155 |
96-48-0 |
PON2 |
Homo sapiens |
PON2 protein results in increased susceptibility to N-(3-oxododecanoyl)homoserine lactone |
increases^response to substance |
25627690 |
2156 |
96-48-0 |
PON2 |
Homo sapiens |
PON2 protein results in increased susceptibility to N-(3-oxododecanoyl)homoserine lactone |
increases^response to substance |
25627690 |
2157 |
96-48-0 |
P2RY2 |
Homo sapiens |
N-butyrylhomoserine lactone results in decreased expression of P2RY2 mRNA |
decreases^expression |
10496880 |
2158 |
96-48-0 |
P2RY2 |
Homo sapiens |
N-butyrylhomoserine lactone results in decreased expression of P2RY2 mRNA |
decreases^expression |
10496880 |
2159 |
96-48-0 |
P2RY4 |
Homo sapiens |
N-butyrylhomoserine lactone results in decreased expression of P2RY4 mRNA |
decreases^expression |
10496880 |
2160 |
96-48-0 |
P2RY4 |
Homo sapiens |
N-butyrylhomoserine lactone results in decreased expression of P2RY4 mRNA |
decreases^expression |
10496880 |
2161 |
96-48-0 |
BAX |
Homo sapiens |
protolichesterinic acid results in increased expression of BAX protein |
increases^expression |
22063921 |
2162 |
96-48-0 |
BAX |
Homo sapiens |
protolichesterinic acid results in increased expression of BAX protein |
increases^expression |
22063921 |
2163 |
96-48-0 |
BCL2 |
Homo sapiens |
protolichesterinic acid results in decreased expression of BCL2 protein |
decreases^expression |
22063921 |
2164 |
96-48-0 |
BCL2 |
Homo sapiens |
protolichesterinic acid results in decreased expression of BCL2 protein |
decreases^expression |
22063921 |
2165 |
96-48-0 |
CASP3 |
Homo sapiens |
protolichesterinic acid results in increased activity of CASP3 protein |
increases^activity |
22063921 |
2166 |
96-48-0 |
CASP3 |
Homo sapiens |
protolichesterinic acid results in increased activity of CASP3 protein |
increases^activity |
22063921 |
2167 |
96-48-0 |
HSPA1A |
Homo sapiens |
protolichesterinic acid results in decreased expression of HSPA1A protein |
decreases^expression |
22063921 |
2168 |
96-48-0 |
HSPA1A |
Homo sapiens |
protolichesterinic acid results in decreased expression of HSPA1A protein |
decreases^expression |
22063921 |
2169 |
96-48-0 |
NOS2 |
Homo sapiens |
protolichesterinic acid results in decreased expression of NOS2 protein |
decreases^expression |
22063921 |
2170 |
96-48-0 |
NOS2 |
Homo sapiens |
protolichesterinic acid results in decreased expression of NOS2 protein |
decreases^expression |
22063921 |
2171 |
96-48-0 |
TNFSF10 |
Homo sapiens |
protolichesterinic acid results in increased expression of TNFSF10 protein |
increases^expression |
22063921 |
2172 |
96-48-0 |
TNFSF10 |
Homo sapiens |
protolichesterinic acid results in increased expression of TNFSF10 protein |
increases^expression |
22063921 |
2173 |
96-48-0 |
CCL2 |
|
spirodiclofen results in decreased expression of CCL2 |
decreases^expression |
21788198 |
2174 |
96-48-0 |
CCL2 |
|
spirodiclofen results in decreased expression of CCL2 |
decreases^expression |
21788198 |
2175 |
96-48-0 |
CXCL10 |
|
spirodiclofen results in increased expression of CXCL10 |
increases^expression |
21788198 |
2176 |
96-48-0 |
CXCL10 |
|
spirodiclofen results in increased expression of CXCL10 |
increases^expression |
21788198 |
2177 |
96-48-0 |
SERPINE1 |
|
spirodiclofen affects the expression of SERPINE1 |
affects^expression |
21788198 |
2178 |
96-48-0 |
SERPINE1 |
|
spirodiclofen affects the expression of SERPINE1 |
affects^expression |
21788198 |
Serial No. | Activity Name | Details | References (PubMed) | Other details EPA (U.S) | Clinical Trials (U.S. NIH) |
---|
1 | | |
|
96-48-0 |
Butyro-1,4-lactone |